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Abstract 
 
The aim of this thesis is to understand the role played by a naturally occurring 
disulphide bridge on the bile acid (BA) binding and functional properties of cytosolic 
Liver Bile Acid Binding Protein (L-BABP). Bile acids circulate between liver and 
intestine through a mechanism defined as “enterohepatic circulation”, which is a tightly 
regulated process, particularly by BAs themselves. Indeed BAs are able to influence the 
expression of numerous genes involved in their synthesis and transport by binding to the 
primary intracellular nuclear bile acid receptor, farnesoid X receptor (FXR). 
Understanding the mechanism regulating the interactions of intracellular carriers with 
bile acid is a key step to provide a model for the transfer of BAs from cytoplasm to the 
nucleus and can be used to inspire design of therapeutic agents in the treatment of 
metabolic disorders, such as obesity, type 2 diabetes, hyperlipidaemia and 
atherosclerosis.  
To achieve a detailed molecular and dynamical description of the binding mechanism 
driving to the formation of the ternary complex of L-BABPs with two BA molecules, 
spectroscopic methods together with kinetic and thermodynamic analysis have been 
applied and implemented. In particular structural, dynamical and interaction properties 
of two forms of chicken L-BABP (cL-BABP), differing by the presence/absence of a 
naturally occurring disulphide bridge, have been investigated through nuclear magnetic 
resonance (NMR) approaches. The study of protein-ligand interactions by NMR was 
performed analysing complexes where, alternatively, either the protein or the ligand 
were isotopically labelled. 
15
N enriched glycocholic (GCA) and glycochenodeoxycholic 
acid (GCDA), two of the most important members of bile salts pool, were employed for 
protein titrations and their resonances followed through the acquisition and analysis of 
several NMR experiments (HSQC, DOSY). The obtained results shed light on binding 
stoichiometry and ligand exchange phenomena but were not sufficient to derive detailed 
information on affinity, cooperativity and binding mechanism. Thus NMR lineshape 
analysis as a function of ligand concentration was chosen as an appropriate tool to 
investigate the complex interaction mechanism within the cL-BABP/BA system. In this 
line, new NMR approaches have been recently described which allow a reliable and 
sensitive investigation of ligand binding events occurring on microsecond to 
millisecond (μs-ms) time scales using lineshape and relaxation dispersion 
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experiments[1]. Particularly, the combination of these NMR methods can be useful in 
the study of complex multi-step mechanisms, allowing the correlation between protein 
dynamics and function[2].  
15
N relaxation studies, performed on the apo-protein, revealed the presence of slow 
motions occurring on the microseconds-milliseconds timescale. The central question to 
be addressed is here whether these motions are essential for ligand uptake, how they can 
eventually lead to conformations competent for binding and how they are influenced by 
the presence of the disulfide bridge. 
The analysis of titration experiments of 
15
N labelled protein with unlabelled GCDA 
through lineshape analysis and relaxation dispersion allowed to define a multi-step 
binding mechanism for bile salt binding to liver BABPs and to provide an estimate of 
the kinetics involved. 
Summary of the work 
 
*As far as the nomenclature of the mentioned proteins is concerned, the protein with a disulphide bridge was initially 
referred to as cL-BABP T91C. This nomenclature has been recently corrected to L-BABP/S-S and L-BABP to 
underline the existence of both forms in chicken liver. 
 
Summary of the work 
 
The main question addressed in this thesis work is related to the identification of the 
role played by a disulphide bridge on the structural, dynamic and binding properties of 
cL-BABP/S-S*. 
To this aim the following steps had to be accomplished: 
Set up of the protocol for high yield expression and purification of cL-BABP/S-S 
(unlabelled, singly (
15
N) and doubly (
13
C, 
15
N) labelled samples): 
 Assignment of the backbone resonances of cL-BABP/S-S in its apo form, in 
homotypical complexes with chenodeoxycholic, glycochenodeoxycholic and cholic 
acids (CDA, GCDA, GCA) and in a heterotypical complex with both GCDA and GCA; 
 Study of the backbone dynamics of cL-BABP/S-S in its apo form, in homotypical 
complexes with CDA, GCDA, GCA and in a heterotypical complex with both GCDA 
and GCA, through measurement of 
15
N T1, T2 and 
1
H-
15
N Nuclear Overhauser Effects 
(NOE); 
 Study of the interaction mode of cL-BABP/S-S with bile acid glycoderivatives through 
NMR titration experiments, exploiting either protein or ligand observation; 
 Lineshape analysis simulations applied to a series of titration experiments for the 
identification of the kinetic parameters defying the binding mechanism; 
 Analysis of the relaxation dispersion data to investigate a “conformational selection” 
model of binding. 
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1. Introduction 
 
To better understand biological functions of bile acid transporters and the rules 
regulating their interactions within the cell, it is here briefly described the physiological 
context within which they are inserted. 
 
1.1 Enterohepatic circulation 
 
Liver hepatocytes metabolize cholesterol to cholic acid and chenodeoxycholic acid. 
These lipid-soluble bile acids are conjugated mainly to glycine or taurine molecules to 
form water soluble primary conjugated bile acids. After conjugation bile acids are 
secreted into the canalicular space between hepatocytes via two ATP-binding cassette 
transporters: bile acids export pump (BSEP), that carries monovalent bile acids[3] and 
multidrug resistance protein 2 (MRP2), that transports divalent sulfated or 
glucuronidated molecules[4]. Thus bile acids are secreted against steep concentration 
gradients in the gallbladder, together with cholesterol and phospholipids. The 
gallbladder stores about 50 ml of bile, which is released when food containing fat enters 
the digestive tract. Through the bile duct, bile acids reach the intestinal lumen, where 
they carry out their role in emulsifying dietary lipids. Some of the secreted bile acids 
undergo bacterial deconjugation in the distal small intestine and in the colon, becoming 
then membrane permeable. The transformation of bile acids by bacterial enzymes 
promotes passive absorption in the colon of those molecules escaping the active uptake 
that takes place in the ileum. If both mechanisms operate normally, only 1%-3% of the 
amount of bile acids secreted by the liver is ultimately excreted in faeces (deconjugated 
and otherwise transformed). While unconjugated bile acids may passively diffuse across 
the small intestinal and colonic epithelia, conjugated bile acids are actively absorbed in 
the distal ileum via the apical sodium-dependent bile acid transporter (ASBT), which 
imports bile acids coupled to Na
+
 absorption in a 1:2 stoichiometry[5]. Bile acids 
species are not equally transported by ASBT: conjugated (more hydrophilic) forms are 
preferred to unconjugated forms. This is physiologically consistent with the fact that 
deconjugation normally takes place in the colon. The affinity of ASBT is also higher for 
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dihydroxy (CDCA and DCA) than for trihydroxy (CA, taurocholic acid-TCA, 
glycocholic acid-GCA) bile acids[6]. Bile acids are believed to be transferred directly 
from ASBT to the ileal bile acid-binding protein (I-BABP) through the formation of a 
2:1 stoichiometric complex[7]. I-BABP is supposed to facilitate transport of bile acids 
within the enterocyte to the basolateral membrane. The basolateral efflux of bile acids 
from enterocytes into the portal vein is mediated by the organic solute transporter α and 
β (OSTα/OSTβ)[8]. Once in the portal vein, bile acids associate with albumin and reach 
the space of Disse through the large fenestrae of the liver sinusoids. After their 
dissociation from albumin, conjugated bile acids uptake into hepatocytes is mediated by 
Na
+
-taurocholate cotransporting polypeptide (NTCP), a basolateral sodium-dependent 
cotransporter that shares homology with ASBT[9], [10]. Uptake may also be mediated 
by one or more of the multiple sodium independent anion transporters belonging to the 
organic anion transporting polypeptide (OATP) family and by the microsomal epoxide 
hydrolase (mEH)[11], [12]. The mechanisms by which unconjugated bile acids enter the 
hepatocyte have not been clarified yet. Four possible mechanisms are likely: i) transport 
mediated by the fatty acid transport protein 5 (FATP5)[13]; ii) transport via NTCP, 
since at least one unconjugated bile acid (UDCA) has been shown to be a substrate for 
this carrier[14]; iii) transport via the multiple (sodium-independent) OATP carriers; iv) 
passive flipflop across the basolateral membrane[15]. Conjugated bile acids are also 
transported from the hepatocytes back into sinusoidal blood via the multidrug resistance 
proteins 3 and 4 (MRP3 and MRP4), that are cotransporters of bile acids and 
glutathione. There is thus uptake, regurgitation, and further uptake of bile acids as bile 
acids move down the sinusoid[16]. 
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A schematic representation of bile acids enterohepatic circulation is shown in Figure 
1.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Enterohepatic circulation of bile acids [12]. 
 
1.2 Bile Acids 
 
Bile acids are amphipathic steroidal compounds biosynthesized from the enzymatic 
catabolism of cholesterol in the liver, are stored in gallbladder and are the main 
components of bile. 
All primary bile acids appear to have three features in common: (i) they are the major 
end-products of cholesterol metabolism, (ii) they are secreted into the bile largely in a 
conjugated form, and (iii) these conjugates are membrane-impermeable, water-soluble, 
amphiphilic molecules having a powerful ability to transform lamellar arrays of lipids 
into mixed micelles[17], [18], [19], [20], [21]. The bile acid skeleton, illustrated in 
Figure 1.2, consists of a steroid body (nucleus) and a tail (side chain). Both parts of the 
bile acid molecule have a large number of possible polar substituents and conjugating 
groups may be present on the nucleus (e.g. sulphate, glucuronate, phosphate) or on the 
side chain (glycine, taurine or other amino acids, and even sugars). 
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Figure 1.2 Schematic representation of a bile acid molecule. The most common substituents for positions 
C-12, C-7, are reported in Table (R1 and R2). For position C-24 and C-3 the substituents are: R3 = Taurine 
(-NH-CH2-CH2-SO3H), glycine (-NH-CH2-CO2H), or hydrogen (H); R4 = Sulphuric acid (-HSO4), 
glucuronic acid (-C6H9O7) or hydrogen (H), respectively. 
 
Both bile acid chemistry and nomenclature are complex because of the great variety of 
chemical structures in naturally occurring compounds. The great number of different 
bile acids can be explained by the evolution of several biochemical pathways converting 
cholesterol, a poorly soluble membrane lipid, into conjugated bile acids, which are 
highly water-soluble molecules with amphipathic and membranolytic properties. 
Bile acids from different species chemically differ in three respects: (i) side-chain 
structure, (ii) stereochemistry of steroid rings fusion, and (iii) the distribution of 
number, position and stereochemistry of hydroxyl groups in the steroid nucleus. 
 
1.2.1 Bile acid biosynthesis 
 
Cholesterol degradation to bile acids in the liver can be initiated by either cholesterol 
7α-hydroxylase (CYP7A1) in the classic (neutral) pathway, or by mitochondrial sterol 
27-hydroxylase (CYP27A1) in the alternative (acidic or sterol 27-hydroxylase) 
pathway. In the classic pathway, modification of the sterol nucleus, including saturation 
of the double bond, epimerization of the 3β-hydroxyl group, and hydroxylation at the 7α 
and 12α- positions, precedes oxidative cleavage of the side chain. In the alternative 
pathway, side chain oxidation precedes steroid ring modification. While the classic 
pathway of bile acids biosynthesis is limited to hepatocytes, the alternative pathway 
exists in all tissues. 
 
 
 
 R1 R2 
Cholic Acid OH OH 
Chenodeoxycholic Acid H OH 
Deoxicholic acid OH H 
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In Figure 1.3 a schematic version of these complex metabolic pathways is reported. 
 
Figure 1.3 Bile acids biosynthetic pathways. Only major regulatory steps and enzymes are shown[22]. 
 
This biosynthesis is characterised by a number of complex steps involving modification 
in both the steroid nucleus and the side chain. In the first step, believed to be the rate 
limiting step, cholesterol is oxidized to 7-hydroxycholesterol by cholesterol 7-
hydroxylase. 7-hydroxycholesterol is then converted to the key intermediate cholest-
7-hydroxy-4-3-one through the action of an isomerase and a reductase. This 
unsaturated oxo derivative is the branching point for cholic (CA) and chenodeoxycholic 
acid (CDA) biosynthesis. Hydroxylation at C-12 leads to the formation of the cholic 
acid backbone. This oxo derivative is then stereoselectively reduced to afford the 5-
bile acid skeleton. The second key metabolic step, 27-hydroxylation followed by the 
formation of a C27 carboxylic acid, is believed to occur in the mitochondrion mediated 
by a P-450 hydroxylase. Then the oxidative cleavage of the side chain (C27 acid to C24 
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acid) mediated by peroxisomal enzymes affords the mature C24 bile acids. Bile acids 
are bio-transformed into glycine and taurine conjugates by the amidation reaction 
catalysed by an acyltransferase. 
The relative contribution of the classic and alternative pathways to overall bile acids 
synthesis is not clear. The classic pathway may be the main process under physiological 
conditions, whereas the alternative pathway may become the major biosynthetic 
pathway in patients with liver diseases[22]. 
 
1.2.2 Micelle formation  
 
In aqueous environments, bile salts aggregate to form micelles[23], [24], [25]. Bile 
acids perform almost all physiological functions in the form of mixed-micelles. Bile-salt 
micelles can solubilise cholesterol, lecithin, monoglycerides, etc., which are 
intrinsically water-insoluble[26]. The aqueous solubility of cholesterol (~1 nM) can 
increase more than a million fold in the presence of bile-salt micelles[27], [28]. The 
cholesterol solubilisation ability is far better with dihydroxy bile-salts (i.e.: 
chenodeoxycholate salt) than with trihydroxy bile-salts (i.e.: cholate salt). 
Bile acids are facially amphipathic, they contain both hydrophobic (lipid soluble) and 
hydrophilic (polar) faces. The rigid steroid backbone has polar hydroxyl groups on the 
concave -face and methyl groups on the convex -face, see Figure 1.4. 
 
 
 
 
 
 
 
 
 
Figure 1.4 Cartoon representation of the rigid steroic backbone of a bile acid introduced by Small[25]. 
 
This unique facial amphiphilicity of this class of molecules, enable them to aggregate in 
aqueous media in a manner different from conventional detergents. Aggregation of bile 
salts in aqueous solution is largely driven by the hydrophobic association of apolar -
faces of steroid backbones, while further aggregation occurs through hydrogen bonding 
interactions (Figure 1.5). Critical micellar concentrations (CMCs) of dihydroxy bile 
salts are typically below 5 mM, whereas trihydroxy bile salts have higher CMC ranging 
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from 10 to 15 mM. The higher CMC of trihydroxy bile salts is attributed to their higher 
solubility in water. The aggregation number of these bile-salt micelles ranges from 2 to 
10 for globular primary aggregates, which increases as a function of the bile-salt 
concentration (and added salt concentration) to form larger secondary aggregates. 
Emulsification of fat through mixed micelle formation is one of the significant 
properties of bile salts, enabling fat digestion and absorption through the intestinal 
wall[26]. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Cartoon representations of bile salt micelles (primary and secondary aggregation model) as introduced by Small[25]. 
 
1.3 Bile Acid Binding Proteins 
 
Liver basic Fatty Acid Binding Proteins (Lb-FABPs), more accurately described as 
Liver Bile Acid Binding Proteins (L-BABP)[29] are members of the intracellular Lipid 
Binding Proteins (iLBPs) family, involved in the transport and “enterohepatic 
circulation” of bile acids as well as in the regulation of cholesterol metabolism.  
FABPs have been classified and described on the basis of the organ that they were 
initially isolated from, but several instances are known in which more than one FABP 
type have been shown to be produced by a single tissue. A higher similarity of L-
FABPs from non mammalian species with mammalian Ileal Lipid-Binding Proteins (I-
LBPs) rather than with mammalian liver FABPs is reported[29]. In agreement with this 
observation, bile acid binding and transport are emerging as the specific function of the 
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liver non mammalian subfamily, hence called liver bile acid binding protein[30]. At 
variance, the paralogous proteins expressed in the same tissue but in mammals play a 
role in fatty acids binding and transport[31]. A multiple alignment of liver BABP, 
isolated from chicken liver, with ileal BABPs belonging to different species is reported 
in Figure 1.6  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 ClustalW multiple alignment of cL-BABP with ileal BABP sequences. For the ileal proteins 
only the name of the species is reported. cL-BABP residues involved in ligand binding are highlighted in 
bold[32]. 
 
Intracellular LBPs (iLBPs) are a family of phylogenetically related low molecular 
weight (14-15 kDa) proteins. Although various functions have been proposed for iLBPs, 
it is widely accepted that they bind to poorly water soluble ligands in the cytosol, 
thereby facilitating improved intracellular solubilization[33], [34]. Several classes of 
iLBPs have been isolated, including sterol carrier proteins, cellular retinol binding 
proteins (CRABPs), fatty acid binding proteins (FABPs)[35] and BABPs, all of which 
display similar secondary and tertiary structures. A common β-clam shell fold, formed 
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by two orthogonal antiparallel five stranded β-sheets, is capped by a helix-turn-helix 
motif at the N-terminal domain, defining the so-called protein “open-end”. The 
structures of apo and holo chicken L-BABP (cL-BABP) are reported in Figure 1.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7 Three-dimensional structures of cL-BABP in its apo form[29] (PDB ID: 1MVG) (panel a) and 
in complex with two molecules of chenodeoxycholic acid[36] (PDB ID: 2JN3) (panel b). 
 
BABPs are cytosolic lipid chaperones, which play central roles in driving bile flow, as 
well as in the adaptation to various pathological conditions, contributing to the 
maintenance of bile acid homeostasis and functional distribution within the cell. The 
understanding of the binding mode of bile acids with their cytoplasmic transporters is a 
key issue to provide a model for the mechanism of their transfer from cytoplasm to the 
nucleus.  
Recent studies have shown that bile acids not only serve as the physiological detergents 
that facilitate absorption, transport, and distribution of lipid-soluble vitamins and dietary 
fats but also are the signaling molecules that activate nuclear receptors and regulate bile 
acid and cholesterol metabolism. In addition, bile acids induce the cytochrome P450 3A 
family of cytochrome P450 enzymes, to detoxify bile acids, drugs and xenobiotics in the 
liver and intestine, induce hepatocyte apoptosis and activate the gene encoding a 
candidate bile acid transporter protein[37]. Given the important role of bile acids, the 
study of their transport at a molecular level is of special medical and pharmacological 
interest. In this line it is essential to gain insight into the three-dimensional structures 
a) b) 
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and dynamic behavior of the proteins involved in bile acid recycling, both in their free 
and complexed forms. 
 
1.4 Liver BABP and the role of disulphide bridges in 
intracellular proteins 
 
The present thesis work deals with an NMR investigation of the role played by a 
naturally occurring disulphide bridge on the ligand binding, dynamics and functional 
properties of L-BABP. To this purpose we performed a comparative study on two liver 
BABPs, with and devoid of a disulphide bridge, both identified in chicken liver. The 
formation of S-S bridge is one of the factors, together with the chemistry of the ligand 
and the protein plasticity, that has been suggested to modulate bile salts selectivity, 
stoichiometry and binding affinity in BABPs[38]. 
 
To better understand the role of the disulphide bridge in the protein under study, a brief 
summary of the structural characteristics and functions of disulphide bonds, occurring 
in proteins located in the reducing cytoplasmic milieu, is given. 
 
Disulphide bonds are known to play important role in proteins, ranging from folding to 
structure stability, to function. Not all the disulphide bonds in proteins are equally 
important and conserved. Indeed, small proteins with less than 70 residues, are often 
rich in disulphide bonds which are known to contribute critically to their stability[39], 
since they usually lack a strong hydrophobic core[40]. Proteins mainly characterized by 
-helices show least preference for disulphide bridges, probably because of the steric 
hindrances involved in the formation of disulphides between cysteines present in 
different helices or in the same helix. The repertoire of cysteine conformations suggests 
preferences in disulphide distribution within  sheets[41] and highlights their preference 
for stabilizing strands and loops (Figure 1.8).  
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Figure 1.8 Distribution of high, medium, and low conserved disulphide bonds in SCOP (database 
containing disulphide bridge classification in protein families)[42]. 
 
Richardson and Thornton defined backbone protein contexts that could not form 
disulfides between resident Cys residues without introduction of strain into the protein 
structure. With respect to secondary structure, disulfide bonds should not be found 
between Cys pairs: (a) on adjacent -strands[43], [44]; (b) in a single helix or 
strand[44]; or (c) on nonadjacent strands of the same -sheet[44]. Whenever disulphide 
bonds are found in these contexts they are referred to as forbidden disulfides, 
recognized as Cross-Strand Disulfide (CSD). These CSD are expected to have a 
functional, redox-related role rather than a structural role. 
An interesting example of a protein containing forbidden disulphide bridges, the so 
called -flip, is the retinol binding protein[45], a carrier protein that, in complex with 
transthyretin, transports vitamin A within the blood stream to target cells. 
Disulphide bonds are known to be present mainly in the extracellular proteins and rare 
in the cytoplasmic compartments of most organisms, due to the reductive nature of the 
cytosol[46], [47].  
The chemical environment inside a typical cell is reducing, with a reduction potential 
around −200 to −300 mV for Escherichia coli. As a result, cysteine residues in 
intracellular proteins are generally found in their reduced form with free sulfhydryl 
groups.  
However, although rare, there are examples of disulfide bonds in intracellular proteins. 
They are mainly found in proteins that catalyze oxidation-reduction (redox) processes. 
Among these there are members of thoiredoxin family, the thioredoxin and the 
glutathione reductase, in which a disulfide bond forms during the catalytic cycle. In 
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other systems such as Hsp33 and OxyR, the disulfide bond formation is part of a redox-
sensing mechanism[48, 49], [50]. 
These functionally important disulphide bonds are usually very highly conserved even if 
the family members share very low sequence identity. They are however rare and 
generally transiently formed or marginally stable. 
Several functional examples of disulphide bridges have been reported in the literature 
for members of the lipocalin family, where the introduction/removal of a disulphide 
bridge was responsible for changes in ligand binding stoichiometry and affinities.  
Reduction of a disulfide bond in human tear lipocalin has been reported to play a 
relevant functional role as it induces a nine-fold increase in ligand affinity[51]. The 
removal of a disulfide bond in rat lipocalin-type prostaglandin D synthase slightly 
increased the binding affinity for biological ligands, by effect of allowing a less 
compact barrel pocket and a higher number of residues contributing to ligand 
binding[52]. In the cellular retinoic acid binding protein I the introduction of a 
disulphide bond made the binding of the retinoic acid irreversible, as a result of the 
quenching of portal region structural mobility[53]. Most of liver BABPs belonging to 
the non-mammalian species show a disulphide bond involving the conserved Cys 80 
with the cysteine in position 91. The presence of a disulphide bridge in the protein 
scaffold of the homologous liver zebrafish BABP (69.8% of identity with chicken liver 
BABP, calculated with clustalW) was correlated with the exhibited binding 
stoichiometry[54] which varied from one to two ligand molecules, when the disulphide 
bridge Cys 80-Cys 91 was removed.  
In the case of cL-BABP, the two cystein residues forming the naturally occurring 
disulphide bridge, namely Cys 80 and Cys 91, belong to two adjacent antiparallel -
strands, in conflict with Richardson and Thornton‟s rules. What is here expected, for 
cL-BABP, is that the disulfide bridge and the -sheets around it are significantly 
distorted. For these reason the Cys pair in the protein under study does not seem to fit 
the paradigm of disulfides as structural stabilizer[32], [55], [29], [36], [30]. 
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2. Material and Methods 
 
2.1 Materials 
 
2.1.1 Chemicals 
 
All chemicals and reagents used were of analytical grade purity and, if not otherwise 
specified, were purchased from Sigma-Aldrich or Carlo Erba. 
15
N enriched ammonium 
chloride, 
13
C enriched glucose and D2O were purchased from Cambridge Isotope 
Laboratories. 
The DNA coding for cL-BABP, already cloned in the pET24d vector, has been 
originally provided by Dr. J. Foote (Fred Hutchinson Cancer Research, Seattle, USA).  
pET24d(+) (Novagen) is a 5.3 Kb expression vector based on the strong T7 promoter. 
Unlike T5, T7 promoter is recognized only by T7 RNA polymerase, therefore T7 
transcription/expression is induced by providing a source of T7 RNA polymerase in the 
host cell.  
 
2.1.2 Culture media 
 
Media for bacterial growth were prepared as follows, if not otherwise specified. 
 
Luria-Bertani (LB) broth 
For a final 1L: 
- 10g triptone 
- 5g yeast extract 
- 5g NaCl 
pH was adjusted to 7.0. After sterilisation, antibiotic was added. 
 
Minimal medium (MM) 
For a final 500 ml: 
- 400 ml of sterile water 
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- 100 ml of M9 salts (vide infra) 
- 1 ml of sterile 1 M MgSO4 
- 1 ml of sterile 50 mM ZnSO4 
- 500 l of sterile 0.1 M CaCl2 
- 50 l of 10 mM FeCl3 (0.22 lfiltered) 
- 10 ml of glucose from a 40% stock solution (0.22 m filtered) 
- 3 ml of vitamin stock solution (vide infra) 
Sterilisation was achieved in autoclave if not otherwise specified. After sterilisation, 
antibiotic was added. 
 
M9 salts 
For a final 1L: 
- 33.9 g Na2HPO4 
- 15 g KH2PO4 
- 2.5 g NaCl 
- 5 g NH4Cl 
Sterilisation was achieved in autoclave. 
 
Vitamin stock solution 
For a final 200 ml: 
- 100 mg thiamine 
- 20 mg d-biotin 
- 20 mg choline chloride 
- 20 mg folic acid 
- 20 mg niacinamide 
- 20 mg d-panthothenate 
- 20 mg pyridoxal hydrochloride 
- 2 mg riboflavin 
Sterilisation was achieved by 0.22 m filtration. 
In media containing bacteria transformed with pET24d kanamicine was used at a final 
concentration of 50 µg/ml. 
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2.2 Methods 
 
Cloning and site directed mutagenesis procedures have been extensively described in 
Antonio Bertarelli Degree Thesis, titled: “Espressione e caratterizzazione di cL-BABP 
ed opportuni mutanti”. Supervisors: Prof.ssa Henriette Molinari of the University of 
Verona and Dr Laura Ragona of ISMAC-CNR, Milano. 
 
2.2.1 
15
N-
13
C labelled cL-BABP/S-S (T91C cL-BABP) expression 
 
A pre inoculate solution of 30 ml of cL-BABP/S-S in BL21 with 50 µg/ml Kan 
antibiotic was grown in M9 minimal medium, using 
15
NH4Cl and 
13
C enriched glucose, 
shacking overnight at 37°C. BL21 (DE3) (Stratagene) is the E. coli strain for protein 
production in T7 promoter-driven vectors. The advantages of these cells are the high-
level protein expression and the ease of induction. 
The starting culture was used to inoculate 1L of M9, then incubated in a shaker at 37°C 
till an OD600 value of 0.6 was reached. Induction was achieved by addition 1 mM IPTG 
and incubation overnight at 22°C. 
0.7 μl of β-ME per ml were added to the lysis buffer (vide infra) and PMSF 
(phenylmethanesulfonylfluoride) 1:2000. After a centrifugation step at 8000g for 10 
minutes, the pellet was resuspended in 2.5 ml of lysis buffer + β-ME + PMSF/g of 
pellet. The buffer final volume was of 20.75 ml and sonicated with 4 cycles of 30 pulses 
at 60 Watt. The culture was then centrifuged at 10000g for 10 minutes. The pellet 
underwent another resuspension-sonication-centrifugation cycle, while the supernatant, 
containing the soluble protein fraction, was loaded on the first purification column. 
Before induction a 1 ml sample was collected and centrifuged at 10000g for 5 minutes 
and the pellet, resuspended in 200 ml of sterile water, was kept for the evaluation of 
basal protein expression. 
The protocol for the expression of 
15
N labelled proteins or for unlabelled proteins was 
the same, except that a 30 ml starter culture and LB medium was used. 
 
Lysis buffer: 
- 50 mM Tris-HCl pH 8.0 
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- 20% sucrose 
- 1 mM EDTA 
- 1 mM PMSF freshly added 
 
2.2.2 Protein purification (Purification protocols) 
 
An anion exchange chromatography was the first step of purification for His-tagged 
recombinant cL-BABPs. Next steps were a size exclusion chromatography and a 
delipidation, followed by a buffer exchange in the storage/NMR buffer and 
liophylization. 
 
2.2.2.1 Anion exchange chromatography 
 
80 g of DE52 pre-swollen microgranular DEAE cellulose (Whatman) resin were 
resuspended in 200 ml of 0.2 M Tris-acetate pH 7.8. After sedimentation, the 
supernatant was removed and the resin washed twice with 200 ml of 50 mM Tris-
acetate pH 7.8. The resin was then poured into a XK 26/40 (GE Healthcare) column and 
extensively washed with 50 mM Tris-acetate pH 7.8, 0.02% NaN3 (running buffer) by 
using AKTAprime (GE Healthcare), a Fast Protein Purification Chromatography 
(FPLC) platform. The supernatant from the expression of the high pI recombinant 
protein was pumped onto the column at 1 ml/min. Elution of the protein of interest was 
achieved with several volumes of running buffer. Fractions of 10 ml were collected (see 
Figure 2.1) and analyzed by Sodium Dodecyl Sulphate PolyAcrylamide Gel 
Electrophoresis (SDS-PAGE), reported below in paragraph 2.2.3 (see Figure 2.2). 
After use, the resin was regenerated according to the manufacturer‟s instructions. 
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Figure 2.1. Elution profile obtained by the anion exchange column, increasing salt concentration. Eluted 
fractions, of 10 ml each, are reported in red along the x-axis. mAU: milli-absorbance unit. 
 
 
Lane 1: marker 
Lane 2: time zero 
Lane 3: total fraction 
Lane 4: soluble fraction 
Lane 5: fraction number 8 
Lane 6: fraction number 11 
Lane 7: fraction number 14 
Lane 8: fraction number 22 
Lane 9: fraction number 26 
Lane 10: fraction number 29 
 
Figure 2.2 
15
N-
13
C cL-BABP/S-S fraction poured on the SDS-PAGE gel (vide infra). Lane numbers, 
corresponding to the different eluted fractions, are reported at the top of the gel. Fractions containing the 
protein (corresponding to lanes 6 and 7) were concentrated with AMICON. 
 
2.2.2.2 Size exclusion chromatography 
 
500 ml of Sephacryl S-100 HR (GE Healthcare) resin were poured into a XK26/100 
(GE Healthcare) column and extensively washed with 50 mM Tris-HCl pH 7.2, 0.2 M 
NaCl, 0.02% NaN3 (running buffer) by using AKTAprime (GE Healthcare). Fractions 
containing the protein of interest, resolved with the previous chromatographic step, 
were concentrated to 5 ml and pumped onto the column at 1 ml/min (see Figure 2.3). 
Elution of the protein of interest was achieved with several volumes of running buffer. 
Fractions of 10 ml were collected and analyzed by SDS-PAGE (see Figure 2.4). 
L.1  L.2  L.3  L.4  L.5  L.6  L.7  L.8  L.9  L.10 
Elution volume (ml) 
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After use, the resin was regenerated according to the manufacturer‟s instructions. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.3. Elution profile obtained for concentrated fractions collected by the size exclusion column. 
Eluted fractions, of 10 ml each, are reported in red along the x-axis. mAU: milli-absorbance unit. 
 
Lane 1: marker 
Lane 2: fraction number 9 
Lane 3: fraction number 14 
Lane 4: fraction number 18 
Lane 5: fraction number 26 
Lane 6: fraction number 31 
Lane 7: fraction number 38 
Lane 8: fraction number 44 
Lane 9: eluted from small amicon 
Lane 10: eluted from big amicon 
 
 
Figure 2.4 
15
N-
13
C cL-BABP/S-S fraction poured on the SDS-PAGE gel (vide infra). Lane numbers, 
corresponding to the different eluted fractions, are reported at the top of the gel. Fractions containing the 
protein (corresponding to lanes 5, 6 and 7) were collected for the following delipidation. 
 
2.2.2.3 Removing endogenous lipids 
 
In order to eliminate endogenous ligands, a delipidation procedure[56] is required for 
proteins binding hydrophobic molecules expressed in E. coli. 30 ml of Lipidex 1000 
(Packard Bioscience) resin were washed twice with 5 volumes of 10 mM sodium 
phosphate pH 7.4, 0.02% NaN3 (running buffer, vide infra) at 4°C. The resin was then 
poured into a XK16/20 (GE Healthcare) column and extensively washed with the 
running buffer at a flow rate of 36 ml/hour. Prior to loading the sample, the resin was 
L.1  L.2  L.3  L.4          L.5  L.6  L.7        L.8  
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equilibrated for an hour at 37°C by connecting the column to a preheated water bath. 
Fractions containing 
15
N-
13
C cL-BABP/S-S, resolved with the previous 
chromatographic step, were diluted at 1 mg/ml (after elution, the protein concentration 
was of 1.9 mg/ml for a total amount of 68 ml), and applied to the column using a 
peristaltic pump system at a flow rate of 12 ml/hour. Elution of the protein of interest 
was achieved at 37°C with several volumes of running buffer (vide infra) at a flow rate 
of 36 ml/hour. Fractions of 2 ml were collected and analyzed by SDS-PAGE (vide 
infra).  
After delipidation, the protein was firstly washed with phosphate buffer 30 mM pH 7.0 
+ 250 mM NaCl + 0.02% NaN3 and subsequently washed with phosphate buffer 30 mM 
pH 7.0+ 0.02% NaN3. 
 
2.2.3 SDS-PAGE 
 
For protein analysis with Sodium Dodecyl Sulphate PolyAcrylamide Gel 
Electrophoresis (SDS PAGE) a sample with protein (1-5 μg) was made up to 20 l in 
reducing loading buffer (vide infra) and heated at 95°C for 5 minutes. Each 20 l 
sample was loaded into a separate well of a discontinuous 15% polyacrylamide gel. A 5 
μL sample of molecular weight marker (GE Healthcare) was also loaded in a separate 
well for internal referencing. Gels were run at 120 V for approximately one hour. On 
completion, the gel was immersed in the staining solution (vide infra) for 10 minutes, 
followed by 10 minutes in the destaining solution (vide infra) and overnight destaining 
in bidistilled water. 
 
Reducing loading buffer: 
- 50 mM Tris-HCl pH 6.8 
- 100 mM DTT 
- 2% SDS 
- 10% glycerol 
- 0.1% bromophenol blue 
- Polyacrylamide gel 
- Stacking gel solution 
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For a final 2 ml: 
- 330 l of 30% acrylamide mix (BioRad) 
- 250 l of 1 M Tris-HCl pH 6.8 
- 20 l of 10% SDS 
- 20 l of 10% ammonium persulfate 
- 2 l of TEMED 
 
Running gel solution 
For a final 4 ml at 15% of acrylamide: 
- 2 ml of 30% acrylamide mix (BioRad) 
- 1 ml of 1.5 M Tris-HCl pH 8.8 
- 40 l of 10% SDS 
- 40 l of 10% ammonium persulfate 
- 16 l of TEMED 
 
Running buffer: 
- 25 mM Tris-HCl pH 8.3 
- 250 mM glycine 
- 0.1% SDS 
 
Staining solution (for a final 1L): 
- 400 ml of methanol 
- 100 ml of acetic acid 
- 1.5 g Comassie Brilliant Blue 
 
Destaining solution (for a final 1L): 
- 50 ml of methanol 
- 75 ml of acetic acid 
- 20 ml of glycerol 
 
 
 
Chapter 2: Material and Methods 
 
25 
 
2.2.4 Estimation of protein concentration 
 
Protein concentration estimates (𝑐) were calculated from the Beer-Lambert equation: 
𝐴𝑏𝑠280𝑛𝑚  =  𝜀280𝑛𝑚  × 𝑙 × 𝑐 
The absorbance at a wavelength of 280 nm (𝐴𝑏𝑠280𝑛𝑚 ) was detected using a Unicam 
UV2 UV/VIS spectrometer. The path length (𝑙) of the sample in a measurement cuvette 
was 1 cm. A theoretical extinction coefficient at a wavelength of 280 nm measured in 
water (𝜀280𝑛𝑚 ) was estimated for each construct using the ProtParam Tool from the 
Expasy Tools server (http://www.expasy.ch/tools/protparam.html). 
 
2.2.5 Sample storage 
 
Protein samples were exchanged into a buffer suitable for NMR experiments and 
concentrated to 0.5 mM. to minimize protein aggregation and precipitation. 
 
Protein Buffers for: 
cL-BABP: 30 mM potassium phosphate pH 7.2 or 6.5, 135 mM KCl, 10 mM NaCl, 1 
mM DTT, 0.05% NaN3 
cL-BABP/S-S: 30 mM potassium phosphate pH 7.2 or 6.5, 135 mM KCl, 10 mM NaCl, 
0.05% NaN3. In this case DTT has not been used to avoid disulphide bridge reduction. 
Samples were then lyophilized and stored at -20°C.  
 
2.3 NMR analysis 
 
2.3.1 Sample preparation 
 
For NMR analysis lyophilized samples were resuspended in 90% double distilled 
water/10% D2O (v/v) or 100% D2O (v/v). 
In particular L-BABP samples of 4.2 mg were resuspended in 540 µl of H2O + 60 µl of 
D2O, while samples of 2.8 mg were resuspended in 360 µl of H2O + 40 µl of D2O. 
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Unenriched bile acids and [24-
13
C]-glycocholate (GCA) were purchased from Sigma. 
15
N glycine conjugates of of chenodeoxycholate (CDA) and cholate (CA) were prepared 
as follows: 
15
N Fmoc-Glycine was anchored to 2-chlorotrityl chloride resin in the 
presence of N,N-diisopropylethylamine according to the procedures of Barlos et al[57]. 
After removal of the Fmoc group by 20% piperidine in dimethylformamide and further 
washings, a pre-activated pentafluorophenyl ester of CDA or CA in dimethylformamide 
was added in the presence of 1-hydroxybenzotriazole to 
15
N-Glycine anchored to the 
resin and vortexed until the „„Kaiser test‟‟16 was negative. After extensive washings to 
remove the reagents, GCDA and GCA 
15
N enriched in the glycine moiety were removed 
from the resin by repeated treatment with 25% 1,1,1,3,3,3-hexafluoro-2-propanol in 
dichloromethane. Solvents were removed in vacuum, the adduct was dissolved in 
aqueous acetonitrile and concentrated, with concomitant precipitation of the products, 
recovered by filtration. The homogeneity of the derivatives was assessed by Thin Layer 
Chromatography. 
The titration of the unlabelled cL-BABP/S-S protein with increasing amounts of 
15
N 
GCDA or 
15
N GCA has been performed at 7 protein:ligand ratios (1:0.3, 0.6, 1, 1.5, 2, 
2.5, 3). To prepare the holo-protein samples, bile salts were dissolved in 
tetrahydrofuran, and the concentration of the stock solutions was determined by 
measuring dry weights. Appropriate amounts of the stock solution of bile acid were 
aliquoted, and the solvent was evaporated under a stream of nitrogen. The bile acid was 
solubilized using 1:1 equivalents of 1M NaOH. Then 17.5 L of D2O were added to 
332.5 L of protein solution to bring the total volume of the NMR sample to 350 L. 
To acquire these experiments “shigemi” NMR tubes were used. The final 0.5 mM 
protein samples were dissolved in 30 mM potassium phosphate buffer, in 
95%H2O/5%D2O. The pH of the solutions was 7.2. To minimize errors each 
ligand:protein mole ratio sample was prepared and analyzed twice.  
For protein-ligand titration experiments a 
15
N cL-BABP/S-S stock solution 
concentration was diluted to 0,2 mM. The concentration of the ligand stock solutions 
were determined by measuring dry weights using a microbalance. 
Glycochenodeoxycholic acid was dissolved in the same 30 mM phosphate buffer (pH 
7.2). The ligand was added to the protein in small amounts to achieve saturation within 
10 steps (P:L ratios employed 1:0, 0.1, 0.2, 0.4, 0.6, 0.8, 1.0, 1.3, 1.6, 2.0), and three 
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additional aliquots were added to ensure the end of titration (P:L ratios 1:2.5, 3.0, 3.5). 
To acquire these experiments typical 5mm diameter NMR tubes were used.  
 
2.3.2 Data collection 
 
The majority of NMR experiments, acquired for assignments, were recorded on a 
Bruker DMX 500 spectrometer, operating at 500.13 MHz proton Larmor frequency, 
equipped with a triple resonance probehead at the NMR laboratory of ISMAC-CNR, 
Milano, or on a Bruker Avance III 600 spectrometer, operating at 600.13 MHz proton 
Larmor frequency, equipped with a triple resonance TCI cryoprobe, incorporating 
gradients on the z-axis, at the NMR laboratory of the University of Verona. 
The NMR parameters used for setting the experiments are reported in the “Experimental 
Procedure” section of Cogliati, C., et al, FEBS Journal, 2009[38], inserted in Chapter 6. 
Spectra for the titrations of cL-BABP and cL-BABP/S-S with GCDA, were recorded on 
a Bruker AVANCE 500 MHz spectrometer equipped with a cryogenically cooled 5mm 
TXI probe, at the HWB-NMR Facility (University of Birmingham, UK). 
Relaxation Dispersion experiments were acquired on Varian Inova spectrometers 
equipped with room temperature probe heads at two static magnetic fields, 
corresponding to proton Larmor frequencies of 600 and 900 MHz, at the HWB-NMR 
Facility (University of Birmingham, UK). 
The NMR parameters used for setting cL-BABPs titration and RD experiments are 
reported in the “Experimental section” of the manuscript “Site-specific investigation of 
steady-state kinetics and dynamics of the multistep binding of bile acid molecules to a 
lipid carrier protein.”, submitted to Chemistry. A European Journal and inserted in 
Chapter 7 
Experiments requiring a higher sensitivity were recorded on a 4-channel Varian Inova 
operating at 799.766 MHz equipped with HCN 5mm z-PFG cryogenic probe with 
enhanced 
13
C and 
1
H sensitivity and on a Varian Inova spectrometer equipped with a 
room temperature probe head with a corresponding Larmor frequency of 600 MHz, at 
the HWB-NMR Facility (University of Birmingham, UK). The experimental 
temperature was set to 25 °C unless otherwise specified. 
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2.3.3 Data acquisition, processing and visualization 
 
The software Topspin (Bruker, headquartered in Billerica, Massachusetts, USA) and 
NMRPipe[58] were used for data acquisition and processing on Bruker instruments 
while VnmrJ (Varian, headquartered in Palo Alto, CA, USA) and NMRPipe were used 
for data acquisition and processing on the Varian spectrometers. 
NMRLAB toolbox was used for NMR data processing in MATLAB (The Mathworks, 
headquartered in Natick, Massachusetts, USA). MATLAB is a matrix-oriented high-
level programming environment which gives access to fast algorithms for a large 
number of numerical tasks on many common computer platforms UNIX, Windows. 
Data processing can be achieved either by scripts or by a user-friendly command 
structure. The advantage in using NMRLab is that the output files, obtained by the 
processing of Bruker or Varian data, are MATLAB files and can be directly used in 
NMRKIN software without any previous conversion in ASCII or MATLAB 
versions[59]. 
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3. NMR for protein resonance assignments 
 
NMR technique, when applied to the study of biological macromolecules in solution, 
allows the determination of their tridimensional structures, together with the 
characterisation of dynamics and protein-ligand (putative ligands, small organic 
molecules, drugs, nucleic acid), protein-protein interactions. 
NMR has evolved considerably during the last years: high-field spectrometers and ultra-
sensitive cryoprobes allow completely new experiments and applications, and new 
techniques have been developed to study molecules up to sizes as large as 100 kDa. 
This chapter deals with an overview of the NMR experiments used in my research. 
Standard 2D and 3D experiments will be briefly described, while a considerable amount 
of details will be given on the analysis of 3D triple resonance experiments. If more than 
two nuclei are involved, letters like H, N and C will represent the 
1
H, 
15
N and 
13
C 
magnetization, respectively. The angular momentum operators Ix, Iy and Iz represent 
the x, y, z components of the spin angular momentum of the system.  
 
3.1 2D NMR 
 
In a 1D spectrum the signal is recorded as a function of one time-variable. Therefore, 
after Fourier transformation, a spectrum displaying intensities versus frequencies is 
obtained. In this spectrum, each peak will correspond to one frequency. If two or more 
spins are scalar-coupled, the fine structure of a multiplet will be observed. In 1D 
spectra, of complicated molecules like proteins it is difficult to establish which spins are 
coupled to each other. 
In a 2D spectrum the signal is detected as a function of two time-variables t1 and t2. 
Instead of recording one spectrum, a series of spectra is recorded where the time t1, 
which corresponds to the delay between two RF pulses, is systematically incremented. 
Therefore, the recorded signal is a matrix, with axes corresponding to t1 and t2. Fourier 
transformation has to be performed in both t1 and t2 directions, and each signal will be a 
function of this two frequency variables.  
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The scheme below represents the general idea of a 2D experiment: 
 
 
 
 
Figure 3.1 General scheme for a 2D experiment[60],[61]. 
 
The first period called preparation period, usually corresponds to the relaxation delay, 
which is used to restore all the magnetization along the z-axis (equilibrium state). Then 
one pulse creates transverse magnetization which is allowed to evolve during t1. During 
the mixing period there are different pulses that end up converting one coherence into 
another. At the end of the mixing period the transverse magnetization is detected as 
function of the second variable, t2, the acquisition time. The t1 period is also called 
evolution period, because during t1 the chemical shift of the desired nucleus evolve and, 
as a result, the observed 
1
H signal will be modulated by the frequency of the hydrogen, 
or nitrogen, or carbon scalarly or dipolarly coupled to it, depending on the experiment 
we are acquiring. The resulting 2D spectrum will display a cross peak between 
connected resonances. Therefore the main difference between 2D and 1D NMR is that 
in the first it is possible to know which spins are coupled to which. Moreover in 2D 
experiments the overlapping of resonances of the 1D spectrum is reduced because the 
information is spread in the second dimension. 
Generally unwanted coherence transfers can be eliminated by using phase-cycling, field 
gradient pulses or by a combination of both. 
 
3.1.1 TOCSY 
 
The TOCSY experiment[62], is used to observe connectivities between the protons 
within the same amino acid. As in the COSY experiment[60], the magnetization is 
transferred through scalar coupling. The advantages of the TOCSY over the COSY 
experiment is a higher sensitivity for larger molecules, all absorptive line-shapes, and 
the fact that correlations between all nuclei along a spin system are obtained. 
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The pulse sequence is shown in figure 2.2: 
 
 
 
 
Figure 3.2 Basic pulse sequence of TOCSY experiment. A first 90° excitation pulse is followed by a 
variable delay time t1, a spin-lock pulse and the recording of the FID. 
 
The transfer of in-phase coherence from one spin to another is obtained using a spin-
lock period applied in the mixing step. The spin lock is a so-called train of non-selective 
180° pulses. It eliminates the chemical shift evolution, and only J-modulation evolves. 
The result is that relayed and multiple-relayed peaks are observed. 
 
3.1.2 NOESY 
 
The NOESY[63] spectrum is the most important source of structural information of a 
molecule. The basic idea is to create connectivities between the spins via cross-
relaxation. 
 
Figure 3.3 Basic pulse sequence of a 2D NOESY [64]. Thin and thick bars indicate nonselective 90° and 
180° pulses, respectively; t1 is the evolution time. m is the mixing time[65]. 
 
The experiment (Figure 3.3) starts with a relaxation delay to allow the Z-magnetization 
to be restored after a previous scan, and a 90° pulse to create transverse magnetization 
(Iz→Iy and Sz→Sy). In the evolution step, t1, the spins are allowed to precess so that 
the terms Ix, Iy, Sx and Sy are created and labelled with their own frequencies. Here, 
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the J-coupling between them is neglected. The second 90° pulse brings the 
magnetization back to the z-axis. During the mixing time mix, the system undergoes 
relaxation and longitudinal magnetization is transferred from one spin to another, Iz → 
Sz, via cross relaxation. The final 90° pulse brings the magnetization to the xy-plane 
where the Larmor precession will be monitored during t2. The intensity of the NOESY 
cross-peak is proportional to the cross relaxation rate between the two spins I and S, 
which is dependent on their internuclear distance. 
The relation between inter-nuclear distance and peak intensity is given by 
NOE = C/r
6
 (1) 
where to obtain the constant C, a previous calibration with a known distance, or 
distances, is necessary and r is the distance between the nuclei giving rise to the cross 
peak. 
The structural information is extracted from NOESY spectra comparing the intensity of 
each assigned cross-peak with the one taken as reference, between two protons whose 
distance is known and constant, such as, for example, the two protons H and H of a 
tyrosine aromatic ring, or the two methylenic protons.  
 
3.1.3 HSQC 
 
The 
1
H-
15
N-HSQC and 
1
H-
13
C-HSQC experiments are the basic ones to test protein 
samples and their interactions with ligands and also form the basis of heteronuclear 3D 
experiments. The 
1
H-
15
N-HSQC displays cross-peaks for each proton bound to nitrogen, 
in particular backbone or side chain amide protons, while the 
1
H-
13
C-HSQC displays 
cross-peaks for each proton attached to carbon. 
The 
1
H-
15
N-HSQC spectrum is considered a “fingerprint” of the protein. The dispersion 
of the cross-peaks indicates whether the protein is folded and the feasibility and ease of 
the resonance assignment. It is also used to measure the rates of proton-deuterium 
exchange of the labile protons and in titration experiments of proteins with different 
ligands to identify the residues that are involved in interactions. 
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The pulse sequence for the 
1
H-
13
C or the 
1
H-
15
N-HSQC experiment is shown in Figure 
3.4. 
 
 
 
 
 
 
 
Figure 3.4 HSQC experiment pulse sequence. I = 
1
H, S = 
13
C or 
15
N. The pulses in the 1H channel 
(which affect only the protons) and those in the heteronucleus channel are shown separately. Thin and 
thick bars indicate nonselective 90° and 180° pulses, respectively. The 90° pulse followed by a relaxation 
delay, , a 180° pulse, another relaxation delay and finally by a 90° pulse represents an INEPT block[65]. 
 
A first inspection of this pulse sequence shows a basic building block of pulse programs 
called INEPT (Insensitive Nuclei Enhanced by Polarization Transfer) [66], followed by 
an evolution period (t1), another INEPT scheme and then detection. The first INEPT is 
used to transfer magnetization from the 
1
H to the heteronucleus (S = 
15
N or 
13
C). The t1 
period that follows the first INEPT is incremented to build up the indirect 
15
N or 
13
C 
dimension. The second INEPT brings the magnetization back to proton, the observed 
channel. The pathway of the magnetization flow during this experiment is represented 
below: 
                                     JHS                                        JSH 
HS                               SS (t1)                                 H
S (acq) 
The cross peaks don‟t show fine structures due to the NH or CH coupling in the indirect 
and direct dimensions, because during t1 the evolution of the J-coupling is refocused by 
the 180 pulse applied on 1H in the middle of the evolution period, and during 
acquisition, a broadband decoupling is applied.  
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3.2 3D NMR 
 
In a 3D experiment all the concepts of 2D NMR are employed. The 3D experiments are 
essential to study big systems such as proteins, because the overlap observed in 2D 
spectra can be drastically reduced by extending the information to a third dimension. 
The 3D NMR pulse sequences are derived from a combination of two 2D experiments 
as shown below (Figure 3.5). 
 
Figure 3.5 Schematic generation of a 3D NMR experiment from the combination of two 2D experiments. 
The mixing period of one 2D experiment and the preparation period of a second one are combined. The 
3D experiments contain three independent time periods. The FID is acquired during the acquisition 
period, t3, as a function of two independently incremented evolution times, t1 and t2. A mixing period 
follows each evolution time[65]. 
 
The third dimension is created by introducing a second evolution period, t2. Therefore, 
in a 3D experiment the signal, which is monitored during the acquisition time t3, is 
function of two evolution times, t1 and t2, which are incremented independently. The 
signal is a matrix with three axes corresponding to t1, t2 and t3. After Fourier 
transformation a spectrum with three different frequency dimensions F1, F2, F3 is 
obtained. This spectrum can be imagined as a cube (Figure 3.6). 
t3 
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Figure 3.6 The development of a 3D data set from a 2D data set. The 2D depicted here shows a set of 
resonances that, although resolved in F1 dimension , are not clearly determined in the F2 dimension. The 
introduction of an additional evolution period generates a third frequency dimension perpendicolar to the 
first two. The increased resolution afforded by virtue of a second magnetization transfer step can alleviate 
ambiguities in the 2D spectrum[67]. 
 
3.2.1 
15
N-NOESY-HSQC and 
13
C-NOESY-HSQC 
 
3D 
13
C or 
15
N edited NOESY experiments[68], [69], [70] are important in protein 
NMR. They reduce the overlap of the crowded 2D-NOESY spectra by introducing a 
13
C 
or 
15
N dimension, so that each 
15
N or 
13
C plane of the 3D spectrum corresponds to a 
normal 2D NOESY spectrum. 
From the 
15
N-NOESY-HSQC spectrum, short-range NH-NH, intra-residue, sequential 
and long-range NOEs are obtained. In the 
13
C-NOESY-HSQC spectrum, correlations 
within and between side-chains, long-range NOEs, including those involving aromatic 
protons are obtained. With such a big amount of information, these experiments are 
useful not only for the assignment of the backbone, the side chains resonances but also 
to collect NOEs for structural calculation. 
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Figure 3.7 Basic pulse sequence of NOESY-HSQC experiment. Thin bars represent 90° pulses and thick 
bars represent 180° pulses. Pulses are applied with x-phase unless the phase is indicated above the bar. 
The nominal value for 2 = 1/(2JIS) and m is the mixing time. In this scheme I = 
1
H and S = 
15
N or 
13
C. 
SL indicated the Spin-Lock[65]. 
 
The first part of the pulse sequence (Figure 3.7) corresponds to a normal NOESY 
experiment, except for the 180° pulse applied on the 
13
C or 
15
N channel during the t1 
evolution period. This pulse is used to decouple 
1
JIS evolution. After that there is a 
HSQC block, where magnetization is transferred to 
13
C or 
15
N, with chemical shift 
evolution during t2. Finally, magnetization is transferred back to protons and prepared 
for acquisition. 
 
3.2.2 
15
N-TOCSY-HSQC 
 
The 
15
N-TOCSY-HSQC[69] is used to assign the side chains by correlating the intra-
residue N
H
, 
15
N, and the side-chain protons using TOCSY transfer schemes. It is usually 
sufficient to assign the side chains of proteins up to 10 kDa. Unfortunately, in larger 
proteins, the decay of proton magnetization is usually very fast and competes with the 
coherence transfers involving small proton-proton J-couplings, thus making the 
15
N-
TOCSY-HSQC less efficient. However, it is still useful to correlate the intra-residue 
HN, 
15
N and H

, being able, in several cases, to go even further in the side chain. 
S 
 
I 
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Figure 3.8 Basic pulse sequence for a 
15
N- TOCSY-HSQC. Thin bars represent 90° pulses and thick bars 
represent 180° pulses. Pulses are applied with x-phase unless the phase is indicated above the bar. The 
nominal value for 2 = 1/(2JIS) and m is the mixing time. DIPSI-2 isotropic mixing used in m. SL 
indicated the Spin-Lock [65]. 
 
Like the 
15
N-NOESY-HSQC experiment, the 
15
N-TOCSY-HSQC can be described 
using two main blocks (Figure 3.8): the first block corresponds to a general TOCSY 
experiment (with 180° pulse for decoupling 
1
JHN evolution during t1) and the second 
corresponds to a HSQC experiment. A “clean” version of the 15N-TOCSY-HSQC has 
been here employed as the artefacts due to ROESY effects have less probability to 
occur[71]. In this experiment, the conventional 180° pulse train is replaced by series of 
180°-90°-180° pulses separated by a certain delay . By choosing an adequate value for 
 the NOE and ROE effects cancel each other, so that the magnetization is transferred 
only via J coupling. 
 
3.2.3 HCCH-TOCSY 
 
For large proteins (generally >10 kDa) the proton line widths are often too large and 
hinder efficient coherence transfers involving the relatively small 
1
H-
1
H J couplings, 
making the homonuclear or 
15
N edited TOCSY experiments very inefficient. Two 3D 
HCCH-TOCSY experiments were introduced, one aimed at the assignment of carbon 
resonances and one used for assigning proton resonances of the side chains of 
13
C- or 
(
15
N,
13
C)-labelled proteins[72],[73]. A general pulse sequence scheme for the H(C)CH-
TOCSY experiment is given in figure 3.9. 
The HCCH-TOCSY experiments rely on magnetization transfer between 
13
C nuclei by 
isotropic mixing. Since the coherence transfer can be carried out in shorter periods of 
time due to the larger 
13
C-
13
C J couplings (> 35Hz), the experiments are well applicable 
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to larger molecules. Eventually, magnetization is transferred to protons using the large 
heteronuclear 
1
H-
13
C J-coupling. Therefore, the limiting factor of the HCCH J-
correlation methods is the 
13
C line width. 
In the 3D (H)CCH-TOCSY spectrum two of the three dimensions correspond to 
13
C and 
the other one to 
1
H. Using this spectrum it is possible to assign all the carbons of the 
side chains. With the 3D H(C)CH-TOCSY spectrum, in which two of the three axes 
correspond to protons and the third to carbon, side chain protons are assigned. 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Pulse sequence of H(C)CH-TOCSY. Thin bars represent 90° pulses and thick bars represent 
180° pulses. Pulses are applied with x-phase unless the phase is indicated above the bar. Rounded bars 
represented selective 180° pulses applied to 
13
CO spin[65]. 
 
The H(C)CH experiment starts with a 90° pulse on protons, followed by evolution of 
the proton spins during the t1 period. In the centre of t1 a 180° pulse is applied on 
13
C in 
order to refocus the 
1
JHC couplings. Afterwards, one INEPT block is applied to transfer 
magnetization from 
1
H to 
13
C (Hy →HzCy). The duration is 2and the optimal value is 
t=1/4 JCH. In the next block, of total duration 2+t2, the carbon magnetization that is in 
antiphase with respect to its directly attached proton spin is refocused, and the 
13
C 
magnetization evolves during t2. The delay  has to be chosen to allow transfer of CH, 
CH2 and CH3, generally =1/6 JCH. A 180° pulse applied on the carbonyl refocus the 
JCC‟ coupling during this period. The next step of the sequence is the 
13C→13C transfer 
step. A TOCSY-like mixing unit, often a DIPSI composite pulse, is used to transfer in-
phase 
13
C magnetization to its neighbours. The spin lock in front of the DIPSI is used to 
destroy all in-phase carbon coherences that are not aligned with the spin lock field. 
During the DIPSI period there is in-phase transfer among the carbons spins not only to 
direct bound carbons. The final step is an INEPT block that brings back the 
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magnetization to the attached protons which are detected during t3. The flow of the 
coherence transfers in this experiment is given by: 
 
 
The pulse sequence for the (H)CCH-TOCSY experiment can be derived from the 
previous one. The main difference is that the t1 evolution period is now used to 
frequency label the 
13
C spins, instead of the proton spins. The flow of magnetization 
transfer during the (H)CCH-TOCSY experiment is given by: 
 
 
3.3 Triple resonance experiments 
 
An alternative assignment run on a (
13
C,
15
N) doubly-labelled sample and is very useful 
for proteins with MW in the range 10-30 kDa, as in our case. This strategy involves 3D 
triple resonance experiments that correlate backbone H
N
, 
15
N
H
, H

, 
13
C

, 
13
CO, and side 
chain H

 and 
13
C
 
spins using one-bond heteronuclear coupling constants[74]. In this 
way the magnetization moves across peptide bonds, providing information that can be 
used for sequential backbone assignment. In the following paragraphs an overview of 
the triple resonance experiments performed in this study is given. 
 
3.3.1 HNCO and HNCA 
 
The HNCO and the HNCA are the basic 3D triple resonance experiments. In the first 
one the chemical shifts of the H
N
 proton and the 
15
N of one residue (i) are correlated 
with the 
13
CO of the previous residue (i-1), while in the second one the cross-peaks 
correlate each H
N
 with the 
13
C

 of residue i and i-1. The pulse sequence for the HNCO 
experiment is schematized in Figure 3.10. 
 
Hi (t1)
13Ci (t2)
13Cj Hj (t3)
1JCH JCC
1JCH
Hi
13Ci (t1)
13Cj (t2) Hj (t3)
1JCH JCC
1JCH
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Figure 3.10 Pulse sequence of HNCO. Thin bars represent 90° pulses and thick bars represent 180° 
pulses. Pulses are applied with x-phase unless the phase is indicated above the bar[65]. 
  
The HNCO pulse sequence starts with the transfer of H
N
 magnetization to 
15
N via one 
INEPT block. The next step is a constant-time evolution period of the 
15
N-chemical 
shift (t1). During this period, JHN evolves for a time 2, while JNCO evolves during 2. 
By setting  to 1/4JHN (2.75 ms) and  (<16.7 ms) to 1/4JNCO one obtains refocusing of  
HzNy antiphase magnetization and creation of NyCOz anti-phase magnetization. A 
180 pulse is applied on 13C to refocus JNC modulation. After t1, 
15
N anti-phase 
magnetization with respect to 
13
CO is converted into 
13
CO anti-phase magnetization 
with respect to 
15
N by a pair of 90 pulses applied on both channels. During t2 there is 
evolution of the 
13
CO chemical shift, while the J-modulations due to JNCO, JCOC and 
JHCO couplings are refocused by 180 pulses. After the t2 period magnetization is 
transferred back to nitrogen by a pair of 90 pulses, after that NyCz is refocused to Nx 
during the delay 2, and Nx converted into HzNy during the delay 2. A final pair of 
90 pulses on both 15N and 1H channels transfer magnetization from 15N to HN. During 
the final INEPT this coherence is refocused to observable HN-magnetization. In 
summary, the overall flow of magnetization during the HNCO pulse sequence is given 
by: 
Note that the 
13
C

 and the carbonyl 
13
CO are pulsed separately and independently. The 
13
C-channel is split into two bands, one around 55 ppm, where the C
carbons resonate, 
and another around 175 ppm where the carbonyl atoms resonate. This is performed by 
either switching the RF carrier frequency of the 
13
C-transmitter to the appropriate 
HN JHN 15NH (t1) JNCO 13CO (t2)
JNCO 15NH HN (t3)
JHN
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frequency , or by phase-modulating the 
13
C-transmitter source with an appropriate offset 
frequency. 
The pulse sequence for the HNCA experiment is the same as the HNCO, except by the 
fact that the t2 evolution period is on 
13
C

 instead of 
13
CO. 
Here, as in the HNCO, the magnetization starts on the amide proton, and is transferred 
to 
15
N
H
 by the first INEPT block. The evolution of the 
15
N chemical shift is performed 
using a constant-time period. The one-bond 
1
JNC intra-residue coupling (8-12 Hz) and 
two-bond 
2
JNC inter-residue coupling (up to 7 Hz) will evolve simultaneously during t1. 
As a result, the magnetization is transferred to both the intra-residue (i) and the previous 
residue (i-1) 
13
C

 spins. After t1, the 
15
N antiphase magnetization is converted into 
13
C

 
antiphase magnetization by two simultaneous 90 pulses on 15N and 13C, and the 13C 
chemical shift evolves during t2. During this period, the evolution of 
1
JHC, 
1
JNC and 
1
JCOC scalar couplings is refocused by 180 pulses. However, the scalar coupling 
between the 
13
C

 and 
13
C

 spins is still active and therefore the acquisition time in this 
dimension should be shorter than ½JCC. Since the T2 relaxation time of C

 (10-20 ms 
for large proteins) is comparable to ½JCC = ½. 35Hz=14 ms, usually the acquisition 
times in the C dimension are not larger than 10-12 ms, such that 2JCC is not 
influencing the line width. 2JCC can be decoupled by a selective 180°pulse on C

 but 
not for all spin systems. Homonuclear 2JCC can also be refocused by a constant time 
C

 evolution period. 
Finally, the magnetization is transferred back to the amide nitrogen, and converted into 
observable H
N
-magnetization by the reverse pathway. The overall flow of the H
N
 
magnetization during the HNCA experiment is given by: 
 
 
 
3.3.2 CBCA(CO)NH 
 
The CBCA(CO)NH[75] generates correlations between Ni-N
H
i-C

i-1-C

i-1. Besides that, 
the assignment of C

 and C

 chemical shifts also helps in identifying the amino acid. A 
brief analysis of the CBCA(CO)NH pulse sequence is given in Figure 3.11. 
HN JHN 15NH (t1)
1JNC 13C (t2) 15NH HN (t3)
JHN1JNC
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Figure 3.11 Pulse sequence of CBCA(CO)NH. Thin bars represent 90° pulses and thick bars represent 
180° pulses. Pulses are applied with x-phase unless the phase is indicated above the bar. Rounded bars 
represent selective 180° pulses applied to 
13
CO spins[65]. 
 
The first INEPT, of duration of 2 is used to transfer magnetization from the aliphatic 
protons H

 and H

 to the carbons: Hz
→Hz

Cy

 and Hz
→Hz

Cy

. It is followed by a 
constant time evolution period of duration 2TAB combined with refocusing of transverse 
carbon coherence that is antiphase with respect to its attached proton during the delay : 
Hz

Cy
→Cx
. The time  should be chosen to be about 1/3JHC in order to allow 
refocusing of CHn for n=1,2,3. Starting from this point decoupling of 
1
H is necessary. 
During the 2TAB constant time period, the carbon spins are frequency labeled, coupling 
to carbonyls is refocused but JCC couplings evolve, and the 90 pulse on carbon mixes 
C

 and C

 coherences: Cx

  Cz

Cy

. The third INEPT of duration 2 mixes the 
aliphatic carbon magnetization with the carbonyl magnetization (Cz
C‟y term is created) 
and the antiphase coherence Cy

Cz

 is refocused. In the fourth INEPT, during the period 
, the antiphase carbonyl magnetization with respect to C is refocused (CzC
‟
yC
‟
x) 
and subsequently transferred to 
15
N: (Cz
C‟y→ C‟zNy). The carbonyl and 
15
N coupling 
evolves during the period 2. 
The fifth step consists of constant time evolution 
15
N during t2 of duration 2TN. The 
coupling to C

 is refocused with 180° pulses on 
15
N and C

. The 
15
N magnetization 
antiphase with respect to carbonyl is refocused (C‟zNy→Nx). At this point 
1
H and 
15
N 
decoupling is switched off to allow the nitrogen to become antiphase with respect to 
1
H: 
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Nx→NzHy. Finally the last INEPT brings the magnetization to the amide protons which 
are detected during t3: NzHy→Hx. 
The overall flow of magnetization during the CBCA(CO)NH pulse sequence is 
schematized as follows: 
 
 
3.3.3 HNCACB  
 
This experiment, together with the CBCA(CO)NH is very important to get a complete 
sequential assignment of the backbone resonances. Differently from the CBCA(CO)NH, 
this experiment generates four cross peaks correlating the 
15
N amide nitrogen, and the 
H
N
 amide proton to the C

 and C

 frequencies of the residues i and i-1. 
 
 
 
 
 
 
 
 
Figure 3.12 Pulse sequence of HNCACB. Thin bars represent 90° pulses and thick bars represent 180° 
pulses. Pulses are applied with x-phase unless the phase is indicated above the bar. Rounded bars 
represent selective 180° pulses applied to 
13
CO spins[65]. 
 
An inspection of the HNCACB pulse sequence (Figure 3.12) reveals an “out and back” 
mechanism for magnetization transfer between the nuclei. As in previous experiments, 
the magnetization starts on H
N
 and is transferred to the other nuclei by INEPT blocks 
and frequency labeling is performed in constant time units. The pathway of the 
magnetization transfer: 
 
1JCH
C,(t1)
15NH (t2) HN (t3)
JHN
1JNC
,
H, C C
‟
1JC‟N
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   Out         &    back    
One disadvantage of this experiment is that carbon chemical shifts recorded during t1 
are modulated by CC-coupling[76].  
 
 
 
 
1JNH 15N
1JCC
HN C C, (t1)
1JCN C
15N(t2) HN (t3)
1JCC
1JCN
1JNH
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4. NMR to study protein dynamics and interactions 
 
It is becoming increasingly clear that a detailed understanding of molecular function 
requires not only high-resolution structural information of the sort that can be obtained 
through X-ray diffraction or NMR studies but also a quantitative characterization of 
how structure changes with time. In the case of proteins, in particular, dynamics have 
been implicated in many aspects of function, including molecular recognition, 
signaling[77], folding[78], [79], enzymatic catalysis[80], [81] and allostery[82].  
In this research project the attention is mainly focused on dynamic processes related to 
protein-ligand interactions, that could be tightly linked to the BABP biological function 
concerning the regulation of bile acid concentration within cells and delivery to target 
receptors.  
Proteins are dynamic rather than static systems, and they must perform motions to 
execute their functions. Motions are possible only if a given protein can assume a large 
number of somewhat different conformation.  
Molecular motions can be exceedingly complex. To accurately describe their time 
scales, amplitudes and directionalities a very large number of parameters would be 
required, among these: 
1. The line widths dependence on MW and conformational states 
2. The proton amide exchange with solvent 
3. The number of signals per atom 
4. The rates of heteronuclear relaxation processes: (i) R1 (1/T1) for spin-lattice relaxation; 
(ii) R2 (1/T2) for spin-spin relaxation; (iii) Nuclear Overhauser Effect (NOE) for the 
dipole-dipole relaxation. 
Through the measurements of all these parameters, NMR experiments allow the study 
of conformational motions in a very broad time scale, from picoseconds to seconds. T1, 
T2 and NOE values give information on motions in the range of ps-ms time scale. 
Relaxation dispersion CPMG data reveal motion in the range of s-ms time scale. 
Lineshapes together with chemical shifts analysis detect the slowest motions, in the 
range of s to ms for lineshapes and in the range of seconds for chemical shift. 
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Figure 4.1 Scheme of NMR parameters and motion time scales.  
 
All of the mentioned parameters are typically measured using two-dimensional (HSQC 
type) experiments in which the intensities of peaks are modulated as a function of a time 
delay placed at a point in the pulse sequence when the relevant relaxation process is 
active. Each observable relaxation process involves transitions between quantized 
magnetic energy levels. Such transitions are stimulated by magnetic fields that oscillate 
at the transition frequencies. Thus, the relaxation rates are determined by the likelihood 
that the relevant nuclei experience appropriate oscillating magnetic fields. Such 
oscillating fields in proteins result from the movements of magnetic nuclei relative to 
each other or relative to the overall permanent field of the NMR magnet. Consequently, 
relaxation is sensitive to molecular motion. 
In any NMR experiment, the bulk magnetization of the sample is perturbed from its 
equilibrium state (along the z-axis, parallel to the permanent magnetic field), and the 
emitted signal is observed as the sample returns to equilibrium. Relaxation is the 
process by which nonequilibrium magnetization returns to the equilibrium state (or 
transforms to another nonequilibrium state). The longitudinal or spin-lattice relaxation 
rate (R1 = 1/T1) is the rate constant at which the magnetization recover to thermal 
equilibrium. The transverse or spin-spin relaxation rate (R2 = 1/T2) is the rate constant 
for dephasing of magnetization in the x-y plane. Relaxation rates 1/T1 and 1/T2 are often 
very sensitive indicators of binding of a small ligand to a large molecule, as relaxation 
rates for 
1
H and 
13
C nuclei in small ligand molecules are controlled by molecular 
tumbling rates and binding will affect relaxation properties[83]. 
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The Nuclear Overhauser effect (NOE) comes from a particular relaxation path, known 
as cross-relaxation, originated by the dipole-dipole interaction between nuclei close 
together in the space. The NOE is defined as the fractional change in intensity of one 
NMR line when another resonance is selectively perturbed. The steady-state 
heteronuclear {
1
H}-
15
N NOEs are determined as a ratio of cross-peak intensities in two 
experiments, with and without pre-saturation of amide 
1
H nuclear spins, usually referred 
to as NOE and NONOE experiments, respectively[84]. These experiments provide the 
possibility to obtain a complete atomic-level resolution picture of protein dynamics in a 
time range from picoseconds up to nanoseconds, the range where several motions 
relevant to protein interaction take place.  
In this work,
 15
N relaxation HSQC type experiments, were based on INEPT 
magnetization transfer in the 
1
H-
15
N pair and contain relaxation-specific pulse 
sequences inserted during the time period when magnetization is in the 
15
N dimension. 
For T1 and T2 measurements of apo and complexed cL-BABPs, a series of several 2D 
spectra were recorded at different resonance fields, with various relaxation delays, 
ranging from very short to the longest one. The delay values were selected so that they 
were uniformly distributed over this time interval.  
Relaxation times were calculated via least squares fitting of peak intensities, using the 
rate analysis routine of NMRView program. The heteronuclear NOE effects were 
calculated from the ratio of cross-peak intensities in spectra collected with and without 
amide proton saturation. Through the calculation of T1/T2 ratio and by the analysis of 
the NOEs values, it is possible to deduce information about conformational motion of 
individual residues of the protein. Indeed, high values of T1/T2 ratio (higher than the 
average value plus a standard deviation) are indicative of the presence of slow 
conformational motions (s-ms) in NMR time scale, while low values of NOEs (lower 
than the average value minus a standard deviation) are indicative of the presence of fast 
conformational motions (ps-ns).  
Biological processes, occurring on the s to ms time scale, depend on molecular 
dynamics that leads to excursions from highly populated ground states to much less 
populated excited states. The low populations and the transient formation of excited 
states are usually invisible to the conventional methods of structural biology and can be 
studied through NMR relaxation dispersion measurements. The unique capabilities of 
NMR relaxation dispersion to determine exchange rates on the slow time scale, follow 
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from the fact that large numbers of residues can be probed individually in a single 
experiment.  
NMR lineshape analysis has been singled out as the method of choice for ligand binding 
investigation. Indeed NMR lineshape analysis covers a time frame that is highly 
relevant for the dynamic processes associated to ligand interaction and can be used to 
determine kinetic rates involving different steps, intermediates or parallel, so to derive 
kinetic mechanisms. In the case of ligand binding the kinetic analysis is facilitated by 
the fact that a series of lineshapes can be obtained by varying the concentration of the 
ligand. The obtained lineshapes, derived from two-dimensional spectra, provide kinetic 
information on individual residues of the protein.  
 
4.1 Relaxation Dispersion (CPMG) 
 
Here a short description is provided of an NMR technique termed Carr-Purcell-
Meiboom-Gill (CPMG) relaxation dispersion NMR that can give atomic resolution 
information on millisecond time scale conformational transition occurring in 
proteins[85]. In cases where conformational exchange occurs between a ground state 
and “excited” states that are populated at levels of 0.5% or higher with rates of 
exchange on the order of a few hundred to several thousand per second, the relaxation 
data measured for multiple nuclei often allow complete kinetic and thermodynamic 
characterization of the exchange process, even though the resonances of the “excited” 
states cannot be directly observed in NMR spectra. Additionally, relaxation dispersion 
data report NMR chemical shift differences between states, providing structural 
information on the low-populated “excited” species.  
 
4.1.1 CPMG NMR Relaxation Dispersion theory 
 
As clearly described by Kay relaxation dispersion is the dependence of the rate of 
magnetization decay, R2,eff, during the CPMG sequence, on νCPMG. In practice, R2,eff 
rates are quantified from peak intensities in NMR spectra recorded with different 
numbers of repeats of the τ-180x°-τ CPMG block[86]. 
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Although a complete description of many NMR experiments requires quantum 
mechanics, much insight can be obtained from a classical picture in which the 
macroscopic nuclear magnetization at equilibrium is represented by a vector that aligns 
along an axis (Z) that is collinear with the magnetic field, H0. Figure 4.2a[87]. 
Application of a 90y° radio frequency pulse at the appropriate frequency rotates the 
magnetization vector along the X-axis. Subsequently, magnetization rotates about the Z-
axis with a characteristic angular frequency Ω, in the example shown in Figure 4.2a, 
there are two such components (red and blue), each with discrete resonance frequencies. 
Over time each magnetization component will acquire a phase, , with respect to the X-
axis, given by = Ωt. In the basic spin–echo experiment (Figure 4.2b) a τ-180x°-τ 
block is added after the 90y° pulse, followed by signal acquisition. During the first τ 
element, magnetization in each of the red and blue states acquires phase  = ΩAτ and 
 = ΩBτ, respectively, so that a plot of  vs t is linear, with slope Ω (Figure 4.2b, 
middle). At t = τ, a “refocusing” 180x° pulse is applied that inverts the phase of the 
magnetization. The phase then “builds-up” again during the second τ period so that the 
net phase is zero at t = 2τ, giving rise to an ordering of magnetization along the X-axis 
referred to as a spin-echo. Now suppose that the red and blue magnetization components 
derive from a single NMR active probe (a 
1
H, 
13
C, or 
15
N nucleus, for example) on a 
molecule that exchanges stochastically between two distinct conformations. If the 
exchange of conformations leads to a difference in the magnetic environment of the 
probe, corresponding to resonance frequencies ΩA, ΩB, then a plot of  vs t might look 
like one of those shown in Figure 4.2b (bottom), where each magnetization component 
has acquired a different phase before and after the refocusing pulse,  (2τ) ≠ 0. Different 
 (t) profiles would be observed for different molecules since the process of exchange is 
random, and because the net signal is given by the sum of  (2τ) over all molecules, the 
intensity would be reduced relative to the case of no exchange. CPMG-type dispersion 
experiments exploit multiple-echo refocusing pulse sequences. In a typical experiment a 
90y° pulse is followed by an even number of repeats of the τ-180x°-τ block (Figure 
4.2c). The frequency of application of 180x° pulses in the CPMG sequence, 1/(4τ), is 
called the CPMG frequency, νCPMG. 
Qualitatively, if the rate of molecular exchange is slow compared with νCPMG, 
magnetization is nearly completely restored along the X-axis after each block, so the 
amplitude of consecutive spin-echoes is little affected by the exchange process. In 
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contrast, as the exchange events become on the order of νCPMG, the CPMG sequence 
becomes less effective at refocusing, thus leading to a decay of the spin-echo amplitude. 
NMR relaxation dispersion profiles R2,eff(νCPMG) provide sensitive measures of 
conformational/chemical exchange processes allowing extraction of populations of 
exchanging states (pn), rates of transitions between states (kmn), and absolute values of 
frequency differences between states |Δωmn| = |ωm - ωn| (or, equivalently, chemical shift 
differences in ppm |𝜔 mn|) for each pair of exchanging states m and n. All of the 
observables mentioned above can be obtained by a least-squares fit of experimental 
relaxation dispersion data (i) to approximate expressions (which are available for two-
state exchange only) or (ii) by solving the Bloch-McConnell equations numerically for a 
given chemical exchange model[85]. In most cases, exchange contributions to R2,eff 
decrease with increasing νCPMG (see Figure 4.2). In the absence of exchange or in the 
case of 𝜔 mn = 0, R2,eff rates are independent of νCPMG, so that the measured relaxation 
dispersion profiles are flat. 
 
 
 
Figure 4.2 The physical basis underlying CPMG relaxation dispersion NMR spectroscopy[87]. 
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4.1.2. Overview of Relaxation Dispersion experiments 
 
In my thesis, relaxation dispersion experiments were recorded at two magnetic fields, 
on 
15
N cL-BABP/S-S at different level of saturation by GCDA. 
The necessity to acquire these experiments at two magnetic fields, as reported by Millet 
et al.[88], depends on the nature of the chemical or conformational kinetic processes (on 
s-ms). Such processes, generally referred to as chemical exchange contributes to the 
transverse relaxation rate (𝑅2), stochastically transfer nuclear spins between magnetic 
environments with different isotropic chemical shifts. 
Our relaxation dispersion data were investigated taking into account a two-site 
exchange reaction (A ⇌ B), with site A more highly populated than site B (𝑝𝑎  >  𝑝𝑏), a 
shift difference between sites equal to ∆𝜔, and an exchange rate constant 𝑘𝑒𝑥 . The 
transverse relaxation rate constants for the two sites are given by 𝑅𝐴 and 𝑅𝐵, 
respectively. The exchange contribution to the transverse relaxation rate constant for the 
more highly populated site is denoted 𝑅𝑒𝑥  and could be calculated assuming 𝑅𝐴 = 𝑅𝐵. 
The timescale of an exchange process can be estimated by comparing 𝑅𝑒𝑥  at different 
static (B0) magnetic fields. This timescale is characterized by a scaling parameter 
𝛼 given by:  
 
𝛼 =
 𝐵02 + 𝐵01  𝑅𝑒𝑥 2 − 𝑅𝑒𝑥 1 
 𝐵02 − 𝐵01  𝑅𝑒𝑥 2 + 𝑅𝑒𝑥 1 
 
 
where 1 and 2 are referred to two different static magnetic fields and the value of 𝛼 
depends on the NMR chemical shift time scale for the exchange process:  
 for slow exchange (𝑘𝑒𝑥 ∆𝜔 < 1),  0 ≤ 𝛼 < 1;  
 for intermediate exchange (𝑘𝑒𝑥 ∆𝜔 = 1),  𝛼 = 1;  
 for fast exchange (𝑘𝑒𝑥 ∆𝜔 > 1), 1 < 𝛼 ≤ 2.  
The dependence of 𝛼 on a chemical shift time scale is a generalization of the result that 
chemical exchange broadening is independent of static magnetic field in the slow 
exchange limit and scales quadratically with the static magnetic field in the fast 
exchange limit. 
Consequently, the static magnetic field dependence of 𝑅𝑒𝑥  defines the chemical shift 
time scale for an exchange process even if the populations are so highly skewed 
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(𝑝𝑎  ≫  𝑝𝑏 ) that the minor resonance is not observable in the slow exchange limit 
considering a two-site exchange reaction.  
The variation of R2,eff as a function of 1 𝜏𝑐𝑝  is called relaxation dispersion. 1 𝜏𝑐𝑝  is the 
delay between 180° pulses in the CPMG pulse train. 
In this work, a fit of R2,eff values was performed using a master routine in the NMRKIN 
software, taking into account the possibility to have exchange processes at different 
timescales. For exchange processes in the range of intermediate to fast time scales, R2,eff 
was obtained using the equations reported by Millet et al.[88] (see Appendix E). For 
exchange processes in slow time scale was used the equation reported by Tollinger et 
al.[89] (See Appendix E). The values obtained were simultaneously fitted for the two 
magnetic fields[88], using the two site exchange equation. An example of relaxation 
dispersion profile measured at two magnetic fields and fit with the general two-site 
equation is reported in Figure 4.3. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Relaxation dispersion profile of residue E111 of apo cL-BABP/S-S, measured at 600 and 900 
MHz and fit with the general two-site equation. 
 
The pulse sequence, used in the present work, to record relaxation dispersion spectra, is 
characterized by constant-time CPMG intervals[86]. In addition, the use of constant-
time CPMG periods with variable pulse spacing allowed measurement of a complete 
dispersion curve in a short measuring time. The CPMG pulse sequence used for 
15
N cL-
BABP/S-S is represented in Figure 4.4. 
 
 
 
R2,eff (s
-1)
νCPMG (Hz)
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Figure 4.4 Pulse scheme used to measure relaxation dispersion profiles of NH groups in 
15
N-cLBABP/S-
S. All narrow (wide) pulses are applied with a flip angle of 90° (180°) along the x-axis, unless indicated 
otherwise. The shaped 
1
H pulse at the beginning of the sequence is a 7 ms water selective pulse with the 
EBURP-1 profile[90]. All rectangular 
1
H pulses are applied with a field of 30 kHz and are centered on 
water, following WATERGATE strategy. 
CPMG 
15
N pulses are applied with 6.2 kHz field and the other 
15
N pulses are applied with 6.8 kHz field. 
All the 
15
N pulses are centered around 120 ppm. 
15
N decoupling is achieved using a WALTZ-16 field[91] 
(1.2 kHz field at both 600 and 900 MHz). 
Each CPMGy element is of the form (CPMG-180°-CPMG)n/2, where T= n (2CPMG + pwN180), n/2 is 
even, and pwN180 is the 
15
N 180° pulse width. Quadrature detection in F1 is achieved using the enhanced 
sensitivity approach[92], [93] where for each value of t1 separate data sets are recorded for (4,g9) and 
(4+180°,-g9). The delays used are as follows: a < 1/4J = 2.25 ms; b = 1/(4J) = 2.68 ms, T = 40 ms 
(CPMG =1000 Hz). The phase cycle is: 1 = (x,-x);  2 = 2(x),2(-x);  3 = 2(x),2(-x);  4 = x; rec = x,2(-
x),x. For each successive t1 point  2 is incremented by 180° in concert with the receiver[94]. The 
durations and strengths of the gradients are: g1 = (1.0 ms, 5 G/cm); g2 = (0.5 ms, 4 G/cm); g3 = (1.0 ms,-
6 G/cm); g4 = (0.5 ms, 18 G/cm); g5 = (0.8 ms, 15 G/cm); g6 = (1.1 ms, 15 G/cm); g7 = (0.4 ms, 3.5 
G/cm); g8 = (0.3ms, 2.5 G/cm); g9 = (0.11 ms, 29.4 G/cm)[86]. Gradient coherence selection achieved 
with shaded gradients. 
 
During the interval extending from a to e in the sequence a fixed number of 
15
N 
refocusing pulses were applied during each of the two constant time CPMG intervals of 
equal length (a to b and d to e). A series of 2D spectra are recorded as a function of 
effective rf field strength by varying the number of 180pulses and therefore the pulse 
spacing so that the net relaxation time (a - b, d - e) is the same in each experiment. The 
intensities of cross-peaks in 2D spectra recorded for a given rf field, νCPMG, are 
converted into decay rates, 𝑅2,eff , via  
𝑅2,eff  νCPMG =  
−1
𝑇
ln
𝐼(νCPMG)
𝐼0
 
Where 𝐼(νCPMG) and 𝐼0 are the intensities of a given cross-peak with and without the 
CPMG periods from a to b and d to e in Figure 4.4, T/2 is the length of each CPMG 
1
2 3 4
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train and (νCPMG = 4τCPMG), with 2τCPMG the separation between the centers of 
successive refocusing pulses. A plot of 𝑅2,eff  as a function of field strength, νCPMG, 
gives a relaxation dispersion profile for each residue from which exchange parameters 
can be obtained[86]. 
 
4.2 Lineshape analysis in protein interactions 
 
Dynamics processes on the s to ms time scale influence the shape of the NMR signal if 
they are active during the acquisition of the free induction decay (FID). NMR 
lineshapes can therefore be used to derive kinetic mechanisms and to determine kinetic 
rates  
For a protein ligand binding process the relevant factors are the rates of exchange 
between the unbound, complexed and possible intermediate forms and the populations 
of the species involved in the exchange process. It is important to note that exchange 
observed by NMR for a protein ligand interaction does not necessarily represent the rate 
of ligand binding release but rather the relaxation of the protein from one form into 
another. Since binding processes are usually diffusion controlled they don‟t fall into the 
exchange window which influences NMR lineshapes and it is therefore the release 
process that is observed by NMR[2]. 
 
4.2.1 Mathematical treatment of NMR signals  
 
The effect of exchange processes on NMR signals based on Bloch equations (Bloch, 
1946) was first derived by Gutowsky et al (1953) solving the following equation: 
 
M =  
𝑖𝜔1 𝑀0   𝜏𝐴 + 𝜏𝐵 + 𝜏𝐴𝜏𝐵 (𝛼𝐴𝑝𝐵 +  𝛼𝐵𝑝𝐴 
 1 +  𝛼𝐴𝜏𝐴   1 +  𝛼𝐵𝜏𝐵 −  1
 (1) 
Here M is the macroscopic magnetization and 𝑀0  is the magnetization at the 
equilibrium or at the steady-state. With A = T2
-1
 – i ( + /2) and B = T2
-1
 – i ( 
+ /2), 𝜏𝐴 =  
1
𝑘𝐴
  = 𝜏 𝑝𝐵  and 𝜏𝐵 =  
1
𝑘𝐵 
  = 𝜏 𝑝𝐴  . 
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Considering that  = 2is the separation of lines in Hz and /2 is the width of 
the signal at half height. The NMR signal experiences the most extreme broadening 
signal at the coalescence point where exchange rate is kcoal= ;  
For k >> , on a fast exchange on NMR timescale, a single signal is observed at an 
intermediate chemical shift between that of the two exchanging nuclei; 
For k << , on a slow exchange on NMR timescale, two signals are visible for the 
exchanging nuclei (see Figure 4.4). 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Effects of the exchange rate on the appearance of the NMR spectrum from a system in which 
a nucleus is exchanging between two equally populated states in which it has a different chemical 
shift[95]. 
 
For the exchange broadening of lines 𝐿𝑊A =  𝐿𝑊obs  −  𝐿𝑊nat   (where the natural line 
width 𝐿𝑊nat  =
1
𝜋𝑇2
∗ includes inhomogeneity broadening) the following approximations 
are commonly used: 
slow exchange: 1 𝜏𝐴 = 𝑘𝐴 = 𝜋 𝐿𝑊A  
fast exchange: 1 𝜏𝐴 = 𝑘𝐴 =  
∆𝜔2𝑝𝐴𝑝𝐵
2
𝐿𝑊A
  
To study exchange between multiple sites or reactions involving more complex kinetic 
mechanisms, the Bloch equations, modified for chemical exchange, under steady state 
conditions, can be represented in a matrix notation (Binsch, 1968) that has been 
included in the NMRKIN software[2] as: 
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𝐀𝐌 = 𝑖CP (2) 
 
𝑴 is a column vector containing the magnetizations 𝑀𝑖  of the nuclei which are subject 
to chemical exchange; 
𝐏 is a column vector with populations (mole fractions) of the reaction components; 
𝐶 =  𝐵1𝑀0;  
𝐀 is a square matrix that contains the: 
 
𝐀 = 2𝜋𝑖  𝐈𝜈 − 𝐖0 +  𝐑2 +  𝐊 (3) 
 
I is the unit matrix; 
is a variable frequency defining the frequency range; 
W0 is a diagonal matrix with Larmor frequencies i; 
R2 is a diagonal matrix with transverse relaxation rates, R = 1/𝑇2
∗ = LW (line width at 
half height); 
K is a matrix containing the exchange rates. 
 
The total magnetization is the sum of the individual magnetization components: 
 
𝑀𝑡𝑜𝑡 = 𝐈
𝑇𝐌 = 𝑖𝐶1𝑇𝐀−1𝐏 (4) 
 
To calculate lineshape it is necessary the inversion of the matrix 𝐀 for each point of the 
spectrum. From equation (4) the corresponding frequency is calculated: 
 
𝐹 𝑡 =  𝐈 exp     –𝐊 + 2π𝑖𝐖0 −  𝐑2  𝑡  𝐏 (5) 
 
After Fourier transformation the obtained spectra is the same obtained for equation (4). 
With this procedure there is the advantage that typical processing steps as zero filling or 
apodization functions can be incorporated into lineshape simulation. 
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4.2.2 Lineshape simulation through NMRKIN  
 
The matrix notation used till now was implemented within MATLAB language to 
create the routines of NMRKIN[2] necessary for lineshapes cross-sections simulations. 
Input data for NMRKIN software should be a MATLAB matrix or, as in this case, an 
ASCII format directly generated from NMRlab, an NMR processing software 
implemented in MATLAB[59]. 
NMRKIN uses the simulation of the proton and the nitrogen dimensions of HSQC 
spectra that allows calculation of off-rates for protein-ligand interaction observed at 
individual amino acids of the protein. The simultaneous simulation of the cross-sections 
of both dimension give the possibility to consider the effect of the line broadening when 
it occurs in one of the two dimension. 
When the program is started a setup file is requested to determine all important 
parameters. 
Required input parameters: 
LW: line width 
w: position of the line 
𝜏21  “off-lifetime” 
𝜏23  “off-lifetime” 
𝑝𝐴 and 𝑝𝐵or 𝑝𝐶  because 𝑝𝑇𝑂𝑇 = 1 
In the simulation identical exchange parameters (P, and koff) and different peak 
separations (N and H) are considered. The relative intensity of lines in the second 
dimension are used to scale the intensity of lines in the first dimension and vice versa. 
Parameter adjustment can be performed manually, as in this work, or by a least squares 
routine available in the MATLAB optimization toolbox. 
NMRKIN software used for lineshape simulations includes a series of mechanism that 
are commonly observed in proteins and allows the implementation of equations 
corresponding to additional mechanisms in the form of MATLAB scripts. The most 
common mechanism of protein ligand interaction can be viewed as bimolecular second 
order interaction between a protein and a ligand. More complex mechanisms could 
involve intermediates or parallel binding reactions in which different conformers of a 
protein, existing in parallel in the free form, converge to a single end point in the 
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protein-ligand complex. Many more complex mechanisms are theoretically feasible 
although it is usually very difficult to fit calculated lineshapes to the experimental ones. 
 
4.2.3 One step binding mechanism  
 
One of the mechanisms described by NMRKIN is the bimolecular simple one step 
second order reaction that could be represented by the equation: 
P + Ln 
𝑘12
⇄
𝑘21 
PL1L2 
employing a two-state binding mechanism. 
 
The exchange matrix used in NMRKIN to describe the reported binding mechanism is : 
 
𝐊 =   
𝑘12   L −𝑘21
−𝑘21 𝑘12   L 
  =   
𝑘12
′ −𝑘21
−𝑘21 𝑘12
′   
 
Exchange between two states is described by mole fractions (= the populations pi) of 
one of the two states (𝑝 𝑃  = 1 − 𝑝 PL1L2  ), the line widths of the two signals and 
their frequencies separations (Δ𝜈𝑃−PL1L2 ). 
Here the position of the equilibrium between the two states depends on the affinity of 
the ligand L for the two protein binding sites and on amount of L that has been added. 
At the equilibrium  
𝑑 P 
𝑑𝑡
 =  
𝑑   𝑃𝐿1𝐿2 
𝑑𝑡
 = 0; and therefore 𝑘12 L 𝑝P  =  𝑘21𝑝PL1L2 . The 
effective on-rate 𝑘12
′  =  𝑘12   L  depends on the concentration of the ligand L, unknown 
at the equilibrium. 
This bimolecular mechanism is referred in Chapter 8 as m21 binding mechanism. 
 
4.2.4 Two step binding mechanism  
 
In this work, a mechanism for two-stages binding was implemented to simulate the 
lineshapes of cL-BABPs interacting with two bile acid molecules. 
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The kinetic model was written taking into account (i) the presence of a generic 
intermediate that could arise from different types of bound species; (ii) the presence of 
two binding sites, (iii) the dependence of both binding steps on the ligand concentration 
and (iv) the independence of the first on-rate from the second one and vice versa. 
The implemented mechanism is described by 
P + L
𝑘12
⇄
𝑘21 
PLn +  L 
𝑘23
⇄
𝑘32 
 PL1L2 
 
In this model the on-rate and the off-rate of the two binding steps are different and it is 
assumed that second ligand binds sequentially after the formation of the intermediate 
PL. 
Furthermore it is assumed that there is no direct conversion of the free protein P into 
PL1L2, i.e. the rates 𝑘13 and 𝑘31 have a value of zero. 
The rate matrix for this case is: 
𝐊 =  
𝑘12
′ + 𝑘13 −𝑘21 −𝑘31 
−𝑘12
′ 𝑘21 + 𝑘23
′ −𝑘32 
−𝑘13 −𝑘23
′ 𝑘31 + 𝑘32 
 ≡  
𝑘12
′ −𝑘21 0
−𝑘12
′ 𝑘21 + 𝑘23
′ −𝑘32 
0 −𝑘23
′ 𝑘32 
  
Here  𝑘12
′ =  𝑘12 L  =
1
𝜏12
    and 𝑘23
′ =  𝑘23 L1L2  =
1
𝜏23
    depend on the concentration 
of the added ligand. 
The matrix can be also written as 
𝐊 =
 
 
 
 
1
𝜏12 −
1
𝜏21 0
− 1 𝜏12 
1
τ21 +
1
𝜏23 −
1
𝜏32 
0 − 1 𝜏23 
1
𝜏32  
 
 
 
 
Here 
1
𝜏21 
=  𝑘21 =  𝑘off ,1 and  
1
𝜏32 
=   𝑘32 = 𝑘off ,2. 
For equilibrium conditions we get: 
𝑘12 L 𝑝 P =  𝑘21𝑝 PLn  
 
 𝜏21𝑝 P =  𝜏12𝑝 PLn   
and therefore 
𝜏12 =  𝜏21
𝑝 P 
𝑝 PLn 
  (1) 
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And the same for the second step of the mechanism: 
𝑘23 L 𝑝 PLn =  𝑘32𝑝 PL1L2  
 
𝜏32𝑝 PLn =  𝜏23𝑝 PL1L2  
and therefore 
𝜏23 =  𝜏32
𝑝 PLn 
𝑝 PL1L2 
 (2) 
 
After eliminating 𝑝 PLn  from equation (1) and (2) we get 
𝜏21𝜏32
𝑝 P 
𝑝 PL1L2 
=  𝜏23𝜏12  
With 𝑝 𝑃 +  𝑝 PLn +  𝑝 PL1L2 = 1   
𝜏23 =  𝜏32  
1 − 𝑝 PL1L2 − 𝑝 P 
𝑝 PL1L2 
 
 
The NMRKIN mechanism file was set up with these simplifications and is referred in 
Chapter 8 as m2121 binding mechanism. 
Chapter 5: Apo and holo cL-BABP/S-S resonance assignment 
 
61 
 
5. Apo and holo cL-BABP/S-S resonance assignment 
 
The assignment of the NMR resonances of the cL-BABP/S-S apo and in complex with 
different bile acids, is the first step to study the effect of the disulphide bond 
introduction on the protein structure.  
The cL-BABP/S-S samples used for the assignment were enriched in
 15
N or 
15
N and 
13
C. The protein-ligand complexes were in a ratio 1:3 for the homotypic complexes with 
unlabeled CDA or GCDA and in a ratio 1:2:2 for the heterotypic complex with the 
unlabeled GCA-GCDA (see Tables 1-4). 
In 
1
H-
15
N HSQC spectra every cross-peak corresponds to an amide group and thereby 
correlates an amide nitrogen with its covalently bound proton (Figure 5.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 
1
H-
15
N HSQC spectrum of the cL-BABP/S-S recorded at 500 MHz at 298K. Each cross-peak 
represents an amide proton. The correlated proton and nitrogen shifts (frequencies) can be extrapolated 
from the two axes, where F1 is the first dimension (the amide proton dimension) and F2 is the second, 
indirectly detected dimension (the nitrogen dimension). 
 
The backbone resonance assignment of signals was performed, whenever possible, 
comparing the 2D 
1
H-
15
N HSQC spectra of cL-BABP with and without disulphide 
bond. 
1
H, 
15
N chemical shifts changes observed in cL-BABP/S-S spectra, with respect 
to the ones of cL-BABP, gave a first information about the effect of disulphide bond 
introduction.  
15
N  
 
1
H  
 
1
H  
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In this way only 36% of the backbone resonances of cL-BABP/S-S apo and 77% of the 
cL-BABP/S-S complexed with CDA were assigned. To implement the assignment a 
combination of 2D and 3D TOCSY and NOESY HSQC recorded at pH 5.6 and pH 7.2 
for the apo form and at pH 7.2 for the various holo forms were acquired, thus obtaining 
the assignment of ~90% of the 
1
H, 
15
N resonances. 
The assignment was finally completed using 3D heteronuclear triple resonances NMR 
experiments: CBCA(CO)NH/HNCACB and HNCO, recorded on the 
15
N, 
13
C-labelled 
protein samples. CBCA(CO)NH/HNCACB experiments allowed to extend the 
correlations among the amide nitrogen and its attached proton, to C and C atoms 
through bonds. In these 3D heteronuclear experiments the 3rd dimension corresponded 
to the carbon frequency while the first two dimensions corresponded to the amide 
proton (HN) and the amide nitrogen (N) frequencies. The plane described by these two 
axes depicts the reference 
1
H-
15
N-HSQC spectrum. C and C signals from the (i) and 
the (i-1) residue, which are transferred to the (i)-amide proton in HNCACB, were 
correlated with matching carbon signals of the (i-1) residue, transferred to the (i)-amide 
proton, observed in CACBCONH. The redundancy of information in 3D experiments 
allowed overlapping clusters to be placed in sequential order and then matched to 
specific stretches of amino acid residues within the protein sequence. 
 
ASSIGNMENT PERCENTAGE (%) 
cL-BABP/S-S Apo 93% HN,N - 98% C,C 
cL-BABP/S-S:CDA (1:3) 93% HN,N - 98% C,C 
cL-BABP/S-S:GCA:GCDA (1:2:2) 93% HN,N - 98% C,C - 98% CO 
cL-BABP/S-S:GCDA (1:3) 92% HN,N 
 
Table 5.1 Percentages of resonance assignment of Apo cL-BABP/S-S and cL-BABP/S-S complexed with 
CDA, GCDA/GCA, GCDA. 
 
The assignment of HN, N, and where detected, of C, Cand CO, are reported in 
Tables 1-4.  
Protein assignments of apo and holo (CDA) have been deposited in the Biological 
Magnetic Resonance Bank (BMRB), with accession Number 16310 and 16309. 
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6. The disulphide bridge: relevance and influence on 
BABP dynamics and interaction properties 
 
 The effect of the presence of the disulphide bridge (S-S) on ligand binding and 
backbone dynamics of cL-BABPs has been investigated in the following paper [FEBS 
Journal, 276, 6011-6023, (2009)] by combining different labeling strategies and 
appropriate NMR experiments on protein complexes with GCDA and GCA. 
 The obtained data clearly show that the 1:2 protein:ligand stoichiometry is conserved 
for both ligands in the presence of disulphide bridge, as confirmed also by mass 
spectroscopy analysis. 
 To study exchange regimes among the bound and unbound ligands, 2D 1H-15N HSQC 
spectra, at different temperatures, and DOSY experiments were acquired. The exchange 
between the superficial binding site and the free ligand is the most relevant process, 
independently by the presence/absence of the disulphide bridge. Instead the presence of 
the (S-S) bond modulate the affinity of GCA for cL-BABP. 
 NMR competition experiments clearly highlighted a site-selectivity for GCDA and 
GCA, not observable in the absence of the (S-S). Other data indicated that GCDA 
preferentially populates the superficial site while GCA binds to internal site. GCDA 
seems to assume a different orientation in homotypic complex or when GCA is bound 
to the internal site. 
 Changes in motion propagation within the -barrel, induced by the (S-S), have been 
mapped onto the cL-BABP apo structure and the effect of the binding of GCDA and 
GCA on backbone conformation and mobility has been assessed. 
15
N Relaxation 
experiments and chemical shift perturbation (CSP) analysis were performed for apo cL-
BABP/S-S, for cL-BABP/S-S complexed with CDA, GCDA, GCA, and for the 
heterotypic complex with GCDA-GCA. Protein dynamics is largely influenced by the 
presence/absence of the disulphide bridge. Indeed the presence of the (S-S) bridge 
favors the propagation of slow motions from the C-terminal region of the molecule to 
the N-terminal -sheet in the apo protein, and enhanced backbone motions in cL-
BABP/S-S-CDA complex.  
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My contribution to the following publication, titled: “Disulphide bridge regulates ligand 
binding site-selectivity in liver bile acid binding proteins”, consisted of:  
1. Planning of the NMR experiments for the backbone assignment of cL-BABP/S-S apo 
and holo forms;  
2. Backbone assignment of all the proteins described in the paper; 
3. Acquisition and analysis of 15N relaxation experiments; 
4. Acquisition and analysis of all the titration experiments; 
5. Preparation of introduction, results and material and methods section of the paper and 
collaboration in writing the discussion paragraph. 
  
Disulfide bridge regulates ligand-binding site selectivity in
liver bile acid-binding proteins
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Introduction
Bile acids (BAs) are vital components of many biologi-
cal processes and play an important role in the patho-
genesis of numerous common diseases [1], but
the speciﬁc mechanisms coupling intracellular BAs to
biological targets are not well understood. BAs circu-
late between the liver and intestine through a mecha-
nism known as ‘enterohepatic circulation’, which is a
tightly regulated process, particularly by BAs them-
selves. BA-binding proteins (BABPs), belonging to the
intracellular lipid-binding protein (iLBP) family, play a
vital role in the enterohepatic circulation as cytoplas-
matic transporters of BAs. Understanding the mecha-
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Bile acid-binding proteins (BABPs) are cytosolic lipid chaperones that play
central roles in driving bile ﬂow, as well as in the adaptation to various
pathological conditions, contributing to the maintenance of bile acid
homeostasis and functional distribution within the cell. Understanding the
mode of binding of bile acids with their cytoplasmic transporters is a key
issue in providing a model for the mechanism of their transfer from the
cytoplasm to the nucleus, for delivery to nuclear receptors. A number of
factors have been shown to modulate bile salt selectivity, stoichiometry,
and afﬁnity of binding to BABPs, e.g. chemistry of the ligand, protein plas-
ticity and, possibly, the formation of disulﬁde bridges. Here, the effects of
the presence of a naturally occurring disulﬁde bridge on liver BABP
ligand-binding properties and backbone dynamics have been investigated
by NMR. Interestingly, the disulﬁde bridge does not modify the protein-
binding stoichiometry, but has a key role in modulating recognition at both
sites, inducing site selectivity for glycocholic and glycochenodeoxycholic
acid. Protein conformational changes following the introduction of a disul-
ﬁde bridge are small and located around the inner binding site, whereas
signiﬁcant changes in backbone motions are observed for several residues
distributed over the entire protein, both in the apo form and in the holo
form. Site selectivity appears, therefore, to be dependent on protein mobil-
ity rather than being governed by steric factors. The detected properties
further establish a parallelism with the behaviour of human ileal BABP,
substantiating the proposal that BABPs have parallel functions in hepato-
cytes and enterocytes.
Abbreviations
BA, bile acid; BABP, bile acid-binding protein; CA, cholate; CDA, chenodeoxycholate; CSP, chemical shift perturbation; GCA, glycocholic acid;
GCDA, glycochenodeoxycholic acid; I-BABP, human ileal bile acid-binding protein; iLBP, intracellular lipid-binding protein; L-BABP, chicken
liver bile acid-binding protein.
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nism regulating these interactions is a key step in pro-
viding a model for the transfer of BAs from the cyto-
plasm to the nucleus for delivery to nuclear receptors,
and can be used to inspire the design of therapeutic
agents for the treatment of metabolic disorders, such
as obesity, type 2 diabetes, hyperlipidaemia, and
atherosclerosis [1–3].
BABPs are characterized by a conserved b-barrel
structure, formed by two orthogonal b-sheets, and a
helix–loop–helix motif deﬁning, with ﬂexible loops, the
so-called protein open end, delimiting the entrance to
the barrel cavity. BABPs from various organisms have
been shown to bind bile salts with differences in ligand
selectivity, binding afﬁnity, stoichiometry, and binding
mechanism. The two most extensively characterized
BABPs, namely human ileal BABP (I-BABP) and
chicken liver BABP (L-BABP), share the common
property of binding two bile salt molecules with weak
intrinsic afﬁnities and strong positive cooperativity
[4–6]. I-BABP, unlike L-BABP, displays remarkable
site selectivity for the two main glycoconjugated BAs,
glycocholic acid (GCA) and glycochenodeoxycholic
(GCDA). A number of factors have been shown to
modulate ligand binding, e.g. the chemistry of the
ligand and the nature of the protein residues [7,8]. A
prominent role for protein plasticity was suggested for
L-BABP, where binding was found to be regulated by
a dynamic process and accompanied by a global con-
formational rearrangement [9]. Essential dynamics
analysis of the molecular dynamics trajectories
obtained for L-BABP indicated that the portal area is
the region mostly affected by complex formation, and
that the major concerted motions involve the structural
elements of the open end, which are dynamically cou-
pled in different ways, whether in the presence or in
the absence of the ligands [10]. Another source of
ligand-binding variability may be introduced by the
presence of disulﬁde bridges. Indeed, several cases have
been reported in the literature for members of the
iLBP family where the introduction ⁄ removal of a
disulﬁde bridge was responsible for changes in ligand-
binding stoichiometry and afﬁnities. The removal of a
disulﬁde bond in rat lipocalin-type prostaglandin D
synthase slightly increased the binding afﬁnity for bio-
logical ligands, by leading to a less compact barrel
pocket and allowing a higher number of residues to
contribute to ligand binding [11]. In the cellular reti-
noic acid-binding protein I, the introduction of a disul-
ﬁde bond abolished the structural mobility of the
portal region, thus leading to irreversible retinoic acid
binding [12].
Most liver BABPs belonging to nonmammalian
species have a disulﬁde bond involving the conserved
Cys80 and the cysteine at position 91. For L-BABP,
two forms are known, in which residue 91 can be
either a threonine or a cysteine, although all the stud-
ies presented up to now have dealt with the form
devoid of the disulﬁde bridge [5,9,13–15]. The presence
of a disulﬁde bridge in the protein scaffold of the
homologous liver zebraﬁsh BABP (69.8% identity,
calculated with clustalw) was correlated with the
binding stoichiometry [16], which varied from one
ligand molecule, with a disulﬁde bridge, to two ligand
molecules, with the Cys80–Cys91 disulﬁde bridge
removed. On this basis, in a continuous effort to estab-
lish the determinants of binding stoichiometry and site
selectivity in this protein family, the T91C L-BABP
protein, with a Cys80–Cys91 disulﬁde bridge, has been
studied by different NMR and MS approaches.
The role of the disulﬁde bridge in ligand binding
and the backbone dynamics of L-BABP has been
investigated here by combining different labelling strat-
egies for both ligand and protein with appropriate
NMR experiments. The results clearly show that,
although the binding stoichiometry is conserved, site
selectivity for GCDA and GCA, which is not observa-
ble in the absence of the disulﬁde bridge, is now
present. Changes in motion propagation within the
b-barrel, induced by the disulﬁde bridge, have been
mapped onto the BABP apo structure, and the effects
of the binding of the two most abundant glycoconju-
gated bile salts on the backbone conformation and
dynamics have been clearly assessed.
Results
Effect of disulfide bridge on binding properties
Binding site occupancies
1H ⁄ 15N-HSQC spectra were collected on isotopically
enriched physiological glycine conjugates, GCA and
GCDA (differing only in the presence of a hydroxyl
group at position 12; Fig. S1), complexed with unla-
belled T91C L-BABP at different protein ⁄ ligand ratios
(1 : 0.3, 1 : 0.6, 1 : 1, 1 : 1.5, 1 : 2, 1 : 2.5, and 1 : 3),
in order to monitor the number and occupancy of indi-
vidual binding sites. The spectra obtained for
[15N]GCDA revealed the presence of two main
resonances, corresponding to [15N]GCDA bound to
two distinct binding sites, denoted site 1 (7.17,
117.3 p.p.m.) and site 2 (6.0, 117.5 p.p.m.), whose
chemical shifts did not change during the titration, sug-
gesting the presence of a slow exchange regime
(Fig. 1A). A few other cross-peaks with chemical shifts
very close to those of peak 1 and peak 2 were visible,
and were ascribed to heterogeneous binding at site 1
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and site 2. The unbound resonance (7.8, 119.8 p.p.m.)
was visible at protein ⁄ ligand ratios higher than 1 : 2,
together with exchange peaks between the unbound
and site 1 cross-peaks. During the titration, site 1 and
site 2 1H linewidths were substantially unchanged
(Fig. 2A). The quantitative volume analysis of these
predominant forms indicated that binding site occu-
pancies reached a plateau value, for both sites, at a
protein ⁄ ligand ratio of 1 : 2 (Fig. 2B). The NMR data
thus indicate that, even in the presence of the disulﬁde
bridge, L-BABP maintains the ability to bind two
GCDA molecules, at variance with the homologous
zebraﬁsh protein. This result was corroborated by MS
analysis of T91C L-BABP in complex with GCDA,
indicating the presence of the doubly ligated form in
solution at a protein ⁄ ligand ratio 1 : 2 (data not
shown). Similar NMR results were obtained for GCA,
and 1H ⁄ 15N-HSQC NMR titration experiments, per-
formed on the unlabelled T91C L-BABP with increas-
ing amounts of [15N]GCA, indicated the presence of
the three cross-peaks named site 1 (7.2, 117.5 p.p.m.),
site 1¢ (7.2 and 118.0 p.p.m.), and site 2 (6.122,
117.81 p.p.m.) (Fig. 1B). The cross-peak annotated as
site 1¢ was probably due to the presence of slightly dif-
ferent populations of GCA at this site. The resonance
corresponding to the unbound ligand became visible at
a protein ⁄ ligand ratio of 1 : 2 (7.8 and 120.1 p.p.m.)
and exhibited exchange cross-peaks with site 1. The
chemical shifts of GCA resonances did not change dur-
ing the titration, whereas for some of them a variation
in linewidth was observed (Fig. 2C), suggesting the
presence of a slow to intermediate exchange regime.
Site 2 and free GCA resonances exhibited a linewidth
decrease upon an increase in protein ⁄ ligand ratio. This
behaviour is consistent with exchange with free ligand
being abolished as saturation is approached [17]. The
changes in linewidths did not allow a quantitative
determination of site 2 occupancy. The site 1 linewidth
( 33 Hz), which was broader than that of site 1¢
( 22 Hz), is attributable to exchange with free ligand,
as supported by the observation of exchange peaks for
site 1 and unbound GCA. Both site 1 and site 1¢ line-
widths did not decrease as saturation was approached,
thus conﬁrming the presence of conformational hetero-
geneities of the bound states at superﬁcial sites.
Detection of ligand exchange phenomena
The temperature dependence of GCDA and GCA res-
onances was investigated in the range 280–305 K on
samples with a protein ⁄ ligand ratio of 1 : 3
(Fig. 3A,B). In both cases, a slow exchange regime on
the NMR chemical shift time scale was observed for
site 2, which exhibited, upon temperature increase,
decreased linewidths, reﬂecting the shorter protein cor-
relation time at higher temperatures. In contrast, site 1
and the unbound resonances exhibited line broadening
upon temperature increase, further conﬁrming the
involvement of ligand bound to site 1 in exchange phe-
nomena with the free ligand. Interestingly, at all the
investigated temperatures, the resonance of the
unbound GCA showed a similar linewidth but a higher
intensity with respect to GCDA, reﬂecting a minor
overall afﬁnity of GCA for T91C L-BABP.
One alternative way of detecting exchange phenom-
ena between the different species in solution is through
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Fig. 1. [15N]GCDA and [15N]GCA in complex with T91C L-BABP. 2D 1H ⁄ 15N-HSQC spectra at different protein ⁄ ligand ratios (1 : 0.6, 1 : 1,
1 : 1.5, 1 : 2, and 1 : 3) were recorded at 298 K at 500 MHz. The resonances corresponding to the unbound ligand and to binding sites 1
and 2 are indicated as U, 1, and 2, respectively. The satellite peaks of site 1 and site 2 are also marked. Asterisks indicate exchange peaks.
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the measurement of the self-diffusion coefﬁcient (D)
[18]. It is expected that a ligand molecule that is in
exchange with the free form will show a D-value that
is a linear combination of those of the free ligand and
the protein. Diffusion experiments were performed on
wild-type and T91C L-BABP complexed with GCDA
and GCA at protein ⁄ ligand ratios of 1 : 3, and the
diffusion coefﬁcients, calculated from the analysis of
signal decay as a function of the applied gradient, are
reported in Table 1. From comparison of these values
with those previously obtained for the free ligand
(3.97 · 10)6 cm2Æs)1) and the protein (1.04 · 10)6
cm2Æs)1) [14], it is possible to conclude that exchange
processes between bound and free forms are relevant
for site 1 and negligible for site 2 for both wild-type
and T91C L-BABP. However, in the presence of the
Cys80–Cys91 disulﬁde bridge, the diffusion values of
ligand bound to site 1 were lower than those of the
wild-type protein, suggesting a higher afﬁnity for both
ligands at site 1 of T91C L-BABP.
Site selectivity
Previous observations indicated that wild-type L-
BABP did not show any site selectivity for GCDA
and GCA, and revealed a higher afﬁnity for GCDA
at both sites. T91C L-BABP site selectivity for the
two bile salts was investigated in competition experi-
ments, in which unlabelled GCDA was added to a
solution containing a T91C L-BABP ⁄ [15N]GCA molar
ratio of 1 : 2. One-dimensional ﬁrst increments of the
2D 1H ⁄ 15N correlation spectra for the sample con-
taining an equimolar mixture of [15N]GCA and unla-
belled GCDA (Fig. 4A) showed that the peak
corresponding to site 2 was sharpened but its inten-
sity was marginally affected by GCDA addition. In
contrast, [15N]GCA bound to site 1 was completely
displaced by the unlabelled GCDA as its resonance
disappeared. This behaviour clearly indicates that the
presence of a disulﬁde bridge had introduced site
selectivity. Such an effect was conﬁrmed by the com-
plementary competition experiment, in which the
unlabelled GCA was added to a solution containing
a T91C L-BABP ⁄ [15N]GCDA molar ratio of 1 : 2
(Fig. 4B). In agreement with the selectivity of GCA
for site 2, complete disappearance of the resonance of
[15N]GCDA at site 2 was expected. However, only a
60% reduction of this resonance intensity was
observed, which can be explained by a general overall
higher afﬁnity of T91C L-BABP for GCDA than for
GCA. Interestingly, the presence of GCA at site 2
favoured one secondary form at a superﬁcial site,
characterized by chemical shifts close to the site 1¢
resonance, previously observed in 1H ⁄ 15N-HSQC
spectra of the T91C L-BABP–GCDA complex
(Fig. 1). The change of the population at site 1 in
A
B
C
Fig. 2. Analysis of GCA and GCDA resonances at different pro-
tein ⁄ ligand ratios. Plots of linewidths (A) and volume (B) of amide
proton resonances of GCDA as a function of protein ⁄ ligand ratio:
site 1 (empty circle); site 2 (filled black circle); unbound ligand (filled
grey symbols). Plots of linewidths (C) of amide proton resonances
of GCA as a function of protein ⁄ ligand ratio: site 1 (empty triangle
up); site 1¢ (empty triangle down); site 2 (filled black triangle);
unbound ligand (filled grey triangle).
Disulfide bond affects BABP binding and dynamics C. Cogliati et al.
6014 FEBS Journal 276 (2009) 6011–6023 ª 2009 The Authors Journal compilation ª 2009 FEBS
favour of a new site 1¢ suggests that site 1¢ is the pre-
ferred orientation of GCDA at the superﬁcial site
when GCA is bound to site 2.
The different intensities exhibited by the unbound
GCA and GCDA reﬂect, as previously observed for
wild-type protein, both the lower afﬁnity of the protein
for GCA and the onset of different equilibria between
monomeric and micellar bile salts. Indeed, the critical
micellar concentration of GCDA (2.4 mm) is signiﬁ-
cantly lower than that of GCA (10 mm) [19], and the
broader linewidth of the resonance of unbound GCDA
(22 Hz) with respect to that of unbound GCA (15 Hz)
can be explained by the equilibrium between free
monomeric and micellar GCDA. The comparison of
1H-spectra of the two protein samples at a pro-
tein ⁄GCDA ⁄GCA ratio of 1 : 2 : 2 indicated that the
ﬁnal holo state is independent of the order of addition
of the bile salts and supports the results of competition
data.
In summary, competition experiments pointed to a
site preference of GCDA for site 1 and of GCA for
site 2 in T91C L-BABP, together with a higher afﬁnity
of the protein for GCDA.
Conformational changes induced by disulfide
bridge in the apo and holo forms of T91C L-BABP
The effect of the disulﬁde bond introduction on the
structure of the apo protein was investigated by moni-
toring the 1H ⁄ 15N chemical shifts changes observed in
T91C L-BABP with respect to the wild type. The reso-
nance assignment of signals from backbone and side
chains atoms of the apo form of T91C L-BABP was
performed using standard 3D heteronuclear triple reso-
nance NMR experiments, as described in Experimental
Fig. 3. Stacked plot showing the tempera-
ture dependence of the BA amide 1H
resonances in the temperature range
280–305 K. One-dimensional first increment
of the 2D 1H ⁄ 15N-HSQC spectra collected
on T91C L-BABP–[15N]GCDA (left) and T91C
L-BABP–[15N]GCA (right) complexes, using a
protein ⁄ ligand molar ratio of 1 : 3.
Table 1. Diffusion coefficients of bile salt species. D-values mea-
sured for free CDA and holo L-BABP are 3.97 · 10)6 cm2Æs)1 and
1.04 · 10)6 cm2Æs)1, respectively [14]. Errors in D-values were
estimated to be of the order of 10)8 cm2Æs)1 from the fitting
procedure.
Site 1
(· 10)6 cm2Æs)1)
Site 2
(· 10)6 cm2Æs)1)
Wild type–GCDA 2.28 1.57
Wild type–GCA 2.43 1.28
T91C–GCDA 2.02 1.45
T91C–GCA 2.20 1.48
8.0 7.57.0 6.06.5 [p.p.m.]
A
B
Fig. 4. Bile salt site selectivity experiments. One-dimensional first
increment of the 2D 1H ⁄ 15N-HSQC spectra collected on: [15N]GCA
in a 1 : 2 T91C L-BABP ⁄GCA molar ratio [(A), black line]; [15N]GCA
in the presence of equimolar amounts of unlabelled GCDA (T91C
L-BABP ⁄GCA ⁄GCDA molar ratio of 1 : 2 : 2) [(A), red line];
[15N]GCDA in a 1 : 2 T91C L-BABP ⁄GCDA molar ratio [(B), black
line]; [15N]GCDA in the presence of equimolar amounts of unla-
belled GCA (T91C L-BABP ⁄GCA ⁄GCDA molar ratio of 1 : 2 : 2) [(B),
red line]. The resonances corresponding to the unbound ligand are
indicated as U.
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procedures, together with a combination of 2D and
3D TOCSY and NOESY HSQC spectra recorded at
pH 5.6 and pH 7.2. The observed shift of some cross-
peaks, induced by acidic pH, allowed the assignment
of resonances that substantially overlapped at neutral
pH. Backbone amide resonance assignment was com-
plete at 93%, and resonances of residues Thr72,
Met73, Lys77, Leu78, Asn86, Leu89, Lys95 and Phe96
could not be unequivocally assigned, owing to signal
overlap and ⁄or broadening.
The secondary structure of T91C L-BABP is
substantially unchanged with respect to the wild-type
protein. In particular, the secondary structural elements,
as derived with talos [20], include 10 antiparallel
b-strands and two a-helices in the following regions:
5–8 (strand A), 14–18 (helix 1), 25–29 (helix 2), 34–43
(strand B), 46–53 (strand C), 56–60 (strand D), 66–71
(strand E), 76–85 (strand F), 88–92 (strand G), 96–103
(strand H), 105–113 (strand I), and 116–124 (strand J).
The analysis of chemical shift perturbation (CSP)
induced by the introduction of a disulﬁde bridge
showed that the most signiﬁcant changes occurred at
the level of strand E (Ala68, Asp69, and Ile71), strand
F (Lys79, Cys80, Thr81, and Leu84), strand G (Ser93),
and strand H (His98) (Fig. 5). All of the mentioned
residues are in close proximity to the disulﬁde bridge
connecting strand F and strand G, except for Ile71,
which is, however, contiguous with the 68–69 region
affected by the mutation.
The T91C L-BABP–chenodeoxycholate (CDA) com-
plex was characterized by NMR, and the assignment
of backbone amide resonances, performed on a pro-
tein ⁄ ligand sample of molar ratio 1 : 3, was complete
at 95% (missing assignments for Ala1, Gln7, Ile37,
Asn86, Gln100, and Asn105). Resonance assignments
of apo and holo forms of the protein have been
reported in BiomagResBank (accession numbers 16310
and 16309 for the apo and holo proteins, respectively).
Comparison of the chemical shifts of the apo and holo
forms of T91C L-BABP indicated that the regions
mostly affected by binding are mainly located at the
C-terminal part of the protein, at the level of Lys76,
Thr81, and Val82 (strand F), Val90, Lys92, and Ser93
(strand G), Glu94 (loop GH), Phe96, Ser97, and His98
(strand H), together with a few residues in the N-termi-
nal region, namely Arg32 (helix II), Thr57 (strand D),
and Glu67 (strand E) (Fig. 6). Comparison of CSP
induced by complex formation in wild-type and T91C
L-BABP (Fig. 6A) indicated that the same protein
regions are affected by ligand binding, conﬁrming a
conserved binding mode. A few differences were, how-
ever, observed for some residues gathered around the
ligand bound at site 2 (Fig. 6B), closer to the disulﬁde
bridge.
Backbone dynamics of apo and holo forms of
T91C L-BABP
Backbone dynamics were investigated for the apo and
holo forms of T91C L-BABP to assess the relevance of
backbone motions to ligand-binding properties.
15N T1 and T2 relaxation values were calculated for
the apo form of T91C L-BABP, and several residues,
namely Arg32, Lys52, Phe62, Thr71, Asp74, Cys91,
Lys92, Glu94, Ser97, His98, Gln100, Gly104, Glu109,
Ile111 and Gly115, showed high T1 ⁄T2 ratios, indica-
tive of conformational exchange processes on the
microsecond and millisecond time scales (Fig. 8). Inter-
estingly, the introduction of the new disulﬁde bond,
connecting strand F and strand G, did not reduce con-
formational motions, which, on the contrary, were
extended to the N-terminal regions of the protein, as a
result of changes in motion propagation, within the
b-barrel (Fig. S2).
The relaxation experiments were also performed
on a holo T91C L-BABP–CDA sample at a pro-
tein ⁄ ligand ratio of 1 : 3. In these conditions, the
protein is substantially saturated and a negligible
population of the free protein is present, as derived
from the analysis of titration experiments performed
on the 15N-labelled protein (data not shown). As a
consequence, the detected exchange contribution can
be related to protein conformational motions rather
than to free-bound exchange. Analysis of T1 ⁄T2 ratios
Fig. 5. CSP upon disulfide bridge introduc-
tion. Chemical shift differences between
apo T91C L-BABP and wild-type (WT)
L-BABP, at pH 7 and 298 K, calculated as
Dd(HN,N) = [(DdHN(T91C – WT)2 +
DdN(T91C ) WT)2 ⁄ 25) ⁄ 2]1 ⁄ 2) are plotted
versus residue number. The dotted line
corresponds to the mean value plus one
standard deviation.
Disulfide bond affects BABP binding and dynamics C. Cogliati et al.
6016 FEBS Journal 276 (2009) 6011–6023 ª 2009 The Authors Journal compilation ª 2009 FEBS
showed that slow motions were not quenched upon
ligand binding. Indeed, high T1 ⁄T2 ratios were
observed for Tyr9 and Gln11 (strand A), Arg32 (helix
II), Val90, Lys92, and Glu94 (strand G), Phe96 and
Ser97 (strand H), Phe113 (strand I), and Arg120 and
Val125 (strand J) (Fig. 7). We can conclude that, at
variance with what was observed for wild-type protein
(Fig. S2), T91C L-BABP complexation with CDA
enhanced backbone motions that were already present
in the apo protein, except for residues belonging to
strand C and strand D and to loop EF and loop IJ.
In view of the physiological relevance of bile salt
conjugation, which prevents passive diffusion of bile
salts across cell membranes, the NMR analysis was
extended to glycoconjugates, namely GCDA
and GCA. Both homotypic complexes (T91C
Fig. 6. Chemical shift changes upon CDA
binding at pH 7 and 298 K. (A) Chemical
shift differences between apo and holo
resonances for T91C (black) and wild-type
(WT) (grey) L-BABP, calculated as
Dd(HN,N) = [(DdHN(T91C ) WT)2 + DdN(-
T91C ) WT)2 ⁄ 25) ⁄ 2]1 ⁄ 2), are plotted versus
residue number. The dotted line corre-
sponds to the mean value plus one standard
deviation of T91C L-BABP CSP. (B) Resi-
dues showing the major differences upon
introduction of a disulfide bridge (Phe2,
Lys79, Cys80, Leu84, Lys92, Glu94, Phe96,
and His98) are coloured in red on the ribbon
representation of L-BABP. The two ligands
are coloured in green, and the position of
the disulfide bridge is in yellow.
Fig. 7. Comparison of T1 ⁄ T2 ratios for apo and holo T91C L-BABP. [15N]amide T1 ⁄ T2 values as a function of residue number measured at
298 K. Filled black circles: apo T91C L-BABP. Empty circles: T91C L-BABP ⁄CDA at a molar ratio of 1 : 3. Dashed and dotted lines corre-
spond to the mean value plus one standard deviation of apo and holo T91C L-BABP, respectively. Error bars are shown.
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L-BABP ⁄GCDA molar ratio of 1 : 3 and T91C L-
BABP ⁄GCA molar ratio of 1 : 3) and the heterotypic
complex (T91C L-BABP ⁄GCDA ⁄GCA molar ratio of
1 : 1.5 : 1.5) were characterized according to their
relaxation properties. Interestingly, substantial quench-
ing of the motions was observed in the presence of all
the glycine derivatives, independent of the hydroxyl-
ation pattern (Fig. 8). A few residues at the C-terminal
end showed T1 ⁄T2 ratios higher than one standard
deviation for the T91C L-BABP–GCDA complex,
whereas the same behavior was observed for residues
at the N-terminal end for the T91C L-BABP–GCA
complex.
Discussion
Several examples have been reported in the literature,
for members of the lipocalin family, where the intro-
duction ⁄ removal of a disulﬁde bridge was responsible
for changes in ligand-binding stoichiometry and afﬁni-
ties [11,12,21]. In intracellular proteins, disulﬁde bonds
are generally transiently formed, owing to the reduc-
tive nature of the cellular environment. It has been
shown that transient disulﬁde bonds are generally not
essential for structural integrity, but can contribute to
protein function. Reversible disulﬁde bridge formation
within intracellular proteins can give rise to local
and ⁄or global conformational changes that may lead
to distinct binding and functional properties [22,23]. In
line with this, we have shown here that the presence of
a disulﬁde bridge, while maintaining the same binding
stoichiometry, induces changes in binding ability, site
selectivity and dynamic properties of L-BABP. Thus,
the study of a recombinant protein with a stable disul-
ﬁde bridge helps in clarifying the role of transient
intracellular disulﬁde bonds.
Both NMR analysis and MS data conﬁrmed the
ability of T91C L-BABP to bind two GCDA or GCA
molecules, indicating that both protein forms are com-
petent for efﬁcient BA binding and transport within
Fig. 8. T1 ⁄ T2 ratios for T91C L-BABP com-
plexed with the different glycoderivatives.
[15N]amide T1 ⁄ T2 values as a function of
residue number measured at 298 K. Upper
panel: T91C L-BABP ⁄GCDA at a molar ratio
of 1 : 3. Middle panel: T91C L-BABP ⁄GCA
at a molar ratio of 1 : 3. Lower panel: T91C
L-BABP ⁄GCDA ⁄GCA at a molar ratio of
1 : 1.5 : 1.5. Dotted lines correspond to the
mean value plus one standard deviation of
the data. Error bars are shown.
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the cell. These results differ from the recently reported
data for the homologous liver zebraﬁsh protein, where
the introduction of a disulﬁde bridge resulted, intrigu-
ingly, in a singly ligated protein, with the cholate occu-
pying the more superﬁcial binding site [16].
Exchange peaks observed in 1H ⁄ 15N-HSQC spectra
of holo proteins, together with diffusion experiments,
showed that exchange processes between bound and
free forms are relevant for site 1 and negligible for site
2, independently of the presence of a disulﬁde bridge
(Table 1). The introduction of a disulﬁde bridge
induced signiﬁcant changes in the GCA exchange
regime for ligand bound to site 1, whose resonance
was observable at all the investigated protein ⁄ ligand
ratios, at variance with the wild-type protein [5]. In
line with this observation is the trend of diffusion coef-
ﬁcients measured for GCA bound to T91C and wild-
type L-BABP, pointing to a higher afﬁnity of this
ligand for T91C L-BABP site 1 (Table 1).
The most relevant feature emerging from the analy-
sis presented here is the ability of the disulﬁde bridge
to modulate recognition at both sites. Indeed, no site
selectivity was previously observed for wild-type
L-BABP [5], whereas it is now clear that when T91C
L-BABP is incubated with only GCDA or GCA, both
binding sites are occupied, but when the two bile salts,
differing only in hydroxylation at position 12, are pres-
ent, GCDA preferentially binds to site 1 and GCA to
site 2. Site selectivity is, however, observed only when
both GCDA and GCA are present, suggesting that it
does not derive from steric exclusion of one bile salt
from a speciﬁc site.
Protein observation was required in order to investi-
gate the structural basis of these varied ligand-binding
properties. Both CSP (Fig. 5) and talos analysis on
the apo protein indicated that no signiﬁcant change in
3D structure occurred. The comparison of CSP for
the holo forms of T91C L-BABP and the wild type
(Fig. 6A) indicated that the same protein regions are
generally involved in ligand binding, even if all the
residues showing signiﬁcantly different CSP values in
the two proteins were gathered around the ligand
bound at site 2 (Fig. 6B). This result is in perfect
agreement with data derived from ligand observation
(Fig. 9), revealing signiﬁcant changes in the chemical
shifts of site 2 resonance for both bile salts. This
behaviour is ascribed to local changes in the chemical
environment due to the introduction of a disulﬁde
bridge, which involves two residues that are in contact
with the ligand bound to the ‘internal’ binding site in
the holo wild-type structure (Protein Data Bank ID:
2JN3 [14]).
Protein dynamics is largely inﬂuenced by the pres-
ence ⁄ absence of the disulﬁde bridge. Indeed, the pres-
ence of the disulﬁde bridge favoured the propagation
of slow motions from the C-terminal region of the
molecule to the N-terminal b-sheet in the apo protein,
and enhanced backbone motions in the T91C
L-BABP–CDA complex, at variance with the behav-
iour of the wild-type protein, where the binding of this
ligand was accompanied by substantial quenching of
motions (Fig. S2).
Molecular dynamics simulation studies revealed dif-
ferently coupled correlated motions for some iLBPs,
depending on the presence and the type of ligand
[10,24]. These data prompted us to evaluate the effect
of BA glycosylation and hydroxylation pattern on pro-
tein conformational motions. Interestingly, all glycode-
rivative mixtures were efﬁcient in reducing backbone
dynamics (Fig. 8), possibly as a consequence of the
onset of more favourable interactions between the gly-
cine moiety and the protein portal region. Indeed,
comparison of the CSP in the presence of CDA or
GCDA (Fig. 10) suggested that the most affected
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Fig. 9. Comparison of [15N]GCDA and
[15N]GCA in complex with wiild-type (WT)
L-BABP (black) and T91C L-BABP (red).
Superposition of 2D 1H ⁄ 15N-HSQC spectra
of [15N]GCDA (left panel) and [15N]GCA
(right panel) at a 1 : 3 protein ⁄ ligand molar
ratio. The resonances corresponding to the
unbound ligand and to binding sites 1 and 2
are indicated as U, 1, and 2, respectively.
Exchange peaks between site 1 and
unbound resonance are labelled with
asterisks.
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residues are located at the level of the portal area, as
expected in response to the protrusion of the glycine
moieties, and at the level of strand F, strand H and
strand I, in close contact with the ligand bound at site
2. Speciﬁcally, the chemical shift variation observed at
the portal area for Arg32 and Asp33 suggests a differ-
ent positioning of helix II in the two complexes.
Arg32, characterized by high T1 ⁄T2 values in the apo
protein and in all of the investigated holo proteins,
thus plays a key role in regulating the positioning of
the helix–loop–helix motif with respect to the b-barrel
in order to accommodate the different BAs.
Analysis of relaxation data obtained for the glycode-
rivatives showed that GCDA was able to quench
motions affecting the protein open end (helical and
loop EF regions), whereas the bound GCA mostly
inﬂuenced the C-terminal region of the protein, in
agreement with the site selectivity observed for the two
ligands. Interestingly, the heterotypic complex, in
which the proper ligand is expected to be located at
the corresponding binding site, still presented a few
residues with high T1 ⁄T2 values, especially at the
N-terminal end. The competition data (Fig. 4) indi-
cated that GCDA preferentially populates site 1¢ when
GCA is bound to site 2, and this different orientation
at the superﬁcial site may induce different motional
properties at the N-terminal end. The detected site
preferences and changes in chemical shifts in hetero-
typic complexes further establish a parallelism with the
behaviour observed for I-BABP and its mutants [8],
thus substantiating the previous proposal that BABPs
exert a parallel function in hepatocytes and enterocytes
[4,25].
In conclusion, it is shown here that the introduction
of a disulﬁde bond makes the protein competent for
site selectivity. NMR data indicated that protein con-
formational changes induced by the disulﬁde bond are
small and gathered around the inner binding site,
whereas signiﬁcant changes in backbone motions are
observed for several residues distributed over the entire
protein. Site selectivity appears, therefore, to be gov-
erned by protein mobility, rather than by steric factors
related to the hydroxylation pattern of the ligand, in
agreement with what has been observed for other
BABPs [4,25]. These results once more underline the
tight connection between ligand-binding phenomena
Fig. 10. Chemical shift changes upon CDA
or GCDA binding to T91C L-BABP at pH 7
and 298 K. (A) Chemical shift differences
between apo and holo resonances for CDA
(black) and GCDA (grey) complexes, calcu-
lated as Dd(HN,N) = [(DdHN(T91C ) WT)2
+ DdN(T91C ) WT)2 ⁄ 25) ⁄ 2]1 ⁄ 2), are plotted
versus residue number. The dotted line cor-
responds to the mean value plus one stan-
dard deviation of T91C L-BABP CSP. (B)
Residues showing the major differences in
the two complexes (Tyr9, Leu27, Gln42,
Val49, Thr50, Thr59, Asp74, Cys80, Lys86,
and Arg124) are coloured in blue on a ribbon
representation of L-BABP.
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and protein mobility in this protein family, and set the
basis for further NMR kinetic studies based on line-
shape analysis and relaxation dispersion measure-
ments.
Experimental procedures
Protein expression and purification
The expression plasmid for T91C L-BABP was obtained
from that of wild-type L-BABP using the Quickchange
(Stratagene, La Jolla, CA, USA) mutagenesis kit. The pres-
ence of the desired mutation was conﬁrmed by plasmid
sequencing. Recombinant T91C L-BABP was expressed
from Escherichia coli and puriﬁed to homogeneity as previ-
ously described [9]. Delipidated T91C L-BABP was
obtained in a yield of 95 mgÆL)1 of rich medium. 13C ⁄ 15N
labelling was achieved using M9 minimal media containing
1 gÆL)1 15NH4Cl and 4 gÆL
)1 13C-enriched glucose, follow-
ing protocols reported in the literature [26]. 15N-labelled
and 13C ⁄ 15N-labelled T91C L-BABP were both obtained
with a 75 mgÆL)1 yield from minimal media. Protein con-
centrations for sample preparation were determined spec-
trophotometrically. The presence of the disulﬁde bridge was
conﬁrmed by MS.
NMR sample preparation
NMR studies on the apo protein were performed on
0.5 mm 15N ⁄ 13C-labelled samples of T91C L-BABP dis-
solved in 30 mm potassium phosphate buffer in 95%
H2O ⁄ 5% D2O. The pH of the solutions was 5.6 or 7.2.
Unenriched BAs and [24-13C]glycocholate were purchased
from Sigma (St Louis, MO, USA). [15N]Glycine conjugates
of CDA and CA were prepared as previously reported [5].
The titration of the unlabelled T91C L-BABP with increas-
ing amounts of [15N]GCDA or [15N]GCA was performed
at seven protein ⁄ ligand ratios (1 : 0.3, 1 : 0.6, 1 : 1, 1 : 1.5,
1 : 2, 1 : 2.5, and 1 : 3), and the preparation of the holo
protein samples was performed following a procedure previ-
ously described [5]. Protein–ligand complexes were analysed
at pH 7.2 on 0.5 mm T91C L-BABP samples; each pro-
tein ⁄ ligand molar ratio sample was prepared and analysed
twice, in order to minimize errors.
NMR data collection and analysis
NMR spectra were acquired at 298 K on Bruker DMX 500
and Avance III 600 spectrometers equipped with a 5 mm
TCI cryoprobe and a Z-ﬁeld gradient. Data were processed
with nmrpipe [27] and visualized with nmrview [28]. For
the assignment of apo and holo protein resonances, the
following experiments, 1H ⁄ 15N-TOCSY HSQC and NOESY
HSQC, together with HNCACB, CBCA(CO)NH and
HN(CA)CO were performed. The secondary structure ele-
ments were derived with the software talos [20] from
chemical shift data of HN, N, HA, CA and CB nuclei.
15N-relaxation experiments
15N-relaxation experiments for apo and holo (T91C
L-BABP ⁄CDA molar ratio of 1 : 3) samples were acquired
at 600 MHz at pH 7.2. A dataset of 14 variable delays (2.5,
20, 60, 100, 150, 200, 300, 400, 600, 800, 1000, 1500, 1700
and 2500 ms) was used for T1 measurements, and a dataset
of nine variable delays (16.96, 33.92, 50.88, 67.84, 101.76,
135.68, 169.6, 220.48 and 237.44 ms) was used for T2 mea-
surements. For T91C L-BABP in complex with CDA, a
dataset of nine variable delays (0.01, 180, 360, 540, 720,
900, 300, 1080, 1260 and 1440 ms) was used for T1 mea-
surements, and a dataset of seven variable delays (16.96,
33.92, 50.88, 67.84, 101.76, 220.48 and 237.44 ms) was used
for T2 measurements. T1 and T2 values were determined for
112 nonoverlapping cross-peaks. For the holo T91C
L-BABP in complex with GCDA, GCA, or both (T91C
L-BABP ⁄GCDA ⁄GCA molar ratio of 1 : 1.5 : 1.5), 10 vari-
able delays (10, 60, 180, 300, 450, 600, 740, 900, 1100, 1200
and 1400 ms) were used for T1 measurements, and 10 vari-
able delays (16.98, 33.16, 49.74, 66.32, 82.9, 99.48, 132.64,
149.22, 198.96 and 232.12 ms) were used for T2 measure-
ments, recorded at 500 MHz. T1 and T2 relaxation values
were estimated for 92, 65 and 86 residues for the complex
with GCDA, the complex with GCA, and the heterotypic
complex, respectively.
Titration experiments
1H ⁄ 15N-HSQC spectra of unlabelled protein complexed with
labelled ligands were acquired with a 1H spectral width of
6510 Hz and 1024 points, zero-ﬁlled to a total of 2048 points.
Relaxation delays of 1.7 s were employed. In the 15N dimen-
sion, 256 increments were collected, with a sweep width of
2032 Hz, zero-ﬁlled to a total of 1024 points.
The linewidth dependence of ligand 1H resonances as a
function of protein ⁄ ligand ratio was followed through the
ﬁrst increment of 2D 1H ⁄ 15N-HSQC spectra recorded
under identical conditions (8000 points on a sweep width of
6510 Hz).
The temperature dependence of the BA amide 1H reso-
nances for a protein ⁄ ligand molar ratio of 1 : 3 was fol-
lowed through the ﬁrst increment of a 2D 1H ⁄ 15N-HSQC
spectrum collected with 8000 points on a sweep width of
6510 Hz in the temperature range 280–305 K.
Diffusion experiments
15N-edited diffusion experiments were performed on sam-
ples of wild-type and T91C L-BABP in complex with
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[15N]GCDA and [15N]GCA at protein ⁄ ligand ratios of
1 : 3, in order to determine the diffusion coefﬁcients of pro-
tein-bound ligands as compared with those of the free mol-
ecules. The pulse program was obtained by combining the
standard HSQC pulse scheme with a pulsed-ﬁeld gradient
stimulated echo module employing bipolar gradients under
the same conditions previously reported [6]. The measured
signal volumes as a function of the applied gradient were
ﬁtted to the following equation, using a nonlinear least
squares minimization:
I ¼ Ið0Þ exp½Dc2G2d2ðD d=3 s=2Þ ð1Þ
where D is the translational diffusion coefﬁcient, c is the
1H gyromagnetic ratio, G is the gradient strength, D and d
are as deﬁned above, and s is the gradient pulse separation.
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7. NMR lineshape and relaxation analysis of the 
binding mechanism of cL-BABPs with two bile acids 
 
Lineshape analysis of NMR signals and relaxation dispersion experiments can provide a 
direct view of the mechanism and the kinetic rates of binding events or exchange 
processes. In the following paper [Chemistry, A European Journal, submitted], 
lineshape analysis of two-dimensional 
1
H-
15
N-HSQC spectra and relaxation dispersion 
experiments have been used to probe the molecular recognition and the complex uptake 
mechanism of two bile salt molecules by BABPs.  
 cL-BABP/S-S and cL-BABP were titrated with GCDA. For each of the thirteen steps of 
the titration, in the protein:ligand ratios range 1:0 to 1:3.5, a 
1
H-
15
N-HSQC spectrum 
was recorded. 
 NMR lineshape analysis of individual residues provided a direct view of the interaction 
mechanisms. A “conformational selection” model has been postulated as the initial 
recognition process, where the dynamics observed in the apo-form is essential for ligand 
uptake, leading to conformations with improved access to the cavity.  
 Relaxation dispersion experiments were further performed to investigate the nature of 
interconverting conformers in the apo form. The analysis of the obtained data confirmed 
the existence of a conformational selection model, and the presence of a “holo like” 
conformation in the absence of the ligand. 
 Subsequent multistep events could be modelled, in few instances, with a two step 
binding mechanism, where intermediate species should be considered even if they were 
not always easily detectable. Nature, position and lifetime of the intermediates could be 
influenced by several factors and could correspond to various conformations adopted by 
the protein in its free state or bound with different amount of GCDA. 
 Both cL-BABP/S-S and cL-BABP, in the ligand-bound states, exhibit a slow time-scale 
flexibility, suggesting a reorganisation of the protein occurring after that saturation is 
reached.  
 A common binding mechanism was proposed for cL-BABP/S-S and cL-BABP on the 
basis of lineshapes analysis. 
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 The main differences between the two proteins behaviour are related to their affinity for 
GCDA, influencing the kinetics of the first exchange process. 
 
My contribution to the following paper, titled “Site-specific investigation of steady-state 
kinetics and dynamics of the multistep binding of bile acid molecules to a lipid carrier 
protein”, consisted of: 
1. A period of work at the NMR laboratory of the University of Birmingham, under the 
supervision of Prof. U.L. Günther, (i) to acquire the knowledge necessary to deal with 
lineshape and relaxation dispersion studies, through an appropriate analysis and 
simulation procedures, using the dedicated NMRKIN software, and (ii) to register NMR 
titration experiments necessary for the study of the protein-ligand interaction 
mechanisms; 
2. Setting the NMR experiments for cL-BABPs titration, finding conditions and 
parameters to better understand the interaction mechanisms; 
3. Acquisition and analysis of the obtained data; 
4. Paper writing in which I prepared the result section and significantly contributed to the 
development of the discussion. 
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Kinetic mechanism of bile salt binding to a lipid carrier 
Site-specific investigation of steady-state 
kinetics and dynamics of the multistep binding 
of bile acid molecules to a lipid carrier protein. 
 
Clelia Cogliati[a,b], Laura Ragona[a]*, Serena Zanzoni[b], Ulrich Günther[c], Sara 
Whittaker[c], Christian Ludwig[c], Simona Tomaselli[a], Michael Assfalg[b] and 
Henriette Molinari[b]* 
 
The investigation of multi-site ligand protein binding and multistep 
mechanisms is highly demanding and represents a fundamental 
question at the interface between chemistry and biology. Advanced 
NMR approaches, such as 2D 
1
H-
15
N line shape analysis, allowing a 
reliable investigation of ligand binding occurring on microsecond to 
millisecond time scales, have been here extended to model, for the 
first time, a two-step binding mechanism. The molecular recognition 
and the complex uptake mechanism of two bile salt molecules by lipid 
carriers is an interesting example, here discussed, showing that 
protein dynamics has the potential to modulate the macromolecule-
ligand encounter. Kinetic analysis supports a conformational selection 
model as the initial recognition process, where the dynamics 
observed in the apo-form is essential for ligand uptake, leading to 
conformations with improved access to the cavity. Subsequent 
multistep events could be modelled, for several residues, with a two-
step binding mechanism. The protein, in the ligand-bound state, still 
exhibits a conformational rearrangement occurring on a very slow 
time-scale, as observed for other proteins of the family. A global 
mechanism suggesting how bile acids accesses the macromolecular 
cavity is thus proposed.  
 
Introduction 
It is now well recognized that bile acids are important signalling 
molecules that regulate a network of metabolic pathways 
including lipid, glucose, drug and energy metabolism[1, 2], although 
the specific mechanisms that couple intracellular lipid processing 
to biological targets and signalling pathways are not yet well 
understood. In recent years, a number of transport proteins 
expressed in the liver and intestine, belonging to the intracellular 
lipid binding protein family (iLBP), and specifically involved in bile 
acid transport, have been recognized to play central roles in 
driving bile flow, with complex regulation of activity and function in 
the nucleus, cytoplasm and membrane. 
Most members of iLBPs bind a single fatty acid or retinoid 
molecule with relatively high affinity[3-5]. Instead, proteins 
belonging to the bile acid binding protein (BABP) subfamily, seem 
to bind two or more ligands, with differences in ligand selectivity, 
binding affinity, stoichiometry and binding mechanism [6-8]. This 
remarkable binding behaviour has implications for the biological 
function and could be relevant for regulating the passage of bile 
acids through the cytoplasm.  
The investigation of multi-site ligand protein binding and of multi-
step mechanisms is highly demanding and a variety of 
biophysical techniques have been applied to tackle this problem. 
New experimental approaches, provided by advances in nuclear 
magnetic resonance (NMR) spectroscopy, have been described 
which allow a reliable and sensitive investigation of ligand binding 
events occurring on microsecond to millisecond (μs-ms) time 
scales using line shape analysis and relaxation dispersion 
experiments [9]. Particularly, the combination of these methods 
can be useful in the study of complex mechanisms, allowing the 
correlation between protein internal dynamics and function[10]. 
However applications have been restricted, up to now, to binary 
systems, such as, among others, retinol interaction with cellular 
retinol binding protein[9] belonging to the here described iLBP 
family. 
The investigation of the binding mechanism leading to the 
formation of ternary complexes, in systems endowed with 
different levels of cooperativity, such as those formed by bile acid 
binding proteins and their lipidic ligands[11]; [12]is a complex task 
which has been addressed, for example, through stopped-flow 
fluorescence kinetic measurements in the case of human and 
rabbit BABPs[13, 14]. Here we report an investigation, employing 
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NMR lineshape analysis and relaxation dispersion experiments, 
on the multistep binding mechanisms at work in the formation of 
ternary complexes between chicken liver BABPs and two 
molecules of sodium glycochenodeoxycholate (GCDA), the most 
abundant salt of the bile acid pool. Chicken liver BABP displays 
the typical barrel structure of the family, formed by two orthogonal 
sheets, and a helix–loop–helix motif defining, with flexible loops, 
the so-called protein open end, delimiting the entrance to the 
cavity hosting lipophilic ligands. The two most extensively 
characterized BABPs, human ileal BABP (I-BABP)[11, 15] and 
chicken liver BABP (L-BABP)[15], share the common property of 
binding two bile salt molecules with weak intrinsic affinities and 
strong positive cooperativity. A number of factors have been 
shown to modulate ligand binding, e.g. the chemistry of the ligand, 
the nature of the protein residues[6, 16] and the presence of 
disulfide bridges[17]. For chicken L-BABP two forms are known, 
differing by the presence of a cysteine or a threonine at position 
91 of the primary sequence, resulting in the formation of a protein 
with (L-BABP/S-S) or devoid of an intramolecular disulphide 
bridge (L-BABP), which was shown to play an important role in 
regulating site selectivity[17]. Although the ligand binding 
mechanism for both L-BABP/S-S and L-BABP, appears to be too 
complex to determine the rates for all the individual steps, the 
overall mechanism is well defined. The data presented allow the 
distinction between two different mechanisms in response to bile 
acid binding, namely induced fit versus conformational selection. 
This analysis provides strong evidence that molecular recognition 
is promoted by a conformational selection process, where the 
protein dynamics improves access to the cavity and is therefore 
essential for ligand uptake. Subsequent multistep events could be 
modelled, in few instances, with a two-step binding mechanism, 
providing information on the involved kinetic parameters. Finally, 
the protein populates an ensemble of states, even in the ligand-
bound state. 
Results and Discussion 
Line shape analysis of NMR resonances can provide a direct 
view of the mechanisms and the kinetic rates of binding events or 
exchange processes[18]. It has been reported[19] that this approach 
can also be applied to protein signals in 2D NMR spectra of 15N 
labelled proteins, allowing kinetic information to be obtained for 
individual residues of the protein. In the case of protein ligand 
interactions the kinetic mechanism can be studied by recording 
spectra at different concentrations of the binding partner. 
Although experimental data often exhibit complex behaviours, it 
was shown[18] that the analysis of theoretical line shapes derived 
for different simplified mechanisms allows the identification of the 
type of kinetic mechanism responsible for a particular behaviour 
under steady-state conditions. 
In this study line shape analysis of NMR signals has been 
used to elucidate the mechanism of bile salt binding to L-BABPs.  
Thirteen 1H-15N HSQC spectra obtained for different 
protein:ligand (P:L) ratios in the range 1:0 to 1:3.5, were analysed. 
The highest P:L ratio was chosen to exceed the reported 1:2 
stoichiometry, to ensure complete protein saturation. 1D cross-
sections, derived from these two-dimensional NMR spectra, at 
the 1H and 15N resonance frequencies of individual protein 
residues provide information on the effect of binding on two 
adjacent nuclei along the entire titration pathway. The two 
neighbouring nuclei should experience the same kinetic 
mechanism, although differential effects could arise from a lack of 
resolution in one dimension. Owing to resonance overlap, the 
detailed kinetic evaluation could only be performed for sixty-two 
residues which are evenly distributed along the protein sequence, 
and are thus representative of all regions of the protein.  
In order to correctly monitor the behaviour of individual 
cross-peak resonances during the titration, backbone resonances 
of holo L-BABP/S-S complexed with GCDA at a P:L ratio 1:2 
were fully assigned, employing standard 3D heteronuclear 
experiments. The assignment is reported in Table S1 in 
Supporting information.  
Line shapes analysis for steady-state spectra along the 
titration path of L-BABP/S-S reveals different behaviours, as 
summarised in Table 1. The first observation derived from the 
cross-sections analysis is that some residues (Table 1), mostly 
distributed on the β-barrel, are characterised by a low intensity 
signal for the apo form, suggesting conformational exchange 
before ligand addition and/or exchange with solvent (Figure 1a). 
However, most of these residues are involved in H-bonds, as 
evidenced both by H/D exchange experiments[20] and by the 
analysis of the apo X-ray structure (PDB code: 1tvq), suggesting 
that the observed reduced intensity mainly derives from 
conformational heterogeneity. Residues showing this type of 
behaviour form a continuous ridge crossing the protein from the 
loop between the two helices to the C strand, involving residues 
in the EF loop, E and D strands (Figure 1b), thus suggesting a 
possible path for correlated motions. It is therefore plausible that 
the observed conformational averaging provides a conformational 
space favouring ligand binding, i.e. an equilibrium P ⇄P*, where 
P* represents a conformation competent for ligand uptake into the 
internal protein cavity. 
Relaxation dispersion (RD) experiments were further 
performed to investigate the nature of the interconverting 
conformers in the absence of ligand. RD experiments detect 
dynamics on a similar time scale as line shape analysis and can 
also provide information about invisible states with populations 
>0.5% in exchange with a more highly populated ground state[21]. 
This analysis was performed for 71 residues of apo L-BABP/S-S, 
free of overlap, with RD spectra recorded at 600 and 900 MHz. 
48 residues showed a contribution of Rex to the transverse 
relaxation rate R2, and dispersion profiles like those reported in 
Figure 2a were obtained. The kinetics of the exchange process, 
the populations of the exchanging states and the absolute values 
of chemical shift differences between ground and excited states 
were extracted, assuming a simple two-state exchange model. 
The chemical-shift differences obtained from relaxation dispersion 
data (
regions are evenly distributed in the protein scaffold (Figure 2b) 
and map those regions that show the largest chemical shift 
changes upon bile acid binding (Figure 2c), suggesting that the 
free protein samples a minor conformation similar to the ligand-
bound state. The chemical shift changes between major and 
minor species obtained from relaxation dispersion data (
potentially provide structural information on otherwise 
inaccessible conformational states. Linear correlations of 
vs. the chemical shift differences between apo and holo 
states have been interpreted as a small population of a high 
energy conformation similar to the final holo state arising from the 
apo protein[22]. Such a behaviour, when observed, is an indication 
that a “conformational selection” mechanism is driving the ligand 
recognition process.  
For L-BABP/S-S in spite of a generally good qualitative 
agreement between RD results () and the chemical shift 
differences between apo and holo states (Figure 2b, c), a 
limited quantitative agreement was observed. The observed 
differences were larger than the experimental uncertainties, 
despite the good fit obtained for the RD spectra. The lack of 
correlation can be explained in part by the presence of direct 
interactions between several residues of L-BABP/S-S and the 
ligand, which are expected to have a significant influence on the 
chemical shifts of the bound state. Furthermore differences in 
chemical shift changes determined by RD and HSQC of different 
states of a protein are often indicative of a more complex binding 
mechanism involving states with chemical shifts different to those 
of the apo and holo forms[23]. Thus RD data may not be directly 
reconciled within the framework of the two-state exchange model 
employed for the fitting, for example if there is a larger number of 
conformers in exchange with the apo form. Nevertheless, for a 
subgroup of residues we observe a good correlation between  
and (Figure 2d). These residues are mainly located in three 
protein regions, namely the helical and loop regions defining the 
protein open end, the central beta-sheet and the protein anti-
portal region (Figure 2e). A mechanism for ligand uptake, termed 
the “portal hypothesis” was previously proposed where the 
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natural ligand enters the protein through a dynamic area, 
consisting of the helical region and the turns between CD and EF 
strands, before binding inside the cavity[24]. The behaviour of 
BABP/S-S “portal residues” is consistent with the hypothesis that 
a P ⇄ P* equilibrium involves a holo-like conformation, where the 
portal region visits a ligand-accessible open conformation, thus 
supporting a “conformational selection” model of binding.  
Line shape simulation was then applied, where possible, to 
analyse 1H and 15N cross-sections at each titration point. A simple 
one step-model was initially employed but then discarded as 
simulated lines differed from those observed for most of the 
analyzed residues. Therefore a kinetic model describing a two-
step binding mechanism was implemented in the NMRKIN 
software (see Experimental session)[10].for the protein in complex 
with two ligands. The quantitative analysis yielding kinetic 
parameters and a validation of this kinetic model was feasible for 
a group of twenty-one residues (see group A, Table 1).The two-
step binding mechanism can be described by a general equation 
of the type:  
P*+L ⇄PLn+L⇄PL1L2     [1] 
where PLn represents a generic intermediate which could derive 
either from differences in protein conformations or in the type of 
bound species. Such an intermediate is generally not directly 
observed owing to fast exchange with apo or holo protein and/or 
small populations of intermediate states. In some cases, however, 
shoulders in HSQC cross-sections clearly indicated the presence 
of further intermediates. Simulations required that both steps are 
ligand dependent, i.e. kon=kon*[L], differently from the kinetic 
model employed for cellular retinol-binding protein [9]. 
In this line shape analysis conformational exchange in the 
apo form, as identified by lower intensity resonances, was 
considered as a slow outside exchange with equilibrium constant 
Kex (Kex<1) as described previously
[10]. This treatment is 
equivalent to adding an extra reaction component in slow 
exchange except that no chemical shift or reaction rate must be 
assumed for the additional reaction partner[10].This approach 
should be valid in all cases where the apo resonance is not 
exchange broadened. 
For all the analysed residues kinetic parameters for a two-
state binding model show reasonable agreement with 
experimental line shapes indicative of a binding process involving 
an initial fast exchange process with an intermediate of relatively 
low population followed by a slower step.  
The first step, initiated by ligand addition, represents a lower 
affinity interaction with the first ligand molecule, followed by a 
high affinity binding of the second ligand, consistent with an 
allosteric control where the second binding event is favored by 
the binding of the first ligand. This could indicate that the system 
is endowed with some positive cooperativity, in agreement with 
previous results[17].  
Among residues sensing the two-step binding mechanism, 
a subgroup (see group A1, Table 1) exhibits measurable 
chemical shift changes in the first titration steps on the side of the 
apo-protein, typical of a fast exchange regime (koff,1 ≥ 2000 s
-1), 
followed by a slow second step (koff,2  10-20 s
-1). The behaviour 
of D69 is shown as an example in Figure 3a,c. These koff rates 
point to the presence of a transient intermediate. An evaluation of 
the population of each species at the different protein:ligand 
ratios, was obtained from line shape simulation, as reported in 
Figure 3e. The derived intermediate population reaches 20% at 
its maximum, and decays to zero once the two-fold stoichiometric 
amount of ligand has been reached. The residues displaying this 
behaviour are evenly distributed on the protein, consistent with 
the fact that they are part of an allosteric system where binding 
and protein conformational changes are tightly linked  
Another subgroup of the residues fitting a two-step binding 
mechanism (see group A2, Table 1) is characterized by a fast to 
intermediate koff,1 rate (koff,1 ~ 400-600 s
-1) for the first step, 
followed by a slow second step (koff,2 10-20 s
-1) (Figure 3b,d). 
The derived population of the intermediate state appears to be 
maximal (up to 20%) around a 1:1 P:L ratio and decays to zero 
once the two-fold stoichiometric amount of ligand has been 
reached (Figure 3f). Interestingly, mass spectrometry data 
recorded for different protein:ligand ratios (P:L 1:1, 1:2, 1:5) 
showed the presence of a non-negligible population of a protein 
bound to a single bile acid[17], thus suggesting that an 
intermediate could be the singly ligated species PL1. As all the 
residues characterised by the A2 type behaviour (Table 1) are 
localized in the portal region of the cavity (Figure 4), we suggest 
that whenever a singly ligated complex is formed, bile acid binds 
to the superficial site. We do not have evidence whether this 
equilibrium is part of a productive binding mechanism or 
represents an off-pathway intermediate. However, the 
identification of a singly ligated species, where the ligand 
occupies preferentially the superficial site, is consistent with the 
finding that in zebrafish liver BABP, the only reported protein of 
the family exhibiting a 1:1 stoichiometry, the ligand binds at a 
superficial site, located in the portal region[25].  
A large number of residues (see group B, Table 1) is 
characterized by complex lineshapes showing many shoulders 
(Figure 5a). These residues are distributed throughout the β-
barrel region of the protein structure (Figure 5b). Although the 
complexity of such line shapes is beyond the scope of simulations, 
the observation of ligand addition causing shoulders making the 
apo signal gradually disappear has previously been associated 
with series of slowly exchanging conformers as described by 
Scheme 1: 
 
 
 
 
 
 
Scheme 1. Suggested parallel binding mechanisms derived by complex 
behaviour displayed by line shapes. 
Here the heterogeneity in the intermediate state (PLn with n=1,2) 
can only arise from different apo states which all bind the ligand. 
In particular this holds for all those cases where the signal with 
shoulders is also moving upon ligand addition (Figure 3a). 
Shifting signals associated with pseudo slow-exchange line 
shapes is also a clear indication of a low population 
intermediate[10]. 
Binding heterogeneity is also reflected in the 1H-15N HSQC 
spectra of enriched GCDA bound to unlabelled protein at different 
P:L ratios, where multiple resonances are detected for the ligand 
bound at both sites[17].  
The cross sections of a few residues (Table 1) show a holo 
resonance displaying lower intensity compared to the apo signal 
(Figure 5c), suggesting the presence of a slow to intermediate 
exchange between different holo species. Most of the residues 
displaying this behaviour cluster nicely in the two helices and in A, 
B, C and J strands (Figure 5d). This pattern points to modulation 
in protein dynamics after ligand binding consistent with the onset 
of the equilibrium PL1L2⇄PL1L2*. As previously described for the 
conformational equilibria of the apo form, the onset of a similar 
equilibrium for the holo protein was taken into account in the 
simulation by using an external Kex value >1 for those residues 
where the signal intensity was lower in the holo form. This final 
protein rearrangement, relevant for binding affinity, may occur on 
a very slow timescale, as previously suggested for human ileal 
BABP [14]. Interestingly, for one residue (V116) it was possible to 
detect two holo forms exhibiting a measurable chemical shift 
difference of 20 Hz between the two holo resonances, 
corresponding to an upper limit of 125 s-1  for the interconversion 
between PL1L2 and PL1L2* (Figure S1). Relaxation dispersion 
experiments, performed on the holo protein, did not show 
dispersive behaviour for any residue, thus indicating that 
conformational rearrangement should indeed occur on a slow 
time scale, in the order of seconds. 
The same line shape analysis was performed, for 
comparison, on L-BABP (devoid of disulphide bridge), where 42 
residues could be analysed, yielding results in complete 
agreement with the mechanism proposed for L-BABP/S-S.  
In L-BABP an intermediate exchange regime characterizes 
the interconversion between apo conformers, as revealed by the 
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presence of a high number of residues displaying signals with 
lower intensity (see Table 2). The simulation of residues 
exhibiting an apparent slow exchange regime could not be 
performed employing a single step binding mechanism model, 
thus suggesting the presence of an intermediate. The line shapes 
of many residues (see group A, Table 2) located in helical regions 
and in the barrel, have been fitted with a two-step binding 
mechanism model, as observed for L-BABP/S-S. A subgroup of 
residues (see group A2, Table 2) is characterized by a slow koff 
rate for both steps (koff,1  in the range of 20-60 s
-1 and koff,2 in the 
range of 10-20 s-1) while another subgroup (see group A1, Table 
2) by a first step with a fast or a fast to intermediate koff rate (koff,1 
~ 100-2000 s-1), followed by a slow second step (koff,2  10-20 s
-1).  
In general L-BABP exhibits lower koff,1 rates compared to L-
BABP/S-S suggesting a higher affinity of L-BABP for GCDA. As 
an example line shapes simulations of residue S122 are reported 
in Figure 6 a, b. Many residues, evenly distributed in the protein 
scaffold (Figure S2), exhibit lineshapes intensities very similar to 
those of the final holo state around 1:1.6 P:L ratio (Figure 6b). 
This observation is consistent with an allosteric behaviour and 
correlates with the high binding cooperativity reported for this 
protein[12].  
The intermediate species formed along the binding pathway 
in L-BABP are, most likely, interconverting doubly ligated forms, 
as confirmed by mass spectrometry which does not detect a 
singly ligated species at any P:L ratio under 1:2. 1H-15N HSQC 
spectra of the protein recorded during the titration with the ligand 
support the presence of these intermediates. In fact in some 
cases the cross peaks describe a curve from apo to holo state for 
increasing ligand concentrations instead of moving along a 
straight line between the apo and holo cross peaks (Figure 7). 
This behaviour is only possible if low-population intermediates 
with different chemical shifts are present.  
Residues characterized by complex lineshapes, showing 
small shoulders along the titration pathway were additionally 
detected (see group B, Table 2), again suggesting the presence 
of slow binding involving intermediates. Finally, residues were 
detected exhibiting holo resonances with lower intensity with 
respect to the corresponding apo (Table 2), consistent with the 
slow (of the order of 110 s-1)  rearrangement PL1L2 ⇄ PL1L2*.  
The presented analysis allows to rationalise the behaviours 
observed for different residues in the two proteins (L-BABP/S-S 
and L-BABP) contributing to the definition of the following 
simplified multi-step binding mechanism (Scheme 2): 
P⇄P*+L⇄PLn+L⇄PL1L2⇄PL1L2*  with n=1,2 
Scheme 2 General multistep binding mechanism proposed for 
bile salts binding to liver BABPs 
 
These results additionally suggest that the presence/absence of 
a disulphide bridge in L-BABPs is not affecting the general 
binding mechanism, rather it seems to have an  influence on the 
kinetics of the first exchange process, which in turn translates, in 
the case of cL-BABP/S-S, into a less cooperative but site-
selective system towards glycochenodeoxycholic and glycocholic 
salts[17]. cL-BABP does not display any site-selectivity, but is an 
extremely cooperative system[12]. Thus the different behaviour of 
the two proteins may be related to the bile-acid binding capability, 
which seems to be directly correlated with cooperativity.  
In intracellular proteins, disulfide bonds are generally 
transiently formed, owing to the reductive nature of the cellular 
environment. It‟s plausible that equilibrium between oxidized and 
reduced forms of L-BABPs, may respond to different needs for 
ligand uptake.  
 
In conclusion, the combination of dynamic data derived for 
a lipid carrier from line shape analysis and relaxation dispersion 
has facilitated the distinction between two fundamentally different 
mechanisms in response to bile acid binding, namely, induced fit 
versus conformational selection. The data presented here 
unambiguously support the conformational selection model for 
liver BABPs, in which the apo protein samples both the non-
competent and binding competent conformations, involving 
opening at the portal area. Despite the complexity exhibited by a 
ternary complex, the mechanism involved in the binding of the 
two ligands could be tackled providing an estimate of the kinetics 
involved. These findings, while providing a general approach to 
the analysis of complex binding mechanisms, represent the first 
step towards the global description of the mechanism of bile acid 
binding and release within the cell. 
 
 
Figure 1. L-BABP/S-S residues showing a low intensity signal for 
the apo form. a) 1H cross sections through 1H-15N HSQC titration 
spectra of residue L23. Experimental lines are indicated as solid 
lines graded from blue (apo protein) to red (holo protein) for 
subsequent steps of the titration. b) Residues showing low 
intensity signal for the apo form are mapped in colour on the 
structure. In the left panel, residues defining a ridge are colour 
coded from helical region (yellow), through the EF loop (light 
orange) to the C, D, E strands (orange). The right panel  
represents the complementary view obtained after a rotation of 
180° around z-axis. No specific pattern is here identified and all 
residues are coloured in yellow. Selected secondary structural 
elements are labelled. 
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Figure 2. Comparison of chemical shift differences deduced from 
relaxation dispersion and titration data. a) Representative 15N 
relaxation dispersion curves obtained for L21 and R32 at 600 
MHz (blu) and 900 MHz (red). b) Residues showing exchange 
contribution to backbone 15N relaxation dispersion are mapped on 
the structure and are coloured according to their  values using 
a scale from yellow (low values, <0.8 ppm) to red (high values, 
>1.5 ppm). c) 15N Chemical shift differences between apo and 
holo proteins are mapped on the structure and are coloured 
according to their  values using a scale from yellow (low values, 
<0.8 ppm) to red (high values, >1.5 ppm). Data are shown only 
for values of  >0.3 ppm, which is the smallest value detected 
from relaxation dispersion analysis. d) Correlation between  
values, obtained from relaxation dispersion measurements, and 
differences (between 15N chemical shifts available for apo 
and holo protein states observed for residues: S3, A20, L21, A22, 
I34, I40, Q41, Q56, T59, A68, K76, V102, E109, T110 (slope 0.97, 
R2 0.98). e) Residues for which the linear correlation was 
obtained are indicated as red dotted spheres on the structure. 
Selected structural elements are labelled 
 
Figure 3 Line shape simulation of L-BABP/S-S titrated with GCDA 
using a two step binding mechanism (eq.[1]). a) 15N cross 
sections through 1H-15N HSQC titration spectra of residue D69. b) 
15N cross sections through 1H-15N HSQC titration spectra of 
residue A20. Lines are graded from blue (apo protein) to red (holo 
protein) for subsequent steps of the titration c,d) Line shape 
simulation performed with NMRKIN for residue D69 (c) and A20 
(d) (triangles). Calculated off-rates : koff,1 = 3000 s
-1, koff,2 = 10 s
-1 
for D69; koff,1 = 500 s
-1 and koff,2,= 30 s
-1 for A20. e,f) Populations 
of species P (filled circle), I (empty circle) and PL2 (triangle), as 
deduced from the line-shape analysis, are reported for residue 
D69 (e) and A20 (f).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Mapping of residues characterized by a fast to 
intermediate koff rate in the first binding step (eq. [1]). Residues 
Y14, E16, F17, A20, L21, M30, Q56, G115 are coloured in cyano 
and labelled on the surface of L-BABP/S-S in complex with two 
bile salts. The superficial ligand is coloured in red. 
 
 
Figure 5. Residues characterized by conformational averaging. a) 
I111 15N cross section exhibiting several shoulders, indicated by 
arrows, in intermediate titration steps. Lineshapes are graded 
from blue (apo protein) to red (holo-protein) for subsequent steps 
of the titration. b) Residues showing lineshapes with shoulders 
after the addition of the ligand (T5, W6, Y9, E12, N13, I34, V38, 
E39, F47, T50, N60, F62, T63, G65, A68, T71, D74, G75, A85, 
F96, V102, T110, I111, L118, I119, K123, V125) are labelled in 
blue on the holo L-BABP/S-S complex. c) V125 15N cross 
sections exhibiting low intensity signal for the holo form. 
Lineshapes are graded from blue (apo protein) to red (ligand-
bound protein) for subsequent steps of the titration. d) Residues 
exhibiting low intensity signal in the holo form. (T5, V8, E12, E15, 
A22, L27, M30, V38, E39, T50, Q56, G114, V116, S122, V125) 
are labelled in green on the holo L-BABP/S-S complex. 
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Figure 6. 1H and 15N cross sections through S122 cross peak for 
subsequent steps of the titration of L-BABP/S-S (upper panel) 
and L-BABP (lower panel) with GCDA. Experimental line-shapes 
are indicated as solid lines graded from blue (apo) to red (holo 
protein) for subsequent steps of the titration. a) 1H and 15N cross 
sections through residue S122 in L-BABP/S-S protein. Calculated 
off-rates: koff,1 = 3000 s
-1 and koff,2 = 15 s
-1. b) 1H and 15N cross 
sections through residue S122 in L-BABP. Calculated off-rates: 
koff,1 =  100 s
-1 and koff,2 = 10 s
-1. In b) the lineshapes 
corresponding to P:L ratios of 1:1.3 and 1:1.6 are labelled. 
 
Figure 7. Superposition of the thirteen 1H 15N HSQC spectra, 
recorded for subsequent steps of L-BABP titration with GCDA, 
showing cross-peaks of residue G115 a) and L118 b) moving on 
a „curve‟. The dotted arrow indicates the path followed by the pick 
along the titration going from apo to holo protein. 
 
Table 1 Grouping of residues of L-BABP/S-S according to binding mechanism 
they sense as suggested by lineshapes analysis 
Kinetic model residues 
Kex on Apo 
Y9, L23, I34, F47, V48, N60, F62, G65, 
A68, D69, T71, D74, G75, A85, F96, 
V102, K103, T110, I111, G115, L118, 
K123 
Two step binding mechanism (A)  
A1. Fast/slow exchange 
regime 
S3, V8, E15, A22, L23, L27, V48, D69, 
G87, K103, G114, V116, S122 
A2. Fast to intermediate / 
slow exchange regime 
Y14, E16, F17, A20, L21, M30, Q56, 
G115 
Parallel binding mechanism (B) 
T5, W6, Y9, E12, I34, V38, E39, F47, 
T50, N60, F62, T63, G65, A68, T71, D74, 
G75, A85, F96, V102, T110, I111,L118, 
I119, K123, V125 
Kex on Holo 
T5, V8, E12, E15, A22, L27, M30, V38, 
E39, T50, Q56, G114, V116, S122, V125 
 
 
 
 
 
 
Table 2 Grouping of residues of L-BABP according to binding mechanism they 
sense as suggested by lineshapes analysis 
Kinetic model residues 
Kex on Apo 
Q7, N13, F17, L21, T63, G65, A68, G75, 
K79, A85, L89, T112, G115, V116, L118, 
I119  
Two step binding mechanism (A)  
A1. Fast-fast to 
intermediate/slow 
exchange regime 
G4, L23, E25, L27, M30, S61, K103, L118  
A2. Slow/slow exchange 
regime 
Q7, V8, N13, E15, F17, A20, L21, V38, 
Q56, T112, G114, G115, V116, S122  
Parallel binding mechanism (B) 
W6, E39, I40, F47, T50, T63, G65, A68, 
G75, K79, A85, T112, I119, V125  
Kex on Holo 
V8, A20, L27, M30, K35, V38, I40, F47, 
S51, Q56, V116, V125  
Experimental Section 
Sample preparation. The proteins were expressed as previously 
reported 
[8, 17]
. All the protein preparations were checked by 1D 
1
H 
NMR prior to and after delipidation, and reproducible spectra were 
always obtained for the apo and undelipidated forms. The molecular 
weight of the two proteins and the extent of labelling was verified by 
MALDI mass analysis. NMR samples contained 0.5 mM 
15
N-BABP 
protein dissolved in 30 mM phosphate (Na2HPO4/NaH2PO4), 
90%H2O-10%D2O. The pH of the solutions was 7.2. Protein stock 
solution concentrations were determined by UV. Bile salts were 
purchased from Sigma. The concentration of the ligand stock 
solutions were determined by measuring dry weights using a 
microbalance. Ligands were dissolved in the same 30 mM phosphate 
buffer (pH 7.2). For protein-ligand titration experiments, 
glycochenodeoxycolate was added to the protein in small amounts to 
achieve saturation within 10 steps (P:L ratios employed 1:0, 0.1, 0.2, 
0.4, 0.6, 0.8, 1.0, 1.3, 1.6, 2.0), and three additional aliquots were 
added to ensure the end of titration (P:L ratios 1:2.5, 3.0, 3.5).  
NMR assignments. NMR spectra were acquired at 298 K on 
Bruker spectrometers DMX 500 and Avance III 600 equipped with a 
5mm TCI cryoprobe and Z-field gradient. Data were processed with 
NMRPipe
[26]
 and visualized by NMRView
[27]
. For resonance 
assignment of L-BABP/S-S complexed with GCDA 
1
H-
15
N 3D TOCSY 
and NOESY-HSQC were collected. Standard pulse sequence 
schemes using pulsed field gradients were employed to achieve 
suppression of the solvent signal and spectral artefacts. Proton 
chemical shifts were referenced to external 3-(trimethylsilyl)-3,3,2,2-
d4-propionic acid, while nitrogen chemical shifts were referenced 
indirectly as described
[28]
.  
1
H and 
15
N protein resonance assignment has been reported in 
Table S1 in Supporting information.  
Line shape analysis. For lineshape analysis spectra were 
recorded on a Bruker AVANCE 500 MHz spectrometer equipped with 
a cryogenically cooled 5mm TXI probe. The operating field was 
chosen to keep exchange in a faster exchange regime than it would 
otherwise be at higher field strengths. After each ligand addition, a 
high-resolution sensitivity enhanced 
1
H/
15
N-HSQC spectrum was 
recorded with 2048 × 800 data points. Spectra were processed with 
zero-filling and sine window functions.  
For residues which were not subject to chemical shift 
degeneracy, cross sections in both spectral dimensions were 
extracted from all spectra by carefully selecting slices containing the 
signal maxima. NMRLab software 
[29]
 was employed for spectra 
processing. Line shapes for both dimensions were simulated 
simultaneously for selected kinetic models using the set of thirteen 
experimental spectra. NMRKIN was used to calculate the time 
domain signal for sections of HSQC spectra for a given kinetic 
mechanism assuming steady-state line shapes as described by the 
equations of Gutowsky and McConnell 
[30, 31]
. Chemical shifts of 
signals, line widths, populations, and kinetic rates were adjusted 
iteratively to achieve consistency with experimental data. In the slow 
exchange regime, only an upper limit of the off-rate can be assigned 
because the line shapes depend only slightly on the rate. Residues 
were assigned to the model that best described their line shapes. 
L-BABP/S-S
L-BABP
a
b
 7 
Kinetic model implemented in the NMRKIN software for 
Lineshape Simulations. Lineshapes were simulated as described in 
the original NMRKIN publication 
[10].
. For the case of a two step 
binding mechanism an additional model was implemented which is 
described in the following. As described in 
[10]
 the total magnetization 
is obtained by adding up the individual components: 
 
 
with  where  is the unity matrix, s a 
variable frequency defining the frequency range,  is a diagonal 
matrix with Larmor frequencies ,  a column vector with the 
populations of the individual states,  is a diagonal matrix with 
transverse relaxation rates R = 1/  = 
height),  is a matrix containing the rate constants (rate matrix). 
NMRKIN calculates lineshapes in the time domain according to 
 
followed by the Fourier transformation to obtain the spectrum. 
The mechanism is defined by the matrix  and by associations 
between rates and populations. For the simulations in this work we 
implemented a mechanism for two-stages binding as described by 
 
where ligand is bound in two subsequent steps. 
We assume that there is no direct conversion of free protein P into the 
product with two ligands , i.e. the rates and have a value 
of zero. 
The rate matrix for this case is: 
 
 
 
Here and depend on the 
concentration of the concentration of ligand added. 
For equilibrium conditions we get: 
 
 and therefore  
 
 
and the same for the second step of the mechanism: 
 
 and therefore 
 
 
After eliminating  from equation (1) and (2) we get 
 
 
 
with  
 
 
The NMRKIN mechanism file was set up with these simplifications. 
Relaxation Dispersion. Experiments were acquired on Varian 
Inova spectrometers equipped with room temperature probe heads at 
two static magnetic fields, corresponding to proton Larmor 
frequencies of 600 and 900 MHz using a relaxation compensated 
CPMG dispersion experiment performed in a constant time manner 
[32]
. Spectra were collected as a series of twelve two-dimensional 
spectra with CPMG field strengths CPMG: 50, 100, 150, 200, 300, 400, 
500, 600, 700, 800, 900 and 1000 Hz with repeat experiments 
recorded at fields of 200 and 500 Hz. Eight scans were recorded per 
FID with a 3 s recycle time. The constant time period was set to 40 
ms; the reference experiment was carried out by omitting the CPMG 
period. Spectra were acquired with at least 1024/2=512 complex 
points for 600 MHz data and 1210/2=605 complex points for 900 MHz 
data, in F2 and F1 dimensions, respectively. Processing and analysis 
of the NMR spectra were performed employing NMRlab software 
[29]
. 
For varying echo times, relaxation dispersion curves are obtained 
which depend on the chemical shift differences (), the population of 
the two states, and the exchange rate kex. Exchange rates (kex) were 
determined by fitting relaxation dispersion curves to the general 
expression for the phenomenological transverse relaxation rate 
constant in the case of two-site exchange
[19]
 . 
Pymol (DeLano, W.L. The PyMOL Molecular Graphics System, 
DeLano Scientific, Palo Alto, CA, USA) was used for graphical 
representation of the results employing 1tvq and 2jn3 structures. 
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8.Dynamics and interaction: Additional results  
 
8.1 Lineshape simulation: from “one” to “two binding 
step” mechanisms 
 
In the following paragraph, as a compendium of the previous paper, a short example is 
given of the procedure employed for the selection of the “appropriate” binding model 
for data analysis. 
 
Mechanism files used in NMRKIN, with their respective abbreviation and meaning, are 
listed in Table 8.1.  
 
 
 
Table 8.1. Mechanism files used in NMRKIN software. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
m11.m A ⇌ B 
m21.m P + L ⇌ PL 
m2121.m
 P + L ⇌ PLn + L ⇌ PL1L2 
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Figure 8.1 reports the experimental lineshapes of 8 residues (Y14, E16, F17, A20, L21, 
M30, Q56, G115), obtained during titration of cL-BABP/S-S with GCDA. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1. 
1
H and 
15
N cross sections through 
1
H-
15
N HSQC titration spectra of cL-BABP/S-S residues 
Y14, E16, F17, A20, L21, M30, Q56, G115 firstly simulated with a simple one step model. Experimental 
lines are indicated as solid lines graded from blue (apo protein) to red (holo protein) for subsequent steps 
of the titration. 
 
These cross-sections were initially considered as typical slow exchange lineshapes that 
could be simulated with a second order reaction of the type: 
P + L ⇌  PL  (1) 
where P is the apo protein; L is the ligand and PL is the holo protein. 
The lineshapes simulation, through the m21 mechanism, did not fit with the 
experimental lines observed during the titration.  
The lineshape analysis, performed for comparison on cL-BABP (devoid of disulphide 
bridge), showed that also in this case the simulation of experimental lines could not be 
performed considering a single binding step mechanism. Thus, what was initially 
considered as a simple slow exchange process, in which the line corresponding to P 
decreases, while the line corresponding to PL1L2 increases, without any shift of the 
signal and any intermediate forms, did not properly describe the interaction.  
The presence of an elusive intermediate had to be taken into account to obtain a good 
lineshape simulation. 
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The m2121 kinetic model was subsequently implemented to simulate experimental 
lineshapes. The model represented a two step binding mechanism, by which cL-BABPs 
forms a ternary complex with two bile acid molecules:  
P∗ +  L ⇌
koff ,1
PLn + L ⇌
koff ,2
PL1L2 (2) 
where P∗ represents the protein in one of its apo conformation; L represents the ligand; 
PLn  represents a generic intermediate which could derive either from differences in 
protein conformations or in the type of bound species, and PL1L2 represents the ternary 
complex.  
 
Some examples of simulated lineshapes, not included into the previous paper, are here 
reported.  
 
In Figure 8.2 the simulated 
1
H and 
15
N lineshapes are reported for residue L21 of cL-
BABP/S-S.  
 
 
 
 
 
 
Figure 8.2 Lineshape simulation of L21 residue, obtained through 
1
H-
15
N HSQC titration of cL-BABP/S-
S with GCDA, using a two step binding mechanism (eq.(2)). 
1
H and 
15
N cross sections (panel a and b, 
respectively), are indicated with simple lines. Simulated lineshapes are indicated with triangles. Lines are 
graded from blue (apo protein) to red (holo protein) for subsequent steps of the titration. Calculated off-
rates are reported in Table 2 
 
Figure 8.3 reports examples of 
15
N lineshape simulations of cL-BABP/S-S residues 
characterised by koff,1 values typical of a fast exchange regime (koff,1 ≥ 2000 s
-1
) and koff,2 
values characteristic of a slow exchange regime (~ 15-20 s
-1
).  
 
 
 
 
 
L21
1H
L21
15N
a) b) 
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Figure 8.3 Lineshape simulation of L23, L27 and S122 residues, obtained through 
1
H-
15
N HSQC titration 
of cL-BABP/S-S with GCDA, using a two step binding mechanism (eq.(2)). 
15
N cross sections are 
indicated with simple lines. Simulated lineshapes are indicated with triangles. Lines are graded from blue 
(apo protein) to red (holo protein) for subsequent steps of the titration.  
 
The kinetic constants, obtained for the residues of Figure 8.3 are reported in Table 8.1. 
 
cL-BABP/S-S koff,1(s
-1
) koff,2(s
-1
) Kex(s
-1
) 
L23 2500 20 0,89 
L27 2000 20 1,14 
S122 3000 15 1,02 
 
Table 8.1 Examples of cL-BABP/S-S residues with a fast koff,1 rate, a slow koff,2 rate and various 
equilibrium constants depending on a pre-existing equilibrium among apo forms (Kex<1) or on an 
equilibrium among holo forms (Kex>1). 
 
Figure 8.4 reports examples of 
15
N lineshape simulations of cL-BABP/S-S residues 
characterized by koff,1 values typical of a fast to intermediate exchange regime (koff,1 ~ 
300-600 s
-1
) and a koff,2 values characteristic of a slow exchange regime (~ 10-20 s
-1
).  
 
 
 
 
Figure 8.4 Lineshape simulation of M30, Q56 and G115 residues, obtained through 
1
H-
15
N HSQC 
titration of cL-BABP/S-S with GCDA, using a two step binding mechanism (eq.(2)). 
15
N cross sections 
are indicated with simple lines. Simulated lineshapes are indicated with triangles. Lines are graded from 
blue (apo protein) to red (holo protein) for subsequent steps of the titration.  
 
15N
M30
15N
Q56 G115
15N
L23
15N
S122
15N
L27
15N
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The kinetic constants, obtained for the residues of Figure 8.4 are reported in Table 8.2. 
 
cL-BABP/S-S koff,1(s
-1
) koff,2(s
-1
) kex(s
-1
) 
L21 300 15 1 
M30 400 10 1,05 
Q56 600 20 1,08 
G115 500 20 0,89 
 
Table 8.2 Examples of cL-BABP/S-S residues with a fast to intermediate koff,1 rate, a slow koff,2 rate and 
various equilibrium constants depending on a pre-existing equilibrium among apo forms (Kex<1) or on an 
equilibrium among holo forms (Kex>1). 
 
Examples of 
15
N lineshape simulations obtained for cL-BABP (devoid of disulphide 
bridge) are reported in Figure 8.5 for residues of characterised by koff,1 values typical of 
a fast to intermediate exchange regime (koff,1 ~ 300-600 s
-1
) and koff,2 values 
characteristic of a slow exchange regime (~ 10-20 s
-1
).  
 
 
 
 
 
 
Figure 8.5 Lineshape simulation of L27, M30 and L118 residues, obtained through 
1
H-
15
N HSQC 
titration ofcL-BABP with GCDA, using a two step binding mechanism (eq.(2)). 
15
N cross sections are 
indicated with simple lines. Simulated lineshapes are indicated with triangles. Lines are graded from blue 
(apo protein) to red (holo protein) for subsequent steps of the titration.  
 
The kinetic constants, obtained for the residues of Figure 8.5 are reported in Table 8.3. 
 
cL-BABP koff,1(s
-1
) koff,2(s
-1
) Kex(s
-1
) 
L27 100 10 1,15 
M30 100 10 1,15 
L118 2000 10 0,96 
 
Table 8.3 Examples of cL-BABP residues with a fast to intermediate koff,1 rate, a slow koff,2 rate and 
various equilibrium constants depending on a pre-existing equilibrium among apo forms (Kex<1) or on an 
equilibrium among holo forms (Kex>1). 
 
L118
15N
L27
15N
M30
15N
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Figure 8.6 reports examples of 
15
N lineshape simulations of cL-BABP residues 
characterised by koff,1 (koff,1 ~ 20-60 s
-1
) and koff,2 (10s
-1
) values typical of a slow 
exchange regime.  
 
 
 
 
 
 
 
 
Figure 8.6 Lineshape simulation of A20 and S122 residues, obtained through 
1
H-
15
N HSQC titration of 
cL-BABP with GCDA, using a two step binding mechanism (eq.(2)). 
15
N cross sections are indicated 
with simple lines. Simulated lineshapes are indicated with triangles. Lines are graded from blue (apo 
protein) to red (holo protein) for subsequent steps of the titration.  
 
The kinetic constants, obtained for the residues of Figure 8.6 are reported in Table 8.4. 
 
cL-BABP koff,1(s
-1
) koff,2(s
-1
) Kex(s
-1
) 
A20 20 5 1,34 
S122 60 15 1,1 
 
Table 8.4 Examples of cL-BABP residues with both slow koff,1 and koff,2 rates and various equilibrium 
constants (Kex) depending on a pre-existing equilibrium among apo forms (Kex<1) or on an equilibrium 
among holo forms (Kex>1). 
 
Table 8.5 lists the MATLAB routines used in NMRKIN software to simulate 
experimental lineshapes of cL-BABP/S-S and cL-BABP titrated with GCDA.  
 
 
 
 
 
 
 
 
        a
 Apodization routine from NMRlab 
Table 8.5 Routines used in NMRKIN software.  
 
 
Calling routine 
mklspar.m Read and check parameters 
testpar.m Sample parameter file 
redat.m Read experimental data 
wdwf.m Calculate window funcion
a
 
A20
15N
S122
15N
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8.2 Relaxation Dispersion experiments at various 
GCDA concentrations 
 
The CPMG 
1
H-
15
N HSQC spectra were recorded at two different fields, 600MHz and 
900 MHz, for (i) the apo cL-BABP/S-S protein, (ii) the protein complexed with GCDA 
at 1:0.1 P:L ratio, (iii) the protein complexed with GCDA at 1:1 P:L ratio and (iv) the 
protein complexed with GCDA at 1:2.5 P:L ratio. The NMR relaxation dispersion 
profile of cL-BABP/S-S, at different bile acid concentrations and the comparison 
among the obtained chemical shifts, give the possibility to provide a kex (exchange rate) 
and an hypothetical mechanism of reaction.  
The presence of significant s-ms conformational exchange processes has been 
observed in early stages of the titration, at 0% and 10% ( P:L = 1:0.1) of the ligand. At 
highest concentrations of GCDA relaxation dispersion was no more observable, 
possibly because exchange does not fit with the timescale detected by relaxation 
dispersion experiment. 
Relaxation dispersion profiles at the different concentrations of GCDA are reported in 
Figure 8.7. 
 
Figure 8.7 NMR CPMG (Carr-Purcell-Meiboon-Gill) Relaxation Dispersion profile. R2,eff (s
-1
): relaxation 
rate constant plotted versus CPMG (Hz). The data were collected at two different (B0) magnetic fields: 14,1 
Tesla (in blue) and 21,12 Tesla (in red). Panel a shows the relaxation dispersion profile of residue I111 in 
the apo cL-BABP/S-S; panel b shows relaxation dispersion profile of residue I111 in the complex cL-
BABP/S-S:GCDA at 1:0.1 P:L ratio; panels c and d show how relaxation dispersion is no more visible for 
residue I111 in the complex cL-BABP/S-S:GCDA at 1:1 and 1:2.5 P:L ratio. 
 
Tables 8.6-8.9 report kex rates and extracted for the residues exhibiting non flat 
relaxation dispersion profiles. Obtained data are derived from analysis at four different 
protein:ligand ratios. The data have been analysed, up to now, only with a two-site 
exchange model which does not reflect the complexity of the involved mechanism. 
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Further analysis and experiments are done in order to improve the relaxation dispersion 
analysis.  
 
cL-BABP/S-S 
apo 
kex(s
-1
) (Hz) 2 
E16 733 90.47 2.7 
K19 917.8 96.78 3.8 
A20 755.9 115.29 3.7 
L21 752.3 104.68 2.9 
A22 1135.5 197.67 1.8 
L23 704.7 100.96 2.9 
I28 587.4 121.47 1.8 
K29 789.4 137.29 5 
M30 484.3 322.6 2.3 
R32 650.5 439.45 13.9 
D33 745.9 420.59 26.8 
I34 158.8 811.61 12.1 
K35 774.8 136.76 5.3 
V38 194.4 516.04 8.9 
I40 116 62.69 6.6 
Q41 596 217.04 13.5 
F47 970.2 158.97 17.3 
V48 729 116.46 6.7 
T50 892 435.78 23.1 
S51 427.5 540.73 33.9 
Q56 683.4 136.28 19.3 
T59 37.4 69.67 3.9 
S61 501 336.72 4.6 
F62 663.5 135.42 12 
T63 817 626.34 28 
L64 10.6 995.11 18 
G65 762.4 167.09 38.5 
A68 4.7 628.34 8.4 
D69 1074.6 147.8 38.4 
T71 20.3 873.76 20.1 
G75 534.5 148.36 32.1 
K76 579.7 662.81 85.1 
H83 1961.2 320.5 27 
L84 175.2 440.03 6.8 
S97 648.8 300.19 11.5 
V102 2.9 568.4 8.2 
K103 885.7 234.15 24.3 
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E106 942.6 64.78 7 
V108 585.4 221.42 13.7 
E109 843.8 141.2 43 
T110 1719.9 181.49 11.3 
I111 929.9 149.55 38.1 
K123 1033.4 188.91 18.5 
V125 3629.5 137.64 5 
 
Table 8.6 kex and valuesobtained for the residues of apo cL-BABP/S-S showing a RD profile. The 
obtained parameter 2, indicative of the goodness of the fit, is reported in the third column. 
 
cL-BABP/S-S 
GCDA 1/0.1 
kex(s
-1
) (Hz) 2 
E16 787.4 136.96 5.2 
K19 725 563.65 10.3 
A20 616.2 138.37 4.2 
L21 382.3 378 2.7 
L23 537.1 585.52 8.3 
L27 452.4 164.15 4.2 
K29 788.4 373.82 3.4 
M30 10.4 838.98 3.2 
D33 558 175.44 28.4 
I34 11.6 819.86 12.5 
I37 696.2 681.87 7 
V38 63.4 921.77 8.9 
I40 470.6 411.79 17.3 
F47 63.7 243.72 13.2 
V48 792.8 251.83 6.3 
V49 674.3 303.24 13.4 
Q56 613.3 414.04 15.2 
T63 2016.4 389.26 22.1 
K66 494.7 538.98 3.6 
D69 828.8 558.99 9 
K76 110.3 573.69 19.5 
L84 756 581.76 12.1 
F96 388.7 660.53 21.7 
S97 22.2 899.9 27.7 
V102 23.4 783.48 24.7 
E106 610.8 78.53 1.8 
V108 9.3 292.73 9.5 
K123 459 377.22 30.9 
V125 596 887.82 10.2 
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Table 8.7 kex and valuesobtained for the residues of cL-BABP/S-S complexed with GCDA at a 1:0.1 
P:L ratio, showing a RD profile. The obtained parameter 2, indicative of the goodness of the fit, is 
reported in the third column. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 8.8 kex and valuesobtained for the residues of cL-BABP/S-S complexed with GCDA at a 1:1 
P:L ratio, showing a RD profile. The obtained parameter 2, indicative of the goodness of the fit, is 
reported in the third column. 
 
cL-BABP/S-S 
GCDA 1/ 2.5 
kex(s
-1
) (Hz) 2 
D46 4.9 946.13 7.9 
G114 10.5 360.5 5 
 
 
Table 8.9 kex and valuesobtained for the residues of cL-BABP/S-S complexed with GCDA at a 1:2.5 
P:L ratio, showing a RD profile. The obtained parameter 2, indicative of the goodness of the fit, is 
reported in the third column. 
 
cL-BABP/S-S 
GCDA 1/1 
kex(s
-1
) (Hz) 2 
E12 694.8 507.33 19.9 
E15 35.4 60.25 7.2 
L18 599.3 66.33 11.4 
A20 8.3 383.89 5.9 
L21 4.6 838.78 5 
L23 6.2 483.52 4.7 
L27 3.6 585.46 2.4 
I28 1889.3 843.46 9.6 
M30 104.5 356.24 4 
A31 9.1 788.85 4.5 
T72 187 492.92 26.1 
D74 850.2 175.14 53 
K79 557.6 648.97 2.4 
L84 392.8 43.43 4.6 
L89 808.6 105.83 20.5 
S93 6.6 838.96 9.3 
V125 1213.5 172.14 88 
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8.3 Mass Spectrometry results 
 
To confirm NMR data on cL-BABP/S-S binding stoichiometry and to investigate the 
occupancy of the two binding sites of the protein, mass spectra of cL-BABP/S-S at 
different ratios of 
15
N GCDA were acquired.  
The obtained data confirmed that cL-BABPs, even in the presence of the disulphide 
bridge, maintains the ability to bind two GCDA molecules.  
Moreover, mass spectrometry analysis of cL-BABP/S-S complexed with GCDA 
indicated that both the singly ligated (PL1) and the doubly ligated (PL2) forms are 
present at different concentrations of the ligand (See Figure 8.8), in agreement with the 
general binding mechanism obtained from NMR data. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.8 Mass spectra of cL-BABP/S-S complexed with 
15
N GCDA at different protein:ligand (1:1, 
1:2, 1:5) ratios. P indicates the signal corresponding to the apo protein, PL1 to the singly ligated form, and 
PL2 to the doubly ligated form. 
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Table 8.10 reports the intensity percentages of the peaks for 1:1, 1:2 and 1:5 
protein:ligands ratios.  
 
 
 
 
 
Table 8.10 Percentages of the peak intensities of P, PL1 and PL2 at 1:1, 1:2 and 1:5, protein:ligand ratios, 
where P represent the apo cL-BABP/S-S; PL1 the singly ligated form; PL2 the doubly ligated form. 
 
Table 8.11 reports the normalized values of the intensities scaled on P values. 
 
 
 
 
 
Table 8.11 Normalized values of P, PL1 and PL2 relative intensities, scaled on P, for 1:1, 1:2 and 1:5, 
protein:ligand ratios, where P represent the apo cL-BABP/S-S; PL1 the singly ligated form; PL2 the 
doubly ligated form. 
 
Intensity percentage(%) 
P PL1 PL2 
15N GCDA 1:1 24 64 12 
15N GCDA 1:2 22 63 15 
15N GCDA 1:5 13 52 35 
  
  
Normalised Intensity(%) 
P PL1 PL2 
15N GCDA 1:1 1 2.7 0.5 
15N GCDA 1:2 1 2.9 0.7 
15N GCDA 1:5 1 2.7 2.3 
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9. Conclusions 
 
The structural data, already known for chicken Liver Bile Acid Binding Protein (cL-
BABP) devoid of disulphide bridge, and those obtained in the present work for the 
protein with a disulphide bridge (cL-BABP/S-S), represented the body of starting 
information necessary for further analysis of the binding kinetic characteristic of these 
proteins. The dynamics and the mechanism of protein ligand interactions are strongly 
related to BABPs biological functions. A number of factors have been shown to 
modulate ligand binding, e.g. chemistry of ligand and nature of protein residues but, 
here, the attention was mainly focused on another source of ligand binding variability: 
the presence of disulphide bridge (S-S). In intracellular proteins, disulfide bonds are 
generally transiently formed, owing to the reductive nature of the cellular environment. 
It’s plausible that equilibrium between oxidized and reduced forms of cL-BABPs may 
respond to different needs for ligand uptake. 
NMR titration experiments, recorded to observe alternatively the enriched bile acids and 
the proteins, have shown that the presence of a disulphide bridge, while maintaining the 
same binding stoichiometry, induces changes in binding ability, site selectivity and 
dynamic properties of cL-BABPs. Both NMR analysis and mass spectrometry data 
confirmed the ability of cL-BABP/S-S and cL-BABP to bind two GCDA or GCA 
molecules.  
The most relevant feature emerging from NMR data analysis is the ability of the 
disulphide bridge to modulate recognition at both sites. No site selectivity for the two 
bile salts, GCDA and GCA, was previously observed for cL-BABP devoid of 
disulphide bridge. It is now clear that when the disulphide bridge is present, GCDA 
preferentially binds to the superficial site and GCA to the internal one. Site selectivity 
was however observed only when GCDA and GCA are present simultaneously, 
suggesting that the observed selectivity does not derive from steric exclusion of one bile 
salt from a specific site.  
Chemical Shift Perturbation (CSP) data and cL-BABP/S-S TALOS analysis indicated 
that no significant change in the tridimensional structure of the apo protein occurred 
upon disulphide bridge addition. NMR data indicated only minor conformational 
changes gathered around the inner binding site. 
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Significant changes in backbone motions were, at variance, observed for several 
residues distributed over the entire protein. Indeed the presence of the S-S bridge 
favoured the propagation of slow motions from the C-terminal region of the molecule to 
the N-terminal -sheet in the apo protein, and enhanced backbone motions in cl-
BABP/S-S-CDA complex, differently to what observed for cL-BABP, where the 
binding of this ligand was accompanied by a substantial quench of motions. 
In conclusion site-selectivity appeared to be governed by protein mobility, rather than 
by steric factors related to the hydroxylation pattern of the ligand. These results 
underlined the tight connection between ligand binding phenomena and protein mobility 
in this protein family and set the basis for NMR kinetic studies based on lineshape 
analysis and relaxation dispersion measurements. 
NMR lineshapes were analysed as a function of ligand concentration and simulated with 
the NMRKIN software specifically implemented to treat multisite binding mechanisms.  
The ligand binding mechanism, investigated through the combination of lineshape 
analysis and relaxation dispersion experiments, allowed the distinction between two 
fundamentally different binding mechanisms namely, “induced fit” versus 
“conformational selection”. The binding mechanism resulted extremely complex to be 
deconvoluted, but the reported data unambiguously support the “conformational 
selection” model for cL-BABPs. The apo protein samples both the competent and non-
competent binding conformations, involving opening at the portal area. Despite the 
complexity exhibited by ternary complex, the mechanism involved in the binding of the 
two ligands could be tackled providing an estimate of the kinetics involved. The 
presented lineshape analysis allowed us to rationalise the behaviours observed for 
different residues in the two proteins (cL-BABP/S-S and cL-BABP) contributing to the 
definition of the following simplified multi-step binding mechanism: 
P⇄P*+L⇄PLn+L⇄PL1L2⇄PL1L2*  with n=1,2 
where P represents the apo protein; P* represents a possible low-populated 
conformation visited by the apo protein; L represents the ligand; PLn represents a 
generic intermediate which could derive either from differences in protein 
conformations or in the type of bound species; PL1L2 represents the protein at saturation 
and PL1L2* is a low-populated conformation of the holo protein. 
The obtained results showed that the presence/absence of a disulphide bridge in L-
BABPs is not affecting the general binding mechanism, rather it seems to have an 
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influence on the kinetics of the first exchange process. In general cL-BABP exhibits 
lower koff,1 rates compared to cL-BABP/S-S suggesting a higher affinity of cL-BABP 
for the ligand. Slow (in the range of 20-60 s
-1
) or fast to intermediate(~ 100-2000 s
-1
) 
koff,1 rates were deduced from lineshape simulations of cL-BABP residues. Fast to 
intermediate (~ 400-600 s
-1) or fast (≥ 2000 s-1) koff,1 rates were deduced for cL-
BABP/S-S, which in turn translates, into a less cooperative but site-selective system 
towards GCDA. cL-BABP does not display any site-selectivity, but is an extremely 
cooperative system. Thus the different behaviour of the two proteins may be related to 
the bile-acid binding capability, which seems to be directly correlated with 
cooperativity.  
These findings represent the first step towards the global description of the mechanism 
of bile acid binding and release within the cell, necessary to understand the role of L-
BABPs and their involvement in cholesterol homeostasis. The gain of this research 
could be relevant, among others, in the field of health. Indeed the understanding of 
mechanisms regulating the interaction of bile acids with their cytoplasmic transporters 
is necessary for the design of drugs which may have utility in treating metabolic 
dysfunctions. 
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Table 1 Backbone (
1
H, 
15
N) and side chain (C and C) assignments of BABP/S-S apo 
form, pH 7.2, 298K 
 
Residue HN N C C 
A1 8,71 125,27 51,50 19,09 
F2 8,40 113,00 58,52 38,22 
S3 8,00 111,19 57,73 61,59 
G4 9,06 111,36 41,85  
T5 8,36 117,70 60,37 66,90 
W6 9,50 127,67 52,84 28,33 
Q7 9,40 123,50 51,35 28,60 
V8 8,31 131,32 60,96 29,13 
Y9 9,52 124,01 54,13 38,03 
A10 7,37 125,76 49,35 19,86 
Q11 8,92 120,41 52,20 28,70 
E12 9,27 124,85 53,81 28,60 
N13 9,23 118,45 51,58 35,38 
Y14 7,89 118,01 56,61 36,40 
E15 8,99 118,00 58,65 26,52 
E16 8,68 118,02 57,50 26,16 
F17 8,23 123,39 59,92 37,83 
L18 8,53 117,89 55,54 39,30 
K19 7,96 117,28 57,10 29,68 
A20 8,00 125,71 52,43 15,30 
L21 7,30 116,87 52,70 39,79 
A22 8,00 118,26 50,12 13,49 
L23 7,13 120,01 51,10 39,23 
P24     60,03 30,07 
E25 8,83 122,30 57,70 27,27 
D26 8,92 116,88 54,40 36,98 
L27 7,28 120,49 54,50 39,02 
I28 7,89 121,49 63,85 35,02 
K29 7,85 117,70 57,10 29,80 
M30 7,25 115,29 54,88 30,76 
A31 8,05 121,21 51,34 16,95 
R32 7,97 115,95 56,80 27,23 
D33 8,05 117,27 52,10 39,28 
I34 7,63 121,13 58,44 35,70 
K35 8,76 129,10 50,52 30,05 
P36     60,17 30,59 
I37 8,10 118,48 57,89 37,97 
V38 9,60 128,89 58,50 32,13 
E39 9,64 128,24 52,25 29,82 
I40 9,57 125,50 58,62 37,57 
Table 1 Chemical shift of apo cL-BABP/S-S 
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Q41 9,24 127,69 52,42 29,15 
Q42 8,31 125,54 51,71 27,87 
K43 8,31 130,17 52,85 30,79 
G44 8,94 117,30 45,01  
D45 8,85 127,51 52,08 38,92 
D46 8,01 119,87 51,74 39,33 
F47 9,28 121,40 54,23 41,17 
V48 8,57 121,66 60,27 31,91 
V49 9,31 128,04 59,02 31,94 
T50 9,74 127,77 59,15 68,33 
S51 9,37 122,73 54,60 62,12 
K52 9,64 126,07 53,96 33,33 
T53 8,52 115,98 56,70 67,11 
P54     63,19 29,58 
R55 7,97 111,49 53,76 29,39 
Q56 7,60 117,77 52,51 29,87 
T57 8,70 123,26 59,89 68,36 
V58 8,90 127,02 59,29 32,65 
T59 8,96 125,52 59,31 68,20 
N60 9,24 125,30 50,14 40,69 
S61 8,81 116,89 54,43 62,69 
F62 8,34 119,00 53,97 38,08 
T63 9,24 119,01 58,73 69,91 
L64 9,07 125,00 54,32 39,26 
G65 8,74 108,50 43,21  
K66 7,90 119,93 51,86 32,46 
E67 8,69 125,10 55,82 28,25 
A68 9,18 130,54 48,62 20,37 
D69 8,26 119,57 51,12 39,55 
I70 8,99 125,31 55,93 37,08 
T71 9,12 122,47 59,51 67,12 
T72       
M73     56,27 30,47 
D74 8,19 114,51 50,83 38,56 
G75 8,06 107,75 43,15  
K76 7,42 121,30 52,95 30,23 
K77       
L78     51,41 42,14 
K79 8,12 120,21 52,24 32,70 
C80 8,69 116,83 52,26 43,009 
T81 8,78 119,14 60,33 66,49 
V82 8,68 131,26 59,26 29,38 
H83 8,61 123,73 52,71 31,12 
L84 9,09 123,97 51,37  
Table 1 Chemical shift of apo cL-BABP/S-S 
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A85 9,02 128,64 49,02  
N86     51,67  
G87 8,62 103,30 43,23  
K88 7,87 120,32 52,70 31,80 
L89     52,64 42,36 
V90 9,21 127,60 52,64 31,89 
C91 8,50 125,50 51,68 41,21 
K92 8,86 123,90 53,09 33,67 
S93 9,19 121,27 54,20 63,80 
E94 8,99 120,70   
K95       
F96 8,88 116,90 54,30 41,60 
S97 8,12 119,41 58,90 67,60 
H98 8,00 123,90 60,60 29,90 
E99 8,25 121,80 58,40 36,40 
Q100 8,37 127,60 51,50 30,15 
E101 8,66 123,73 52,44 31,40 
V102 8,70 126,50 59,17 31,34 
K103 8,95 129,26 52,66 31,14 
G104 9,11 116,74 45,15  
N105 8,98 125,50 50,68 36,45 
E106 8,09 120,34 53,18 30,94 
M107 8,80 123,77 51,65 32,73 
V108 8,95 126,50 59,10 31,87 
E109 9,26 128,70 51,30 31,80 
T110 8,75 120,13 59,40 66,90 
I111 9,44 132,25 58,13 37,47 
T112 9,29 122,73 58,46 68,43 
F113 9,04 125,26 55,32 40,49 
G114 8,46 115,50 44,44  
G115 8,50 105,57 42,50  
V116 8,02 123,36 59,87 31,02 
T117  8,72 123,53  59,82 67,86 
L118 9,60 132,50 50,92 41,88 
I119 7,85 125,25 56,96 36,85 
R120 9,24 126,76 52,33 32,00 
R121 8,93 126,51 52,65 29,64 
S122 9,33 117,75 55,52 65,02 
K123 8,45 118,0 51,45 33,82 
R124 8,30 125,73 54,65 27,94 
V125 8,31 129,53 61,37 30,62 
 
Table 2 Chemical shift of cL-BABP/S-S complexed with CDA (P:L ratio 1:3) 
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Table 2 Backbone (
1
H, 
15
N) and side chain (C and C) assignments of BABP/S-S 
complexed with CDA (P:L ratio 1:3), pH 7.2, 298K 
 
Residue HN N C C 
A1     51,67 16,51 
F2 8,55 113,37 58,20 38,04 
S3 7,93 111,63 58,67 61,32 
G4 9,07 111,07 41,57  
T5 8,21 118,00 59,96 66,40 
W6 9,61 127,57 52,65 29,51 
Q7     51,84 29,53 
V8 8,24 131,82 61,04  
Y9 9,55 123,85 54,16 38,18 
A10 7,33 125,98 49,22 19,28 
Q11 8,72 119,20 51,86 28,32 
E12 9,09 123,85 53,14 28,89 
N13 9,11 118,00 51,53 34,26 
Y14 7,80 118,53 57,90 36,68 
E15 8,95 118,53 58,12 26,25 
E16 9,03 118,48 58,03 26,07 
F17 8,36 123,85 59,88 37,69 
L18 8,27 116,94 55,55 37,92 
K19 7,79 116,64 56,30 29,54 
A20 7,95 126,50 52,35 14,96 
L21 7,37 116,94 52,53 40,12 
A22 7,83 118,53 49,81 13,15 
L23 6,87 118,48 50,96 37,94 
P24     59,83 29,66 
E25 8,82 123,32 57,51 26,78 
D26 8,89 116,41 54,27 36,98 
L27 7,19 122,22 54,42 39,25 
I28 7,87 120,11 63,89 34,67 
K29 7,80 116,94 57,05 29,82 
M30 7,44 116,94 55,07 30,13 
A31 8,55 120,66 50,583 16,58 
R32 7,77 121,18 57,85 27,76 
D33 8,24 116,40 57,89 39,11 
I34 7,31 120,34 58,00 35,27 
K35 8,92 131,29 50,19 29,97 
P36       
I37     57,48 37,90 
V38 9,45 129,70 58,03 37,72 
E39 9,56 128,63 52,01 29,44 
I40 9,63 125,98 58,31 37,38 
Q41 9,25 128,10 52,02 28,67 
Table 2 Chemical shift of cL-BABP/S-S complexed with CDA (P:L ratio 1:3) 
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Q42 8,23 126,50 51,10 27,56 
K43 8,80 130,29 52,69 30,46 
G44 8,92 118,00 44,82  
D45 8,84 128,09 51,84 38,53 
D46 8,01 120,66 51,70 38,86 
F47 9,27 122,25 53,86 41,00 
V48 8,52 121,72 59,92 31,90 
V49 9,31 127,57 58,42 31,92 
T50 9,80 129,16 58,88 67,89 
S51 9,15 122,25 54,09 61,68 
K52 9,34 126,50 53,28 33,48 
T53 8,97 116,67 56,26 66,65 
P54     63,10 30,11 
R55 8,24 112,70 54,22 30,11 
Q56 7,68 116,40 52,70 30,17 
T57 8,49 118,00 58,99 68,68 
V58 8,90 125,97 58,75 32,56 
T59 8,96 127,03 59,35 67,94 
N60 9,13 124,90 50,35 41,45 
S61 8,85 116,40 54,16 62,83 
F62 8,25 118,00 54,01 37,53 
T63 9,65 120,13 58,29 69,10 
L64 9,21 127,03 53,62 38,62 
G65 9,01 107,38 43,09  
K66 7,92 121,19 51,66 31,87 
E67 8,92 130,22 56,44 27,73 
A68 8,67 131,29 48,27 19,62 
D69 8,32 120,13 52,01 39,21 
I70 8,95 125,80 54,82 36,66 
T71 9,41 123,85 58,44 67,54 
T72 8,55 115,88 57,83 68,23 
M73 10,32 120,13 56,21 31,81 
D74 8,68 112,70 50,26 35,93 
G75 7,57 107,90 43,57  
K76 8,12 120,67 53,18 30,93 
K77 8,04 119,60 52,01 30,59 
L78 9,03 123,85 50,76 42,84 
K79 8,21 119,60 52,07 33,75 
C80 8,39 117,00 54,04 44,60 
T81 8,74 124,00 59,61 65,34 
V82 9,51 132,35 58,92 28,54 
H83 8,65 123,85 52,34 30,92 
L84 8,77 122,25 50,92 41,48 
A85 9,24 129,70 48,70 18,07 
Table 2 Chemical shift of cL-BABP/S-S complexed with CDA (P:L ratio 1:3) 
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N86     51,41 34,57 
G87 8,58 103,13 42,98  
K88 7,83 120,13 52,83 31,75 
L89 8,97 124,90 51,79 41,07 
V90 8,96 121,72 57,82 33,28 
C91 8,86 125,40 58,4 39,93 
K92 9,23 128,60 52,50 32,99 
S93 8,49 119,60 52,76 63,36 
E94 9,15 128,78 56,21 26,69 
K95 8,15 114,81 53,00 32,26 
F96 6,93 113,22 52,98 40,34 
S97 8,80 112,59 54,80 60,87 
H98 9,16 129,06 54,55 32,99 
E99 7,99 125,10 52,09 31,62 
Q100       
E101 8,87 125,052 52,00 32,15 
V102 8,73 124,91 58,83 31,54 
K103 8,92 129,16 52,38 31,04 
G104 9,40 115,53 44,97  
N105    50,33 35,93 
E106 8,06 120,13 52,79 30,59 
M107 8,87 123,95 51,09 33,77 
V108 9,02 126,50 58,74 32,73 
E109 9,11 129,16 51,66 31,40 
T110 8,84 120,67 59,14 66,74 
I111 9,35 130,22 57,50 37,40 
T112 9,47 122,79 58,38 68,26 
F113 9,12 127,05 55,88 40,95 
G114 8,36 116,94 44,55  
G115 8,53 105,25 42,26  
V116 8,14 124,38 59,55 30,98 
T117 8,74 123,46 59,41 66,85 
L118 9,57 132,35 50,68 41,64 
I119 7,73 124,91 56,88 36,84 
R120 9,42 127,57 52,41 31,85 
R121 9,09 127,03 52,48 29,13 
S122 9,28 118,21 55,49 63,10 
K123 8,66 120,67 51,06 33,54 
R124 8,17 124,91 54,24 27,81 
V125 8,17 128,96 60,96 30,50 
 
Table 3 Chemical shift of cL-BABP/S-S complexed with GCDA (P:L ratio 1:3) 
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Table 3 Backbone (
1
H, 
15
N) assignments of BABP/S-S complexed with GCDA (P:L 
ratio 1:3), pH 7.2, 298K 
 
Residue HN N 
A1   
F2   
S3 7,95 111,40 
G4 9,05 111,45 
T5 8,18 117,77 
W6 9,61 127,50 
Q7 9,20 120,90 
V8 8,26 131,44 
Y9 9,52 123,13 
A10 7,32 125,87 
Q11 8,70 118,34 
E12 9,09 123,37 
N13 9,13 117,64 
Y14 7,99 118,48 
E15 8,94 118,51 
E16 9,09 118,80 
F17 8,41 124,11 
L18 8,30 117,01 
K19 7,78 117,05 
A20 7,93 126,14 
L21 7,43 116,47 
A22 7,91 118,79 
L23 6,94 118,64 
P24   
E25 8,83 123,24 
D26 8,93 116,60 
L27 7,25 121,69 
I28   
K29 7,69 116,53 
M30 7,38 117,04 
A31 8,49 120,35 
R32 7,83 120,89 
D33 8,09 116,08 
I34 7,27 120,34 
K35   
P36   
I37   
V38 9,44 129,01 
E39 9,51 128,32 
I40 9,65 126,13 
Q41 9,24 128,17 
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Q42 8,24 125,97 
K43 8,82 130,39 
G44 8,93 117,57 
D45 8,85 127,56 
D46 8,03 120,38 
F47 9,27 122,38 
V48 8,52 121,76 
V49 9,34 127,08 
T50 9,71 128,49 
S51 9,16 122,46 
K52 9,40 125,93 
T53 8,87 116,19 
P54   
R55 7,98 111,33 
Q56 7,57 118,62 
T57 8,60 120,83 
V58 8,86 125,63 
T59 8,95 126,51 
N60 9,17 124,67 
S61 8,83 116,20 
F62 8,26 117,56 
T63 8,64 119,89 
L64 9,23 126,60 
G65 9,07 107,52 
K66 7,92 121,13 
E67 8,99 130,34 
A68 8,72 130,92 
D69 8,32 120,45 
I70 8,90 125,93 
T71 9,39 123,99 
T72 8,63 116,02 
M73 10,43 120,16 
D74 8,70 112,11 
G75 7,59 107,88 
K76 8,13 120,29 
K77 7,91 120,74 
L78 9,01 124,05 
K79 8,23 119,32 
C80 8,27 116,37 
T81 8,78 122,41 
V82 9,48 131,95 
H83 8,67 123,45 
L84 8,82 122,37 
A85 9,25 129,25 
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N86   
G87 8,60 103,33 
K88 7,86 120,52 
L89   
V90 8,93 121,63 
C91 8,88 124,74 
K92   
S93 8,55 119,07 
E94   
K95 8,31 114,10 
F96 7,03 113,53 
S97 8,80 112,44 
H98 9,10 127,85 
E99 7,89 125,13 
Q100 9,08 125,06 
E101 8,91 125,41 
V102 8,77 125,05 
K103 8,92 129,31 
G104 9,11 117,56 
N105   
E106 8,09 120,05 
M107 8,90 123,95 
V108 9,05 126,91 
E109 9,29 128,18 
T110 8,72 120,75 
I111 9,41 130,23 
T112 9,51 122,77 
F113 9,03 125,75 
G114 8,43 116,10 
G115 8,58 105,36 
V116 8,09 123,87 
T117 8,74 123,43 
L118 9,65 132,55 
I119 7,79 125,11 
R120 9,36 126,12 
R121 9,14 127,02 
S122 9,31 118,32 
K123 8,63 120,41 
R124 8,10 124,49 
V125 8,19 128,16 
 
Table 4 Chemical shift of cL-BABP/S-S complexed with GCDA-GCA (P:L ratio 
1:2:2) 
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Table 4 Backbone (
1
H, 
15
N, 
13
C) and side chain (C and C) assignments of BABP/S-S 
complexed with GCDA-GCA (P:L ratio 1:2:2), pH 7.2, 298K 
 
Residue HN N C C C  
A1      
F2   61,17 40,69 175,90 
S3 7,94 111,31 59,97 64,14 174,70 
G4 9,06 111,53 44,30  171,80 
T5 8,21 117,66 62,72 69,31 173,190 
W6 9,53 127,77 55,49 32,29  
Q7   54,55 32,27 175,90 
V8 8,28 131,58 63,60 32,20  
Y9 9,54 123,32 56,80 40,88 174,60 
A10 7,34 125,87 51,98 22,16 175,20 
Q11 8,69 118,37 54,46 32,87 174,70 
E12 9,12 123,79 55,55 31,76 175,70 
N13 9,13 117,55 54,10 36,80 175,60 
Y14 7,89 118,28 60,70 39,45 176,50 
E15 8,95 118,61 60,89 28,70 178,50 
E16 9,10 118,79 60,30 28,60 178,60 
F17 8,41 124,24 62,60 40,38 176,40 
L18 8,20 116,41 58,34 40,75 178,80 
K19 7,78 116,59 59,07 32,15 179,80 
A20 7,97 125,98 55,04 17,80 178,60 
L21 7,37 116,86 55,40 42,70 176,10 
A22 7,92 118,82 52,40 15,96 177,00 
L23 6,95 118,47 53,60 41,11 174,50 
P24   62,50 32,60 177,50 
E25 8,81 122,50 60,10 29,69 177,90 
D26 8,92 116,62 57,08 39,62 177,90 
L27 7,22 121,99 57,16 42,23 178,07 
I28 7,88 120,35 66,59 37,29 177,40 
K29 7,84 117,01 59,78 32,39 178,90 
M30 7,44 117,17 57,70 32,97 177,50 
A31 8,41 120,25 53,19 19,29  
R32 7,75 121,91 60,70 30,60 176,50 
D33 8,35 116,23 54,22 41,76 175,90 
I34 7,22 120,06 60,80 37,86 176,10 
K35 8,99 130,99 52,97 32,75 173,70 
P36      
I37   60,26 40,17 175,50 
V38 9,54 129,02 61,13 34,85 175,10 
E39 9,59 128,35 54,54 32,07 176 
I40 9,63 125,98 61,33 40,16 175,80 
Q41 9,25 128,16 54,94 31,36 173,90 
Table 4 Chemical shift of cL-BABP/S-S complexed with GCDA-GCA (P:L ratio 
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Q42 8,24 125,94 54,15 30,25 174,70 
K43 8,81 130,36 55,26 33,27 176,03 
G44 8,94 117,52 47,48  174,30 
D45 8,86 127,51 54,57 41,27 174,70 
D46 8,08 119,68 54,29 41,57 175,07 
F47 9,28 122,53 56,42 43,80 176,40 
V48 8,52 121,69 62,77 34,77 175,70 
V49 9,31 127,22 61,18 34,66 175,70 
T50 9,73 128,52 61,53 70,76 173,81 
S51 9,17 122,59 56,99 64,55 173,80 
K52 9,46 125,38 56,12 36,13 175,90 
T53 8,73 116,01 59,14 68,78 173,40 
P54   66,08 32,08 177,20 
R55 8,00 111,52 55,60 32,52 175,80 
Q56 7,52 118,61 55,61 33,09 174,20 
T57 8,59 121,60 61,50 71,50 174,00 
V58 8,82 125,49 61,38 35,56 174,40 
T59 8,99 126,57 61,98 70,77 173,40 
N60 9,18 124,70 53,00 44,27 173,30 
S61 8,84 116,25 56,91 65,59 173,30 
F62 8,23 117,63 56,59 40,03 173,10 
T63 9,64 119,92 61,10 72,06 175,60 
L64 9,26 126,68 56,10 41,33 178,00 
G65 9,08 107,52 45,78  173,80 
K66 7,91 121,07 54,44 34,62 175,60 
E67 8,92 128,89 59,22 30,40 175,03 
A68 8,64 130,94 51,00 22,10 176,00 
D69 8,33 120,50 54,67 41,93 174,40 
I70 8,83 125,44 57,69 39,67 175,30 
T71 9,44 123,95 61,61 70,37 174,60 
T72 8,69 116,15 60,55 70,71 177,30 
M73 10,40 119,90 58,90 34,45 176,20 
D74 8,65 112,23 52,63 38,42 175,60 
G75 7,59 108,04 46,40  175,00 
K76 8,25 120,45 54,24 33,50 175,40 
K77 8,12 119,47 54,36 32,84 176,10 
L78 9,01 123,77 53,17 45,78 175,60 
K79 8,23 119,28 55,00 36,85 176,60 
C80 8,29 116,27 56,50 45,70 173,50 
T81 8,84 122,44 62,46 67,85 173,10 
V82 9,48 131,83 61,61 31,20 175,10 
H83 8,68 123,47 54,99 33,40 173,50 
L84 8,84 122,03 53,79 44,31 176,50 
A85 9,22 128,80 55,48 20,91 177,00 
N86   54,14 37,55 175,40 
Table 4 Chemical shift of cL-BABP/S-S complexed with GCDA-GCA (P:L ratio 
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G87 8,62 103,43 45,67  173,80 
K88 7,85 120,74 54,14 34,61 175,50 
L89 8,77 124,60 54,50 43,70 176,70 
V90 9,03 122,66 60,35 35,63 175,20 
C91 8,82 123,42 55,23 42,97 172,70 
K92 9,44 128,97 55,36 35,96 174,27 
S93 8,56 118,78 55,43 66,07 174,20 
E94 8,60 119,46 59,44 29,36 177,60 
K95 8,29 113,91 56,18 35,22 175,98 
F96 6,98 113,34 55,71 43,56 173,90 
S97 8,78 112,21 57,87 65,99 172,56 
H98 9,16 126,31 56,26 36,27 174,50 
E99 8,31 126,82 55,00 34,00 175,40 
Q100      
E101   55,29 34,80  
V102 8,77 124,83 61,38 34,10 175,20 
K103 8,94 129,42 55,34 33,76 176,50 
G104 9,34 119,14 47,68  174,50 
N105 9,01 125,35 53,13 39,06  
E106 8,10 120,08 55,55 33,16  
M107 8,91 124,08 53,70 36,80  
V108 9,017 126,82 61,34 34,90  
E109 9,10 127,91 54,44 34,27 174,41 
T110 8,85 120,76 61,98 69,52 174,90 
I111 9,47 131,56 60,31 40,78 174,60 
T112 9,46 122,80 61,37 71,25 174,37 
F113 9,00 124,67 58,80 43,48 175,70 
G114 8,41 116,25 46,84  175,30 
G115 8,57 105,64 44,89  174,20 
V116 8,15 124,05 62,25 33,82 174,64 
T117 8,74 123,47 62,17 70,45 173,80 
L118 9,69 132,76 53,57 44,73 175,20 
I119 7,79 125,02 59,34 39,55 175,90 
R120 9,37 126,27 54,99 34,13 175,30 
R121 9,09 126,82 55,25 31,83 175,02 
S122 9,27 118,30 58,10 66,85 173,01 
K123 8,62 120,15 53,93 36,33 175,60 
R124 8,18 124,87 56,90 30,38 176,50 
V125 8,22 128,52 63,57 33,18  
 
  
 
 
 
 98 
 
 
 
 
 
 
Appendices
Appendix A Master file for lineshape simulation: fiftex 
 
99 
 
% ==================================================================== 
%              FITFTEX - Main program to fit lineshapes. 
% ==================================================================== 
 
% 2009 version with parameter handling through a structure. 
% A parameter file similar to testpar.m is required. 
% 
% Needs: A parameter file (sample file: testpar.m) 
%        a routine which creates the parameter structure (mklspar.m) 
%        data matrices 
%        uses redat.m to read data from disk (if necessary) 
%        a mechanism file (e.g. m21) 
% 
  
% Copyright (c) 
% Ulrich Guenther 20-3-97, Feb 2008 
% 
  
global SPC;             % spectra parameters 
global DISP;            % display parameters 
global LSPAR;           % Lineshape parameters 
global HANDLES;         % graphics handles 
global P; 
  
%plot_LW1 = 1.5; 
%plot_LW2 = 3.0; 
plot_LW1 = 0.5; 
plot_LW2 = 2.0; 
MarkSiz  = 9;  
MarkLW   = 2.8; 
  
DEBUG=0; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
%filename = 'testpar.m'; 
%filename = 'testpar_m21.m'; 
filename = 'testpar_m2121.m'; 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
clear FN 
LFN=length(filename); 
FN(1:LFN-2)=filename(1:LFN-2); 
  
LSPAR=mklspar2(FN);         % no path for feval in mklspar 
  
% ************************************************ 
% ****************** READ DATA ******************* 
% ************************************************ 
if LSPAR(1).USE_DATA 
  disp('Reading dim 1 data.') 
  % DIM 1 setup 
   
  if isempty(LSPAR(1).w) | LSPAR(1).w==0 
    % Call graphical routine to set maxima of peaks 
    MX1 = redat2(1,1);              % dim 1, set w 
  else 
    MX1 = redat2(1,0);          % dim1, don't set w 
  end 
  [MX1siz no_spcs_1] = size(MX1); 
  LSPAR(1).MXsiz     = MX1siz; 
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  LSPAR(1).NO_SPCS   = no_spcs_1; 
  no_spcs            = no_spcs_1; 
   
  % ************************************************************** 
  % ********************** READ DIM 2 DATA *********************** 
  % ************************************************************** 
  if LSPAR(1).DIM==2 & ~isempty(LSPAR(2).filename) 
    disp('Reading dim 2 data.') 
    if isempty(LSPAR(1).w) | LSPAR(1).w==0 
      MX2 = redat2(2,1); 
    else 
      MX2 = redat2(2,0); 
    end 
    [MX2siz no_spcs_2] = size(MX2); 
    LSPAR(2).MXsiz     =  MX2siz; 
    if no_spcs_2 ~= no_spcs_1 
      error('Number of spectra in dim 1 and 2 differs.') 
    end 
  end 
  PLOT_DIM_2_DATA=1; 
else    % no DIM 2! 
  MX2siz  = LSPAR(2).MXsiz; 
  MX1siz  = LSPAR(1).MXsiz; 
  no_spcs = LSPAR(1).NO_SPCS; 
  PLOT_DIM_2_DATA = 0; 
end 
  
% Create Cell array MX 
clear MX 
if LSPAR(1).USE_DATA & LSPAR(1).DIM==1 
  temp=MX1; 
  MX{1}=temp; 
elseif LSPAR(1).USE_DATA & LSPAR(1).DIM==2 
  temp=MX1; 
  MX{1}=temp; 
  MX{2}=MX2; 
  %  MX(:,:,1) = MX1; 
  %  MX(:,:,2) = MX2; 
elseif LSPAR(1).USE_DATA  
  error('DIM must be 1 or 2!') 
end 
  
% call mechanism file, 2nd dim is calles autorecursively in mechanism file 
if exist(LSPAR(1).MECH)==2              % MECH must exist as .m-file 
  if LSPAR(1).DIM==2 & exist(LSPAR(2).MECH)==2 
    disp('++++++++++++++++++++++++++++++++++++++++'); 
    disp('     Calculating 2D lineshapes'); 
    disp('++++++++++++++++++++++++++++++++++++++++') 
    [calcM,calcXY] = feval(LSPAR(1).MECH,[],'CALC',1); 
     
  elseif LSPAR(1).DIM==1 
    disp('++++++++++++++++++++++++++++++++++++++++'); 
    disp(['     Calculating dim ' num2str(LSPAR(1).DIM) ]); 
    disp('++++++++++++++++++++++++++++++++++++++++') 
    calcM = feval(LSPAR(1).MECH,[],'CALC',1); 
    % Convert to cell array for compatibility with 2DIM 
    temp = calcM; 
    clear calcM 
    calcM{1} = temp; 
    clear temp 
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  else 
    error('Probably some mechanism missing.') 
  end 
else 
  tmp_str=['DIM 1: Mechanism ' LSPAR(1).MECH ' does not exist.']; 
  error(tmp_str) 
  return 
end 
  
% ****************** Set display pars ****************** 
if ~isfield(LSPAR(1),'colstep') 
  colstep = 1/no_spcs; 
  for n=1:no_spcs   
    % CyanRed 
    % ColPal(n,:) = [n*colstep, 1-n*colstep, 1-n*colstep]; 
    % BlueRed 
    ColPal(n,:) = [n*colstep, 0.0, 1-n*colstep]; 
  end 
  LSPAR(1).ColPal = ColPal; 
  LSPAR(2).ColPal = ColPal; 
end 
  
if LSPAR(1).USE_DATA==0 
  MX = []; 
end 
if LSPAR(1).DIM==1 
  calcXY = []; 
end 
  
plot_lineshapes(MX,calcM, calcXY) 
  
if LSPAR(2).realdim==1 
  LSPAR = LSPAR([2,1]); 
end % if ~(LSPAR(1).DIM2MODE==2 & DIM==2) 
  
  
% ************************************************************ 
%                        Data fitting 
% ************************************************************ 
  
FIT=LSPAR(1).FIT;   
  
if FIT 
  clear OPTIONS 
  OPTIONS=optimset; 
  % OPTIONS=optimset(OPTIONS,'HessUpdate','dfp'); 
  %OPTIONS=optimset(OPTIONS,'HessUpdate','steepdesc'); 
  %OPTIONS=optimset(OPTIONS,'HessUpdate','dfp'); 
  %OPTIONS=optimset(OPTIONS,'HessUpdate','bfgs'); 
  %OPTIONS.MaxIter = 5000; 
  %OPTIONS.maxFunEvals = 10000;  
  OPTIONS=optimset(OPTIONS,'maxFunEvals',5000); 
  OPTIONS=optimset(OPTIONS,'tolX',1e-12); 
  OPTIONS=optimset(OPTIONS,'tolFun',1e-6); 
   
  OPTIONS=optimset(OPTIONS,'Algorithm','trust-region-reflective'); 
  %OPTIONS=optimset(OPTIONS,'Algorithm','levenberg-marquardt'); 
  
  %OPTIONS=optimset(OPTIONS,'LevenbergMarquardt','on'); 
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  %OPTIONS=optimset(OPTIONS,'GaussNewton','on'); 
  %OPTIONS=optimset(OPTIONS,'LevenbergMarquardt','off'); 
  %OPTIONS=optimset(OPTIONS,'LargeScale','off'); 
   
  PAR_0 = feval(LSPAR(1).MECH,[],'PAR0'); 
  par0  = PAR_0{1}; 
  LB    = PAR_0{2}; 
  UB    = PAR_0[85]; 
   
  %PAR_0 = m21_2D([],'PAR0'); 
  %PAR_0 = m2121_2D([],'PAR0'); 
   
  %[par_final,fval,exitflag,output] = 
fminsearch('m21_2D',par0,OPTIONS,'FIT',1,MX); 
  %[par_final,fval,exitflag,output] = 
fminsearchbnd('m2121_2D',par0,LB,UB,OPTIONS,'FIT',1,MX); 
  [par_final,fval,exitflag,output] = 
lsqnonlin(LSPAR(1).MECH,par0,LB,UB,OPTIONS,'FIT',1,MX); 
end 
  
return 
  
 
Appendix B New mechanism file implemented for simulation: m2121 
 
103 
 
% ==================================================================== 
%      m2121 – Mechanism file implemented for cL-BABP/S-S and cL-BABP  
%              by U.Günther-2009 
% ==================================================================== 
 
function [R1, R2] = m2121_2D(par,action,curdim,MX,Plothandle) 
% 
% m2121 - kinetic mechanism P + L <=> PLn + L <=> PL1L2 
%         = both steps are ligand concentration dependent.  
%         = i.e. kon = kon* [L]. 
% 
% X is:  
% X.tau21 = 1; 
% X.tau32 = 2; 
% X.pa = X.tau21 + (1:no_spcs)'; 
% X.pb = X.pa    + (1:no_spcs)'; 
  
global HANDLES 
global LSPAR 
  
% NEW LSPAR type used 
%if ndims(LSPAR)==2 
%  LSPAR0 = LSPAR; 
%  clear LSPAR 
%  LSPAR  = LSPAR_conv(LSPAR0); 
%end 
  
DISPLAY_PAR=1; 
UPDATE_PLOT=1; 
VERBOSE=0; 
  
if VERBOSE 
  disp(['m2121(' num2str(curdim) ')']); 
end 
  
if nargin<1 
  error('Usage: [R1, R2, par] = m2121(curdim,MX,par)'); 
end 
  
% define action: PAR0  - create par0 
%                CALC  - calculate calcM and calc FID 
%                FIT   - fit data 
% 
  
if ~exist('action') 
  error('Input argument action may not be empty.') 
else 
  action=upper(action); 
end 
if ~exist('curdim') 
  curdim=0; 
end 
if strcmp(action,'FIT') | strcmp(action,'CALC') 
  if curdim<1 | curdim>2 
    error('curdim must be 1 or 2!') 
  end 
end 
if strcmp(action,'FIT') 
  if ~exist('par') | isempty(par) 
    error('You must provide par for a successful FIT.') 
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  end 
  if ~exist('MX') | isempty(MX) 
    error('You must provide MX for a successful FIT.') 
  end 
end 
if VERBOSE==1 
  disp('########################') 
  disp(['Running m2121 in ' action ' mode.']); 
  disp('########################') 
end 
  
% Set global pointers for data fitting 
no_spcs = LSPAR(1).NO_SPCS; 
X.tau21 = 1; 
X.tau32 = 2; 
X.pa = X.tau32 + (1:no_spcs)'; 
X.pb = X.pa    + (1:no_spcs)'; 
%X.pc = X.pb    + (1:no_spcs)'; 
  
% Get parameters for dim2 *************************************** 
if strcmp(action,'PAR0') 
  par0(X.tau21) = LSPAR(1).taus_0(1); 
  par0(X.tau32) = LSPAR(1).taus_0(2); 
  par0(X.pa)    = LSPAR(1).p_a_0; 
  par0(X.pb)    = LSPAR(1).p_b_0; 
  % par0(X.pc)    = LSPAR.p_c_0; 
  LB(X.tau21)  = 1/200; 
  LB(X.tau32)  = 1/20; 
  LB(X.pa)     = .0001*ones(1,LSPAR(1).NO_SPCS); 
  LB(X.pb)     = .0001*ones(1,LSPAR(1).NO_SPCS); 
  
  UB(X.tau21)  = 1/6000; 
  UB(X.tau32)  = 1/5; 
  UB(X.pa)     = .9999*ones(1,LSPAR(1).NO_SPCS); 
  UB(X.pb)     = .9999*ones(1,LSPAR(1).NO_SPCS); 
  PAR_0{1}      = par0; 
  PAR_0{2}      = LB; 
  PAR_0[85]      = UB; 
   
elseif (strcmp(action,'CALC') | strcmp(action,'FIT')) & curdim==2 
  if VERBOSE==1 
    disp('########################') 
    disp('  DIM 2 calculation.') 
    disp('########################') 
  end 
   
  anz      = LSPAR(1).NO_SPCS; 
  no_spcs  = LSPAR(1).NO_SPCS; 
  Hzppt    = LSPAR(2).Hzppt; 
  MXsiz    = LSPAR(2).MXsiz; 
  SWH_MX   = (MXsiz+1) * Hzppt;         % I don't know why +1! 
  SWH      = LSPAR(2).SWH; 
  TD       = LSPAR(2).TD; 
  W        = (LSPAR(2).w-1) * Hzppt; 
  wdwf     = LSPAR(2).wdwf; 
  E        = ones(1,anz); 
  LW       = LSPAR(2).LW; 
  zf       = LSPAR(2).zf; 
  p_a      = LSPAR(2).p_a_0; 
  p_b      = LSPAR(2).p_b_0; 
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  %p_c      = LSPAR.p_c_0_2; 
  tau21    = LSPAR(2).taus_0(1); 
  tau32    = LSPAR(2).taus_0(2); 
  
  % Mechanism specific FIT parameters 
  if ~isempty(par)              % Same tau as in dim 1 
    par   = par(:)'; 
    tau21 = par(X.tau21); 
    tau32 = par(X.tau32); 
    p_a   = par(X.pa); 
    p_b   = par(X.pb); 
    %p_c   = par(X.pc); 
  end 
   
  switch upper(wdwf{1}) 
   case {'QSINE','SINE'} 
    WDWF=wdwf2(ones(MXsiz,1),wdwf{1},wdwf{2},MXsiz); 
   case 'GM' 
    TF = TD/MXsiz;      % thinning factor 
    WDWF=wdwf2(ones(MXsiz,1),wdwf{1},wdwf{2},wdwf[85],SWH/TF); 
    disp(['wdwf2(' num2str(wdwf{1}) ',' num2str(wdwf{2}) ',' ... 
          num2str(wdwf[85]) ',' num2str(SWH/TF) ')']); 
   otherwise 
    WDWF = ones(MXsiz,1); 
  end 
  
  calcM = ftex2121(LW,tau21,tau32,p_a,p_b,W,MXsiz,SWH_MX, ... 
                              WDWF,zf,ones(1,anz)); 
  
elseif (strcmp(action,'CALC') | strcmp(action,'FIT')) & curdim==1 
  if VERBOSE==1 
    disp('DIM 1 calculation.') 
  end 
  anz        = LSPAR(1).NO_SPCS; 
  no_spcs    = LSPAR(1).NO_SPCS; 
  Hzppt      = LSPAR(1).Hzppt;   
  MXsiz      = LSPAR(1).MXsiz; 
  SWH_MX     = (MXsiz+1) * Hzppt; 
  SWH        = LSPAR(1).SWH; 
  TD         = LSPAR(1).TD; 
  W          = (LSPAR(1).w-1) * Hzppt ; 
  wdwf       = LSPAR(1).wdwf; 
  LW         = LSPAR(1).LW; 
  zf         = LSPAR(1).zf; 
  E          = ones(1,anz); 
  LW         = LSPAR(1).LW; 
  zf         = LSPAR(1).zf; 
  p_a        = LSPAR(1).p_a_0; 
  p_b        = LSPAR(1).p_b_0; 
  %p_c        = LSPAR(1).p_c_0; 
  tau21      = LSPAR(1).taus_0(1); 
  tau32      = LSPAR(1).taus_0(2); 
  FITDIM     = LSPAR(1).FITDIM; 
  
  % Mechanism specific FIT parameters 
  if ~isempty(par)          % FIT ==> overwrite p_a and tau 
    par   = par(:)'; 
    tau32 = par(X.tau32); 
    tau21 = par(X.tau21); 
    p_a   = par(X.pa); 
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    p_b   = par(X.pb); 
  end 
   
  % ******************************************** 
  %     autorecursive call of 2nd dimension 
  % ******************************************** 
   
  if LSPAR(1).DIM==2 
    if exist(LSPAR(2).MECH)==2 
      disp(['Calculating 2nd dim: ' LSPAR(2).MECH]) 
      % It shouldn't matter now if par is empty 
      calcM_2 = feval(LSPAR(2).MECH,par,'CALC',2,[]); 
      %max2dim = max(calcM_2) 
       
    else 
      tmp_str=['Mechanism ' LSPAR(1).MECH ' does not exist.']; 
      disp(tmp_str) 
      return 
    end 
   
    % Calculate current dimension 
    switch upper(wdwf{1}) 
     case {'QSINE','SINE'} 
      WDWF=wdwf2(ones(MXsiz,1),wdwf{1},wdwf{2},MXsiz); 
     case 'GM' 
      TF = TD/MXsiz;        % thinning factor 
      WDWF=wdwf2(ones(MXsiz,1),wdwf{1},wdwf{2},wdwf[85],SWH/TF); 
      disp(['wdwf2(' num2str(wdwf{1}) ',' num2str(wdwf{2}) ',' ... 
            num2str(wdwf[85]) ',' num2str(SWH/TF) ')']); 
     otherwise 
      WDWF = ones(MXsiz,1); 
    end 
     
    [calcM calcFID]  = ftex2121(LW,tau21,tau32,p_a,p_b,W,MXsiz,SWH_MX, ... 
                                WDWF,zf,ones(1,anz)); 
    [calcMnew,calcXY] = to2D(calcM,calcM_2); 
     
  elseif LSPAR(1).DIM==1 
        switch upper(wdwf{1}) 
     case {'QSINE','SINE'} 
      WDWF=wdwf2(ones(MXsiz,1),wdwf{1},wdwf{2},MXsiz); 
     case 'GM' 
      TF = TD/MXsiz;        % thinning factor 
      WDWF=wdwf2(ones(MXsiz,1),wdwf{1},wdwf{2},wdwf[85],SWH/TF); 
      disp(['wdwf2(' num2str(wdwf{1}) ',' num2str(wdwf{2}) ',' ... 
            num2str(wdwf[85]) ',' num2str(SWH/TF) ')']); 
     otherwise 
      WDWF = ones(MXsiz,1); 
    end 
    [calcM calcFID]  = ftex2121(LW,tau21,tau32,p_a,p_b,W,MXsiz,SWH_MX, ... 
                                WDWF,zf,ones(1,anz)); 
  end 
end 
  
% ***************** OUTPUT ****************** 
  
if strcmp(action,'FIT') 
  if LSPAR(1).DIM==2 & curdim==1 
    for N=1:2 
      D{N} = sum(sum((MX{N}-calcMnew{N}).^2)); 
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    end 
    if FITDIM(1)==1 & FITDIM(2)==1 
        R1 = D{1}+D{2}; 
    elseif FITDIM(1)==0 & FITDIM(2)==1 
        R1 = D{2}; 
    elseif FITDIM(1)==1 & FITDIM(2)==0  
        R1 = D{1}; 
    else  
        disp('Don''t know what to do with R1.') 
    end 
    R2 = []; 
   
  elseif LSPAR(1).DIM==1 
    D = sum(sum((MX{1}-calcM).^2)); 
    R1 = D; 
  end 
     
elseif strcmp(action,'CALC') 
  if LSPAR(1).DIM==1 
    R1=calcM; 
    R2 = []; 
  
  elseif LSPAR(1).DIM==2 & curdim==1 
    R1=calcMnew;    % cell array!!!  
    R2 = calcXY; 
     
  elseif LSPAR(1).DIM==2 & curdim==2 
    R1=calcM; 
    R2 = []; 
  end 
     
elseif strcmp(action,'PAR0') 
  R1 = PAR_0; 
  clear R2; 
end 
  
% ***************************************** 
%              PLOT output 
% ***************************************** 
if exist('UPDATE_PLOT') & UPDATE_PLOT & strcmp(action,'FIT') & curdim==1 
  for DIM=1:LSPAR(1).DIM 
    figure(DIM) 
    for N=1:no_spcs 
      if LSPAR(1).DIM==2 
        set(HANDLES.LSSIM{(DIM-1)*no_spcs+N},'ydata',calcMnew[82](:,N),'Color', 
LSPAR(1).ColPal(N,:)); 
        drawnow 
      elseif LSPAR(1).DIM==1 
        set(HANDLES.LSSIM{(DIM-1)*no_spcs+N},'ydata',calcM(:,N),'Color', 
LSPAR(1).ColPal(N,:)); 
        drawnow 
      end 
    end 
  end 
end    
  
%if ndims(LSPAR)==2 
%  clear LSPAR 
%  LSPAR = LSPAR0; 
%end 
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return 
  
  
% ************************************************************************** 
%  FTEX2121     FTEX2121     FTEX2121     FTEX2121      
% ************************************************************************** 
  
function [F_w,F_t] = ftex2121(LW,tau21,tau32,p_a,p_b,W,points,SWH,wdwf,zf,scale) 
% 
% ftex2121.m   
% Lineshape calculation for a 2121 model 
% calculating the FID for the actual lineshape  
% as described by Kubo and Anderson. 
% 
% Note: expm used for Matrix Exponential, requires square matrix! 
% This function can only be called from within m2121! 
% 
   
DEBUG=0; 
DEBUG1=0; 
  
global LSPAR 
global P 
if ndims(LSPAR)==2 
  LSPAR0 = LSPAR; 
  clear LSPAR 
  LSPAR  = LSPAR_conv(LSPAR0); 
end 
  
DISPLAY_PAR=1; 
VERBOSE=0; 
  
if isfield(LSPAR,'C') 
  C=LSPAR(1).C; 
else 
  C=1; 
end 
  
starttime = clock; 
LW = LW(:);   % jetzt Spaltenvektor 
p_a = p_a(:)'; 
p_b = p_b(:)'; 
%p_c = p_c(:)'; 
p_c = 1 - p_a - p_b; 
  
% Remove zero populations 
p_a_zero = find(p_a==0); 
if (length(p_a_zero) > 0) 
  p_a(p_a_zero) = 1e-6; 
end 
p_b_zero = find(p_b==0); 
if (length(p_b_zero) > 0) 
  p_b(p_b_zero) = 1e-6; 
end 
p_c_zero = find(p_c==0); 
if (length(p_c_zero) > 0) 
  p_c(p_c_zero) = 1e-6; 
end 
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if any(p_a<0) 
  p_a=p_a.^2; 
end 
if any(p_b<0) 
  p_b=p_b.^2; 
end 
if any(p_c<0) 
  p_c=p_c.^2; 
end 
  
if tau21<0 
  tau21=abs(tau21); 
end 
if tau32<0 
  tau32=abs(tau32); 
end 
tau12 = tau21 * p_a ./p_b    % Zeilenvektor 
tau23 = tau32 * p_b ./p_c    % Zeilenvektor 
  
if isfield(LSPAR(1),'Kex') 
  E(1) = LSPAR(1).Kex; 
end 
  
if exist('DISPLAY_PAR') & DISPLAY_PAR 
  disp('##################################')   
  p_a 
  p_b 
  p_c 
  p_a+p_b+p_c 
  p_c./p_b 
  tau21 
  tau32 
  disp('##################################')   
  %  keyboard 
end  
  
TD = points; 
T2 = 1 ./ (pi*LW);  % Callaghan p. 195 
R2 = diag(1./T2); 
DW = 1/(SWH); 
AQ = DW * TD; 
t = linspace(0,AQ,TD); 
const1 = 2*pi*i; 
%E = [1,1,1]; 
%w = w - SWH/TD;        % start at zero, not 1 
W = diag(W); 
  
if isfield(LSPAR(1),'Kex')  
  if LSPAR(1).Kex~=0 & ~isempty(LSPAR(1).Kex) 
    E=[LSPAR(1).Kex,1,1]; 
  end 
elseif isfield(LSPAR(1),'E') 
  E=LSPAR(1).E; 
  if length(E)~=3 
    error('Wrong parameter E, must have length 3.'); 
  end 
else 
  E = [1,1,1];     
end 
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TD_wo_zf = floor(TD/zf);        % TD without additional zf in 
                                        % K = p_c/p_b                    
for m = 1:length(p_a) 
  %  K = [1/tau12(m), -1/tau21,     0 
  %      -1/tau12(m),  1/tau21+1/tau, -1/tau         
  %       0,       -1/tau,      1/tau ]; 
  
  %  K = [1/tau12(m), -1/tau21,     0 
  %      -1/tau12(m),  1/tau21+1/tau, -1/tau         
  %       0,       -1/tau,      1/tau ]; 
  
  K = [1/tau12(m), -1/tau21,        0 
       -1/tau12(m),  1/tau21+1/tau23(m), -1/tau32        
       0,      -1/tau23(m),     1/tau32 ]; 
  
  KW = (-K + const1*W - R2); 
  P = [p_a(m), p_b(m), p_c(m)]'; 
  
  for n = 1 : TD_wo_zf                  % consider zerofilling of orig data 
    F_t(n,m) = E * (expm(KW * t(n)) * P);   % FIDs in Spalten 
                                            % F_t(TD_wo_zf,m) = 0; 
                                            % fill up to TD_wo_zf 
  end 
end 
WDWF = wdwf(:) * ones(1,length(p_a)); 
F_t_wdwf =  F_t .* WDWF;        % wdwf applied 
  
% keyboard 
  
% 1st point 1/2 removes offset from spc 
F_t_wdwf(1,:) = F_t_wdwf(1,:)/2; 
F_w = real(fft(F_t_wdwf,TD));       % no fft_shift here 
                                        % 2nd arg. TD ==> zerofilling ! 
  
SCALEMIN=0;             % not a good idea 
if(SCALEMIN) 
  MIN = min(min(F_w)); 
  F_w = F_w - MIN; 
end 
MAX = max(max(F_w)); 
F_w = C*F_w/MAX; 
  
% scale with second dimension 
scale = diag(scale); 
F_w = F_w * scale; 
  
%disp('Total execution time og ftex312 w/o plot):'); 
%curtime=(clock); 
%time = curtime(6) - starttime(6) 
  
%if ndims(LSPAR)==2 
%  clear LSPAR 
%  LSPAR = LSPAR0; 
%end 
  
return
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% ==================================================================== 
% MKLSPAR - Make LSPAR structure from parameter lineshape input file  
% (specified by filename).    
% ==================================================================== 
 
function LSPAR=mklspar2(filename) 
% 
%  
  
disp(['Reading parameters from file ' filename '.']) 
eval(filename); 
  
% Required fields in setup file 
if ~exist('TITLE') 
  disp('TITLE missing in lineshape setup file.') 
  TITLE=[]; 
end 
  
if ~exist('USE_DATA') 
  disp('USE_DATA missing in lineshape setup file.') 
  USE_DATA=0; 
end 
  
if USE_DATA==0 
  if ~exist('MX1siz') 
    disp('MX_1siz missing in lineshape setup file.') 
  end 
  if ~exist('MX2siz') 
    disp('MX2siz missing in lineshape setup file.') 
  end 
  if ~exist('NO_SPCS') 
    disp('NO_SPCS missing in lineshape setup file.') 
  end 
end 
  
if ~exist('filename') 
  disp('filename missing in lineshape setup file.') 
end 
if ~exist('INVERT') 
  disp('INVERT missing in lineshape setup file.') 
end 
if ~exist('MECH') 
  disp('MECH missing in lineshape  setup file.') 
end 
if ~exist('SWH') 
  disp('SWH missing in lineshape setup file.') 
end 
if ~exist('TD') 
  disp('TD missing in lineshape setup file.') 
end 
if ~exist('Hzppt') 
  disp('Hzppt missing in lineshape setup file.') 
end 
if ~exist('LW') 
  disp('LW missing in lineshape setup file.') 
end 
if ~exist('midmax') 
  disp('midmax missing in lineshape setup file.') 
end 
if ~exist('w') 
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  disp('w (omega) missing in lineshape setup file.') 
end 
if ~exist('zf') 
  disp('zf missing in lineshape setup file.') 
end 
if ~exist('zf0') 
  disp('zf0 missing in lineshape setup file.') 
end 
if ~exist('p_a_0') 
  disp('p_a_0 missing in lineshape setup file.') 
end 
if ~exist('p_b_0') 
  disp('p_b_0 missing in lineshape setup file.') 
end 
if ~exist('p_c_0') 
  disp('p_c_0 missing in lineshape setup file.') 
end 
if ~exist('p_d_0') 
  disp('p_d_0 missing in lineshape setup file.') 
end 
if ~exist('wdwf') 
  disp('wdwf missing in lineshape setup file.') 
end 
  
  
if ~exist('DIM') 
  disp('DIM missing in lineshape  setup file.') 
  DIM=1; 
end 
if ~exist('filename_2') 
  disp('filename_2 missing in lineshape setup file.') 
end 
  
if DIM==2 
  if ~exist('MECH_2') 
    disp('MECH_2 missing in lineshape  setup file.') 
  end 
  if ~exist('INVERT_2') 
    disp('INVERT_2 missing in lineshape  setup file.') 
  end 
  if ~exist('SWH_2') 
    disp('SWH_2 missing in lineshape  setup file.') 
  end 
  if ~exist('TD_2') 
    disp('TD_2 missing in lineshape  setup file.') 
  end 
  if ~exist('Hzppt_2') 
    disp('Hzppt_2 missing in lineshape  setup file.') 
  end 
  if ~exist('LW_2') 
    disp('LW_2 missing in lineshape  setup file.') 
  end 
  if ~exist('midmax_2') 
    disp('midmax_2 missing in lineshape  setup file.') 
  end 
  if ~exist('w_2') 
    disp('w_2 missing in lineshape  setup file.') 
  end 
  if ~exist('zf0_2') 
    disp(' missing in lineshape  setup file.') 
  end 
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  if ~exist('p_a_0_2') 
    disp('p_a_0_2 missing in lineshape  setup file.') 
  end 
  if ~exist('p_b_0_2') 
    disp('p_b_0_2 missing in lineshape  setup file.') 
  end 
  if ~exist('p_c_0_2') 
    disp('p_c_0_2 missing in lineshape  setup file.') 
  end 
  if ~exist('p_d_0_2') 
    disp('p_d_0_2 missing in lineshape  setup file.') 
  end 
  if ~exist('wdwf_2') 
    disp('wdwf_2 missing in lineshape  setup file.') 
  end 
  if exist('FIT') & FIT==1 
    if ~exist('FITDIM')  
      FITDIM=[1,1];  
    end 
  end 
end 
  
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
% DON't TOUCH ANYTHING AFTER THIS POINT % 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
  
LSPAR(1).TITLE      =  TITLE; 
  
LSPAR(1).USE_DATA   =  USE_DATA; 
if USE_DATA==0 
  LSPAR(1).MXsiz  = MX1siz; 
  LSPAR(2).MXsiz  = MX2siz; 
  
  LSPAR(1).NO_SPCS   = NO_SPCS; 
  LSPAR(2).NO_SPCS   = NO_SPCS; 
end 
  
LSPAR(1).realdim    = 1; 
LSPAR(1).filename   =  filename;; 
LSPAR(1).INVERT     =  INVERT; 
LSPAR(1).MECH       =  MECH; 
LSPAR(1).SWH        =  SWH; 
LSPAR(1).TD         =  TD; 
LSPAR(1).Hzppt      =  Hzppt; 
LSPAR(1).LW         =  LW;  
LSPAR(1).midmax     =  midmax; 
LSPAR(1).w          =  w; 
LSPAR(1).zf         =  zf; 
LSPAR(1).zf0        =  zf0; 
LSPAR(1).taus_0     =  taus_0; 
LSPAR(1).p_a_0      =  p_a_0;  
LSPAR(1).p_b_0      =  p_b_0; 
LSPAR(1).p_c_0      =  p_c_0; 
LSPAR(1).p_d_0      =  p_d_0; 
LSPAR(1).wdwf       =  wdwf; 
LSPAR(1).DIM        =  DIM; 
LSPAR(2).DIM        =  DIM; 
LSPAR(1).FIT        =  FIT; 
LSPAR(1).FITDIM     =  FITDIM; 
%LSPAR.NO_SPCS    =  NO_SPCS; 
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% DIM 2 
LSPAR(1).realdim    =  2; 
LSPAR(2).filename   =  filename_2; 
LSPAR(2).INVERT     =  INVERT_2; 
LSPAR(2).MECH       =  MECH_2; 
LSPAR(2).SWH        =  SWH_2;   
LSPAR(2).TD         =  TD_2;   
LSPAR(2).Hzppt      =  Hzppt_2; 
LSPAR(2).LW         =  LW_2; 
LSPAR(2).midmax     =  midmax_2; 
LSPAR(2).w          =  w_2; 
LSPAR(2).zf0        =  zf0_2; 
LSPAR(2).zf         =  zf_2; 
if exist('taus_0_2') 
  LSPAR(2).taus_0   =  taus_0_2; 
else 
  LSPAR(2).taus_0   =  taus_0; 
end 
LSPAR(2).p_a_0      =  p_a_0_2; 
LSPAR(2).p_b_0      =  p_b_0_2; 
LSPAR(2).p_c_0      =  p_c_0_2; 
LSPAR(2).wdwf       =  wdwf_2; 
  
if FIT  
  LSPAR(1).OPTIONS    =  OPTIONS; 
  LSPAR(2).OPTIONS    =  OPTIONS; 
end 
  
% Control parameters 
LSPAR(1).PRINT      =  PRINT; 
LSPAR(2).PRINT      =  PRINT; 
LSPAR(1).PLOT       =  PLOT; 
LSPAR(2).PLOT       =  PLOT_2; 
  
% OPTIONAL PARAMETERS 
if exist('Kex') 
  LSPAR(1).Kex=Kex; 
end 
if exist('Kex_2') 
  LSPAR(2).Kex = Kex_2; 
end 
if exist('K') 
  LSPAR(1).K=K; 
end 
if exist('K_2') 
  LSPAR(2).K=K; 
end 
if exist('E') 
  LSPAR(1).E=E; 
end 
if exist('E_2') 
  LSPAR(2).E=E; 
end 
if exist('p_L') 
  LSPAR(1).p_L=p_L; 
end 
if exist('P0') 
  LSPAR(1).P0=P0; 
end 
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if exist('DIM2MODE') 
  LSPAR(1).DIM2MODE=DIM2MODE; 
  LSPAR(2).DIM2MODE=DIM2MODE; 
end 
  
return 
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% ==================================================================== 
%                      Test file for NMRKIN 
% ==================================================================== 
% example of lineshape parameters file 
  
global HANDLES 
  
USE_DATA=1; 
% IF USE_DATA is 0 you must specify MX1_siz and MX2_siz 
% To plot dim 2 data a filename must be specified and DIM must be 2 
F=4; 
% MX1siz=40*F; 
% MX2siz=40*F; 
NO_SPCS=13; 
  
TITLE      = 'T91C L21 dim2 using m2121'; 
filename   = 'MATLAB/nmrkin_cl/Junesim/NMRLAB_DATA_11_L21_d2.mat';  % path and 
name of data file  
INVERT     = 0; 
MECH       = 'm2121_2D'; 
SWH        = 2000; 
TD         = 1024;                  % TD at which wswf was applied 
Hzppt      = SWH/TD/F; 
REF        = [];                % copy from PROC 
LW         = [11 11 11]; 
midmax     = [6];               % no of row/col of intermediate max 
w          = [51 90 115];           % Pos of maxima in points 
                        % leave empty for mouse selection 
zf         = 1;                 % zeroffilling factor 
zf0        = 1;                                                 
                         
Kex        = 1.;            % account for external exchange 
taus_0     = [1/40 1/20];           % all taus 
  
p_a_0      = [0.99  0.94  0.88  0.77  0.40  0.35  0.24  0.12  0.03  0.008  0.003  
0.001  0.0001]; 
  
p_b_0      = [0.00  0.03  0.09  0.15  0.30  0.32  0.26  0.25  0.16  0.04   0.010  
0.0001  0.0001]; 
%p_c_0      = [-0.0100 0.1000 0.2000 0.3000 0.3000 0.3000 0.5750 0.71000 0.8680 
0.9630 0.9820 0.9990 1.0000]; 
p_c_0      = 1-p_a_0-p_b_0; 
  
%p_b_0      = [0.001  0.11  0.21  0.31  0.45  0.60  0.70  0.79 0.9 0.999]; 
%p_c_0      = [0.000  0.00   0.000  0.000  0.000  0.000 0.000 0.000 0.000]; 
p_d_0      = [0 0 0 0 0 0 0 0 0 0 0 0 0]; 
  
wdwf_2     = {'gm',-5,0.2,3255};        % window function type and pars 
%gb         = 0.1;       
%lb         = -5; 
  
% ==================================================================== 
%                   Parameters for 2nd dimension 
% ==================================================================== 
DIM        = 2;                 % expect 2D data  
TITLE      = 'T91C L21 dim1 using m2121'; 
filename_2 = 'MATLAB/nmrkin_cl/Junesim/NMRLAB_DATA_11_L21_d1.mat';  %  
INVERT_2   = 1;                 % wird im Moment nicht gebraucht 
MECH_2     = 'm2121_2D'; 
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SWH_2      = 6510; 
TD_2       = 2048; 
Hzppt_2    = SWH_2/TD_2/F; 
LW_2       = [21 21 20]; 
midmax_2   = [6]; 
w_2        = [82 110 173];              % leave empty for mouse selection 
zf0_2      = 1; 
zf_2       = 1;         
taus_0_2   = taus_0; 
p_a_0_2    = p_a_0; 
p_b_0_2    = p_b_0;  
p_c_0_2    = 1-p_a_0_2-p_b_0_2; 
%p_c_0_2    = p_c_0;        
%p_d_0_2    = p_d_0;        
wdwf       = {'gm',-3,0.15,1600}; 
  
  
% ==================================================================== 
%                   General control options 
% ==================================================================== 
PRINT      = 1; 
PLOT       = 1; 
PLOT_2     = 0; 
  
% ==================================================================== 
%                   fminu / fmins options 
% ==================================================================== 
FIT        = 0;  
FITDIM     = [1 0]; 
OPTIONS=optimset; 
OPTIONS=optimset(OPTIONS,'LevenbergMarquardt','off'); 
%   OPTIONS=optimset(OPTIONS,'LineSearch','cubicpoly'); 
OPTIONS=optimset(OPTIONS,'LineSearch','quadcubic'); 
OPTIONS=optimset(OPTIONS,'Diagnostics','on'); 
%OPTIONS=optimset(OPTIONS,'DiffMaxChange',1e-1);  % Default: 1e-1 
%OPTIONS=optimset(OPTIONS,'DiffMinChange',1e-6);  % Default: 1e-8 
%OPTIONS=optimset(OPTIONS,'Display','iter');  % 'off,','iter', default:'final' 
%OPTIONS=optimset(OPTIONS,'MaxFunEvals',1000); 
%OPTIONS=optimset(OPTIONS,'MaxIter',1000); 
%OPTIONS=optimset(OPTIONS,'TolCon',1e-3); 
%OPTIONS=optimset(OPTIONS,'TolFun',1e-4); 
%OPTIONS=optimset(OPTIONS,'TolX',1e-4); 
  
    
% ******************************************************************** 
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% ======================================================================= 
% master function for relaxation dispersion analysis of cL-BABP/S-S data 
% ======================================================================= 
 
function val = CPMGfull2f_fitfun(par,R2,tau_cp,B0,action) 
 
PLOT=1; 
EQN=1;  % 1: approx for many pulses,, 2: approx for slow exch 
  
noFIELDs = length(B0); 
B1 = B0(1); 
if noFIELDs==2 
  B2 = B0(2); 
end 
  
% par = real(par);   
dw  = abs(real(par(1))); 
kex = abs(real(par(2))); 
pb  = abs(par(3)); 
%pb  = 0.02; 
  
R2et1  = par(4); 
if noFIELDs==2 
  R2et2  = par(5); 
end 
tau_cp1 = tau_cp(1,:); 
  
data1 = R2(1,:); 
if noFIELDs==2 
  data2 = R2(2,:); 
end 
pa = 1 - pb; 
  
if EQN==1   % Millet, 2000, 122, 2867, intermediate-fast 
  % for R2a = R2b 
  %******** field 1 ************* 
  PSI1 = (pb * kex - pa * kex)^2 - dw^2 + 4*pa*pb*kex^2; 
  CHI1 = 2*dw * (pb * kex - pa * kex); 
  % bei Mulder "tau_cp * sqrt(2)", da tau_cp anders definiert ist - nicht 
  % fuer Varian Pulsprog 
  np1  = tau_cp1*sqrt(2) * ( PSI1 + (PSI1^2 + CHI1^2)^0.5)^0.5; 
  nm1  = tau_cp1*sqrt(2) * (-PSI1 + (PSI1^2 + CHI1^2)^0.5)^0.5; 
  Dp1  = 0.5 * ( 1 + (PSI1 + 2*dw^2)/((PSI1^2 + CHI1^2)^0.5) ); 
  Dm1  = 0.5 * (-1 + (PSI1 + 2*dw^2)/((PSI1^2 + CHI1^2)^0.5) ); 
  y1 = 0.5*( 2*R2et1 + kex - 1./(2*tau_cp1) .* acosh(Dp1 * cosh(np1) - Dm1 * 
cos(nm1))); 
   
  if noFIELDs==2    
    tau_cp2 = tau_cp(2,:); 
    %******** field 2 *************  
    dw2  = dw*(B2/B1); 
    PSI2 = (pb * kex - pa * kex)^2 - dw2^2 + 4*pa*pb*kex^2; 
    CHI2 = 2*dw2 * (pb * kex - pa * kex); 
    % bei Mulder "tau_cp * sqrt(2)", da tau_cp anders definiert ist 
    % not any more tau_cp/sqrt(2) 
    np2  = tau_cp2*sqrt(2) * ( PSI2 + (PSI2^2 + CHI2^2)^0.5)^0.5; 
    nm2  = tau_cp2*sqrt(2) * (-PSI2 + (PSI2^2 + CHI2^2)^0.5)^0.5; 
    Dp2  = 0.5 * ( 1 + (PSI2 + 2*dw2^2)/((PSI2^2 + CHI2^2)^0.5) ); 
    Dm2  = 0.5 * (-1 + (PSI2 + 2*dw2^2)/((PSI2^2 + CHI2^2)^0.5) ); 
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    y2 = 0.5*( 2*R2et2 + kex - 1./(2*tau_cp2) .* acosh(Dp2 * cosh(np2) - Dm2 * 
cos(nm2))); 
  end 
elseif EQN==2    % Tollinger JACS 2001, 123, 11341 for slow exchange 
  tau_cp1 = tau_cp(1,:); 
  y1 = R2et1 + pa*kex - pa*kex*sin(dw*tau_cp1)./(dw*tau_cp1);  
  if noFIELDs==2 
    tau_cp2 = tau_cp(2,:); 
    dw2  = dw*(B2/B1); 
    y2 = R2et1 + pa*kex - pa*kex*sin(dw2*tau_cp2)./(dw2*tau_cp2);  
  end 
else 
  error('EQN must be 1 or 2.') 
end 
  
if PLOT 
  clf 
  plot(1./(4*tau_cp1),data1,'b.') 
  hold on 
  plot(1./(4*tau_cp1),y1,'b-') 
  if noFIELDs==2 
    plot(1./(4*tau_cp2),data2,'r.') 
    hold on 
    plot(1./(4*tau_cp2),y2,'r-') 
    hold off 
    drawnow 
  else 
    hold off 
    drawnow 
  end 
end 
  
if action==0 
  chi2_1 = sum((data1-y1).^2); 
  if noFIELDs==2 
    chi2_2 = sum((data2-y2).^2); 
    chi2_gesamt = chi2_1 + chi2_2; 
  else 
    chi2_gesamt = chi2_1; 
  end 
  val=chi2_gesamt; 
  
elseif action==1 
  val(1,:)=y1; 
  if noFIELDs==2 
    val(2,:)=y2; 
  end 
end 
  
return 
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